{"messages":[{"status":"ok","interval":"2024-08-01:2024-08-31","cursor":0,"count":100,"total":"345"}], "collection":[{"preprint_doi":"10.1101\/2024.02.27.24303143","published_doi":"10.1136\/jnnp-2024-333978","published_journal":"Journal of Neurology, Neurosurgery & Psychiatry","preprint_platform":"medRxiv","preprint_title":"Metal mixtures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control study","preprint_authors":"Jang, D. G.; Dou, J.; Koubek, E. J.; Teener, S.; Zhou, L.; Bakulski, K. M.; Mukherjee, B.; Batterman, S.; Feldman, E. L.; Goutman, S. A.","preprint_category":"neurology","preprint_date":"2024-02-28","published_date":"2024-08-06","preprint_abstract":"BackgroundThe pathogenesis of amyotrophic lateral sclerosis (ALS) involves both genetic and environmental factors. This study investigates associations between metal measures in plasma and urine, ALS risk and survival, and exposure sources.\n\nMethodsParticipants with and without ALS from Michigan provided plasma and urine samples for metal measurement via inductively coupled plasma mass spectrometry. Odds and hazard ratios for each metal were computed using risk and survival models. Environmental risk scores (ERS) were created to evaluate the association between exposure mixtures and ALS risk and survival and exposure source. ALS (ALS-PGS) and metal (metal-PGS) polygenic risk scores were constructed from an independent genome-wide association study and relevant literature-selected SNPs.\n\nResultsPlasma and urine samples from 454 ALS and 294 control participants were analyzed. Elevated levels of individual metals, including copper, selenium, and zinc, significantly associated with ALS risk and survival. ERS representing metal mixtures strongly associated with ALS risk (plasma, OR=2.95, CI=2.38-3.62, p<0.001; urine, OR=3.10, CI=2.43-3.97, p<0.001) and poorer ALS survival (plasma, HR=1.42, CI=1.24-1.63, p<0.001; urine, HR=1.52, CI=1.31-1.76, p<0.001). Addition of the ALS-PGS or metal-PGS did not alter the significance of metals with ALS risk and survival. Occupations with high potential of metal exposure associated with elevated ERS. Additionally, occupational and non-occupational metal exposures associated with measured plasma and urine metals.\n\nConclusionMetals in plasma and urine associated with increased ALS risk and reduced survival, independent of genetic risk, and correlated with occupational and non-occupational metal exposures. These data underscore the significance of metal exposure in ALS risk and progression.","preprint_author_corresponding":"Stephen A Goutman","preprint_author_corresponding_institution":"University of Michigan"},{"preprint_doi":"10.1101\/2023.10.11.23296741","published_doi":"10.1038\/s41467-024-50159-6","published_journal":"Nature Communications","preprint_platform":"medRxiv","preprint_title":"Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature","preprint_authors":"LaFlamme, C. W.; Rastin, C.; Sengupta, S.; Pennington, H. E.; Russ-Hall, S. J.; Schneider, A. L.; Bonkowski, E. S.; Almanza Fuerte, E. P.; Galey, M.; Goffena, J.; Gibson, S. B.; Allan, T. J.; Nyaga, D. M.; Lieffering, N.; Hebbar, M.; Walker, E. V.; Darnell, D.; Olsen, S. R.; Kolekar, P.; Djekidel, M. N.; Rosikiewicz, W.; McConkey, H.; Kerkhof, J.; Levy, M. A.; Relator, R.; Lev, D.; Lerman-Sagie, T.; Park, K. L.; Alders, M.; Cappuccio, G.; Chatron, N.; Demain, L.; Genevieve, D.; Lesca, G.; Roscioli, T.; Sanlaville, D.; Tedder, M. L.; Weisz-Hubshman, M.; Ketkar, S.; Dai, H.; Carlyle Worley, K.; ","preprint_category":"genetic and genomic medicine","preprint_date":"2023-10-13","published_date":"2024-08-06","preprint_abstract":"Sequence-based genetic testing currently identifies causative genetic variants in [~]50% of individuals with developmental and epileptic encephalopathies (DEEs). Aberrant changes in DNA methylation are implicated in various neurodevelopmental disorders but remain unstudied in DEEs. Rare epigenetic variations (\"epivariants\") can drive disease by modulating gene expression at single loci, whereas genome-wide DNA methylation changes can result in distinct \"episignature\" biomarkers for monogenic disorders in a growing number of rare diseases. Here, we interrogate the diagnostic utility of genome-wide DNA methylation array analysis on peripheral blood samples from 516 individuals with genetically unsolved DEEs who had previously undergone extensive genetic testing. We identified rare differentially methylated regions (DMRs) and explanatory episignatures to discover causative and candidate genetic etiologies in 10 individuals. We then used long-read sequencing to identify DNA variants underlying rare DMRs, including one balanced translocation, three CG-rich repeat expansions, and two copy number variants. We also identify pathogenic sequence variants associated with episignatures; some had been missed by previous exome sequencing. Although most DEE genes lack known episignatures, the increase in diagnostic yield for DNA methylation analysis in DEEs is comparable to the added yield of genome sequencing. Finally, we refine an episignature for CHD2 using an 850K methylation array which was further refined at higher CpG resolution using bisulfite sequencing to investigate potential insights into CHD2 pathophysiology. Our study demonstrates the diagnostic yield of genome-wide DNA methylation analysis to identify causal and candidate genetic causes as [~]2% (10\/516) for unsolved DEE cases.","preprint_author_corresponding":"Heather C Mefford","preprint_author_corresponding_institution":"1. Center for Pediatric Neurological Disease Research, St. Jude Children\\'s Research Hospital, Memphis, TN 38105, USA"},{"preprint_doi":"10.1101\/2024.04.08.24305530","published_doi":"10.1002\/alz.14169","published_journal":"Alzheimer's & Dementia","preprint_platform":"medRxiv","preprint_title":"Association of caffeine consumption with memory deficits and cerebrospinal fluid biomarkers in Mild Cognitive Impairment and Alzheimer's Disease: a BALTAZAR cohort study","preprint_authors":"Blum, D.; Cailliau, E.; Behal, H.; Vidal, J.-S.; Delaby, C.; Buee, L.; Allinquant, B.; Gabelle, A.; Bombois, S.; Lehmann, S.; Schraen-Maschke, S.; Hanon, O.; BALTAZAR study group,  ","preprint_category":"neurology","preprint_date":"2024-04-10","published_date":"2024-08-04","preprint_abstract":"STRUCTURED ABSTRACT INTRODUCTIONWe investigated the link between habitual caffeine intake with memory deficits and CSF AD biomarkers in Mild cognitive impairment (MCI) and Alzheimers Disease (AD) patients.\n\nMETHODSMCI (N=147) and AD (N=116) patients of the BALTAZAR longitudinal cohort reported their caffeine intake using a dedicated survey and were followed-up for 3 years. Associations of caffeine consumption with cognition, MMSE decline and CSF biomarkers (Tau, pTau181, A{beta}1-42, A{beta}1-40) were analyzed using logistic and ANCOVA models.\n\nRESULTSAdjusted on APOE{varepsilon}4, age, sex, education level and tobacco, lower caffeine consumption was associated with higher risk to be amnestic (OR: 2.49 [95%CI: 1.13 to 5.46]; p=0.023) and lower CSF A{beta}1-42 (p=0.047), A{beta}1-42\/ A{beta}1-40 (p=0.040) and A{beta}1-42\/pTau (p=0.020) in the whole cohort and a faster MMSE decline in amnestic MCI (p=0.024).\n\nDISCUSSIONData supports the beneficial effect of caffeine consumption to memory decline and CSF amyloid markers in MCI and AD patients.","preprint_author_corresponding":"David Blum","preprint_author_corresponding_institution":"Inserm"},{"preprint_doi":"10.1101\/2024.06.01.24307927","published_doi":"10.3389\/fneur.2024.1443496","published_journal":"Frontiers in Neurology","preprint_platform":"medRxiv","preprint_title":"Longitudinal Assessment of Glymphatic Changes Following Mild Traumatic Brain Injury: Insights from PVS burden and DTI-ALPS Imaging","preprint_authors":"Zhuo, J.; Raghavan, P.; Jiang, L.; Roys, S.; Njonkou Tchoquessi, R. L.; Chen, H.; Wickwire, E. M.; Parika, G. Y.; Schwartzbauer, G. T.; Grattan, L. M.; Wang, Z.; Gullapalli, R. P.; Badjatia, B.","preprint_category":"radiology and imaging","preprint_date":"2024-06-02","published_date":"2024-08-07","preprint_abstract":"AbstractsTraumatic brain injury (TBI) even in the mild form may result in long-lasting post- concussion symptoms. TBI is also a known risk to late-life neurodegeneration. Recent studies suggest that dysfunction in the glymphatic system, responsible for clearing protein waste from the brain, may play a pivotal role in the development of dementia following TBI. Given the diverse nature of TBI, longitudinal investigations are essential to comprehending the dynamic changes in the glymphatic system and its implications for recovery. In this prospective study, we evaluated two promising glymphatic imaging markers, namely the enlarged perivascular space (ePVS) burden and Diffusion Tensor Imaging-based ALPS index, in 44 patients with mTBI at two early post-injury time points: approximately 14 days (14Day) and 6-12 months (6-12Mon) post-injury, while also examining their associations with post-concussion symptoms. Additionally, 37 controls, comprising both orthopedic patients and healthy individuals, were included for comparative analysis. Our key findings include: 1) White matter ePVS burden (WM- ePVS) and ALPS index exhibit significant correlations with age. 2) Elevated WM-ePVS burden in acute mTBI (14Day) is significantly linked to a higher number of post- concussion symptoms, particularly memory problems. 3) The increase in the ALPS index from acute (14Day) to the chronic (6-12Mon) phases in mTBI patients correlates with improvement in sleep measures. Furthermore, incorporating WM-ePVS burden and the ALPS index from acute phase enhances the prediction of chronic memory problems beyond socio-demographic and basic clinical information, highlighting their distinct roles in assessing glymphatic structure and activity. Early evaluation of glymphatic function could be crucial for understanding TBI recovery and developing targeted interventions to improve patient outcomes.","preprint_author_corresponding":"Jiachen Zhuo","preprint_author_corresponding_institution":"University of Maryland School of Medicine"},{"preprint_doi":"10.1101\/2024.01.05.24300886","published_doi":"10.1002\/acr.25409","published_journal":"Arthritis Care & Research","preprint_platform":"medRxiv","preprint_title":"Effect of shared decision-making on trust in physicians in the management of systemic lupus erythematosus: The TRUMP2-SLE prospective cohort study","preprint_authors":"Yoshimi, R.; Yajima, N.; Hidekawa, C.; Sakurai, N.; Oguro, N.; Shidahara, K.; Hayashi, K.; Ichikawa, T.; Kishida, D.; Miyawaki, Y.; Sada, K.-e.; Shimojima, Y.; Ishikawa, Y.; Yoshioka, Y.; Kunishita, Y.; Kishimoto, D.; Takase-Minegishi, K.; Kirino, Y.; Ohno, S.; Kurita, N.; Nakajima, H.","preprint_category":"rheumatology","preprint_date":"2024-01-07","published_date":"2024-08-04","preprint_abstract":"ObjectivesFew studies have explored whether the involvement of patients in shared decision-making (SDM) is beneficial to the management of systemic lupus erythematosus (SLE). Therefore, this study investigated the relationship between patient participation in SDM and their trust in physicians using data from the TRUMP2-SLE study.\n\nMethodsData regarding the nine-item Shared Decision-Making Questionnaire (SDM-Q-9 scores), Trust in Physician Scale (TIPS) scores, and Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) scores for interpersonal trust in a physician and trust in the medical profession were collected from patients with SLE who visited the outpatient clinics of five facilities in Japan through a self-administered questionnaire. The relationships between these scores were analyzed.\n\nResultsThis study included 433 patients with SLE. The median baseline TIPS and A-WFPTS (attending physician version) scores were 82 (73-93) and 80 (70-95), respectively. A higher baseline SDM-Q-9 score was correlated with an increase in the TIPS score at 1 year (adjusted mean difference per 10-pt increase, 0.95 pt [95%CI 0.18-1.71]). A higher baseline SDM-Q-9 score was also correlated with a higher A-WFPTS score for interpersonal trust (adjusted mean difference per 10-pt increase, 2.16 pt [1.41-2.92]). The baseline A-WFPTS (general physician version) score of 65 (50-80) was also correlated with an increase in the A-WFPTS score at 1 year (adjusted mean difference per 10-pt increase, 1.28 pt [0.43-2.14]).\n\nConclusionsEngagement of patients with SLE in SDM elevates their trust in the attending physicians and healthcare providers, potentially enhancing doctor-patient relationships and overall healthcare trust.\n\nKEY MESSAGES What is already known about this subject?[tpltrtarr] The importance of the involvement of patients in shared decision-making (SDM) in the management of systemic lupus erythematosus (SLE) has been emphasized as one of the principles in the EULAR recommendation.\n\n\nWhat does this study add?[tpltrtarr] The baseline SDM-Q-9 scores were correlated with the Trust in Physician Scale (TIPS) and the attending physician version of the Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) scores at 1 year.\n[tpltrtarr]The baseline SDM-Q-9 scores at baseline were correlated with the general physician version of the A-WFPTS score at 1 year.\n[tpltrtarr]These results indicate that the involvement of patients with SLE in SDM increases their trust in the attending physicians and physicians in general.\n\n\nHow might this impact on clinical practice or future developments?[tpltrtarr] This study demonstrated the importance of SDM in maintaining long-term physician-patient relationship during the management of SLE.\n[tpltrtarr]Involvement of patients with SLE in SDM may improve the doctor-patient relationship and trust in healthcare.","preprint_author_corresponding":"Ryusuke Yoshimi","preprint_author_corresponding_institution":"Yokohama City University Graduate School of Medicine"},{"preprint_doi":"10.1101\/2024.03.14.24304306","published_doi":"10.1186\/s12943-024-02060-5","published_journal":"Molecular Cancer","preprint_platform":"medRxiv","preprint_title":"Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer","preprint_authors":"Dogra, P.; Shinglot, V.; Ramirez, J. R.; Cave, J.; Butner, J. D.; Schiavone, C.; Duda, D. G.; Kaseb, A. O.; Chung, C.; Koay, E. J.; Cristini, V.; Ozpolat, B.; Calin, G. A.; Wang, Z.","preprint_category":"oncology","preprint_date":"2024-03-15","published_date":"2024-08-02","preprint_abstract":"Elevated microRNA-155 (miR-155) expression in non-small-cell lung cancer (NSCLC) promotes cisplatin resistance and negatively impacts treatment outcomes. However, miR-155 can also boost anti-tumor immunity by suppressing PD-L1 expression. We developed a multiscale mechanistic model, calibrated with in vivo data and then extrapolated to humans, to investigate the therapeutic effects of nanoparticle-delivered anti-miR-155 in NSCLC, alone or in combination with standard-of-care drugs. Model simulations and analyses of the clinical scenario revealed that monotherapy with anti-miR-155 at a dose of 2.5 mg\/kg administered once every three weeks has substantial anti-cancer activity. It led to a median progression-free survival (PFS) of 6.7 months, which compared favorably to cisplatin and immune checkpoint inhibitors. Further, we explored the combinations of anti-miR-155 with standard-of-care drugs, and found strongly synergistic two- and three-drug combinations. A three-drug combination of anti-miR-155, cisplatin, and pembrolizumab resulted in a median PFS of 13.1 months, while a two-drug combination of anti-miR-155 and cisplatin resulted in a median PFS of 11.3 months, which emerged as a more practical option due to its simple design and cost-effectiveness. Our analyses also provided valuable insights into unfavorable dose ratios for drug combinations, highlighting the need for optimizing dose regimen to prevent antagonistic effects. Thus, this work bridges the gap between preclinical development and clinical translation of anti-miR-155 and unravels the potential of anti-miR-155 combination therapies in NSCLC.","preprint_author_corresponding":"Prashant Dogra","preprint_author_corresponding_institution":"Houston Methodist Research Institute"},{"preprint_doi":"10.1101\/2023.11.09.23298298","published_doi":"10.1002\/jsp2.1356","published_journal":"JOR SPINE","preprint_platform":"medRxiv","preprint_title":"The potential effect of romosozumab on perioperative management for instrumentation surgery","preprint_authors":"Ishikawa, K.; Tani, S.; Toyone, T.; Tsuchiya, K.; Towatari, T.; Oshita, Y.; Yamamura, R.; Nagai, T.; Shirahata, T.; Inagaki, K.; Kudo, Y.","preprint_category":"orthopedics","preprint_date":"2023-11-11","published_date":"2024-08-05","preprint_abstract":"BackgroundAge-related changes in bone health increase the risk for complications in elderly patients undergoing orthopedic surgery. Osteoporosis is a key therapeutic target that needs to be addressed to ensure successful instrumentation surgery. The effectiveness of pharmacological interventions in orthopedic surgery, particularly the new drug romosozumab, is still unknown. We aim to evaluate the effect of 3-month romosozumab treatment on biomechanical parameters related to spinal instrumentation surgery, using the Quantitative Computed Tomography (QCT)-based Finite Element Method (FEM).\n\nMethodsThis open-labeled, prospective study included 81 patients aged 60 to 90 years, who met the osteoporosis criteria and were scheduled for either romosozumab or eldecalcitol treatment. Patients were assessed using blood samples, dual-energy absorptiometry (DXA), and QCT. Biomechanical parameters were evaluated using FEM at baseline and 3 months post-treatment. The primary endpoints were biomechanical parameters at 3 months, while secondary endpoints included changes in regional volumetric bone mineral density around the pedicle (P-vBMD) and vertebral body (V-vBMD).\n\nResultsRomosozumab treatment led to significant gains in P-vBMD, and V-vBMD compared to eldecalcitol at 3 months. Notably, the romosozumab group showed greater improvements in all biomechanical parameters estimated by FEM at 3 months compared to the eldecalcitol group.\n\nConclusionRomosozumab significantly increased the regional vBMD as well as biomechanical parameters, potentially offering clinical benefits in reducing post-operative complications in patients with osteoporosis undergoing orthopedic instrumentation surgery. This study highlights the novel advantages of romosozumab treatment and advocates further research on its effectiveness in perioperative management.","preprint_author_corresponding":"Koji Ishikawa","preprint_author_corresponding_institution":"Department of Orthopaedic Surgery, School of Medicine, Showa University"},{"preprint_doi":"10.1101\/2023.10.15.23297013","published_doi":"10.7554\/elife.92826.3","published_journal":"eLife","preprint_platform":"medRxiv","preprint_title":"Hyperglycemia-induced cathepsin L maturation: Implications for diabetic comorbidities and COVID-19 susceptibility","preprint_authors":"He, Q.; Zhao, M.-M.; Li, M.-J.; Li, X.-Y.; Jin, J.-M.; Feng, Y.-M.; Zhang, L.; Huang, W. J.; Yang, F.; Yang, J.-K.","preprint_category":"endocrinology","preprint_date":"2023-10-15","published_date":"2024-08-16","preprint_abstract":"Diabetes, a prevalent chronic condition, significantly increases the risk of mortality from COVID-19, yet the underlying mechanisms remain elusive. Emerging evidence implicates Cathepsin L (CTSL) in diabetic complications, including nephropathy and retinopathy. Our previous research identified CTSL as a pivotal protease promoting SARS-CoV-2 infection. Here, we demonstrate elevated blood CTSL levels in individuals with diabetes, facilitating SARS-CoV-2 infection. Chronic hyperglycemia correlates positively with CTSL concentration and activity in diabetic patients, while acute hyperglycemia augments CTSL activity in healthy individuals. In vitro studies reveal high glucose, but not insulin, promotes SARS-CoV-2 infection in wild-type cells, with CTSL knockout cells displaying reduced susceptibility. Utilizing lung tissue samples from diabetic and non-diabetic patients, alongside db\/db diabetic and control mice, we illustrate increased CTSL activity in both humans and mice under diabetic conditions. Mechanistically, high glucose levels promote CTSL maturation and translocation from the endoplasmic reticulum to the lysosome via the ER-Golgi-lysosome axis. Our findings underscore the pivotal role of hyperglycemia-induced CTSL maturation in diabetic comorbidities and complications.","preprint_author_corresponding":"Jin-Kui Yang","preprint_author_corresponding_institution":"Capital Medical University"},{"preprint_doi":"10.1101\/2023.09.24.23295907","published_doi":"10.7554\/elife.93260.4","published_journal":"eLife","preprint_platform":"medRxiv","preprint_title":"Maternal smoking DNA methylation risk score associated with health outcomes in offspring of European and South Asian ancestry","preprint_authors":"Deng, W. Q.; Cawte, N.; Campbell, N.; Azab, S. M.; de Souza, R. J.; Lamri, A.; Morrison, K. M.; Atkinson, S. A.; Subbarao, P.; Turvey, S.; Moraes, T.; Teo, K. K.; Mandhane, P. J.; Azad, M.; Simons, E.; Pare, G.; Anand, S. S.","preprint_category":"genetic and genomic medicine","preprint_date":"2023-09-25","published_date":"2024-08-14","preprint_abstract":"Maternal smoking has been linked to adverse health outcomes in newborns but the extent to which it impacts newborn health has not been quantified through an aggregated cord blood DNA methylation (DNAm) score. Here we examine the feasibility of using cord blood DNAm scores leveraging large external studies as discovery samples to capture the epigenetic signature of maternal smoking and its influence on newborns in White European and South Asian populations. We first examined association between individual CpGs and cigarette smoking during pregnancy, smoking exposure in two White European birth cohorts (n = 744). Several previously reported genes for maternal smoking were supported, with the strongest and most consistent signal from the GFI1 gene (6 CpGs with p < 5x10-5). Leveraging established CpGs for maternal smoking, we constructed a cord blood epigenetic score of maternal smoking that was validated in one of the European-origin cohorts (n = 347). This score was then tested for association with smoking status, secondary smoking exposure during pregnancy, and health outcomes in offspring measured after birth in an independent white European (n = 397) and a South Asian birth cohort (n = 504). The epigenetic maternal smoking score was strongly associated with smoking status during pregnancy (OR=1.09 [1.07,1.10], p=5.5x10-33) and more hours of self-reported smoking exposure per week (1.93 [1.27, 2.58], p=7.8x10-9) in White Europeans, but not with self-reported exposure (p > 0.05) in South Asians. The same score was consistently associated with a smaller birth size (-0.37{+\/-}0.12 cm, p=0.0023) in the South Asian cohort and a lower birth weight (-0.043{+\/-}0.013kg, p=0.0011) in the combined cohorts. This cord blood epigenetic score can help identify babies exposed to maternal smoking and assess its long-term impact on growth. Notably, these results indicate a consistent association between the DNAm signature of maternal smoking and a small body size and low birthweight in newborns, in both white European mothers who exhibited some amount of smoking and in South Asian mothers who themselves were not active smokers.","preprint_author_corresponding":"Wei Q. Deng","preprint_author_corresponding_institution":"McMaster University"},{"preprint_doi":"10.1101\/2024.04.05.24305374","published_doi":"10.1080\/16549716.2024.2381878","published_journal":"Global Health Action","preprint_platform":"medRxiv","preprint_title":"Quality of care for chronic conditions: Identifying specificities of quality aims based on scoping review and Delphi survey","preprint_authors":"Ku, G. M. V.; Van De Put, W.; Katsuva, D.; Ag Ahmed, M. A.; Rosenberg, M.; Meessen, B.","preprint_category":"public and global health","preprint_date":"2024-04-09","published_date":"2024-08-16","preprint_abstract":"BackgroundThere is a need to implement good quality chronic care to address the ballooning burden of chronic conditions affecting all countries globally. However, to our knowledge, no systematic attempts have yet been made to define and specify aims for chronic care quality.\n\nObjectiveWe conducted a scoping review and Delphi survey to establish and validate a comprehensive specification of chronic care quality aims.\n\nMethodologyThe Institute of Medicines (IOM) quality of care definition and aims was utilised as our base. We purposively selected scientific and grey literature that have acknowledged and unpacked the plurality of quality in chronic care and which proposed\/made use of frameworks and studied their implementation or investigated minimum two IOM care quality aims and their implementation. We critically analysed the literature deductively and inductively. We validated our findings through Delphi survey involving international chronic care experts, mostly coming from\/have expertise on low-and-middle-income countries.\n\nResultsWe considered the natural history of chronic conditions and the journey of a person with chronic condition to define and identify aims of chronic care quality. We noted that the six IOM aims apply but with additional meanings. We identified a seventh aim, continuity, which relates well to the issue of chronicity. Our panellists agreed with the specifications. Several provided contextualised interpretations and concrete examples.\n\nConclusionsChronic conditions pose specific challenges underscoring the relevance of tailoring quality of care aims. Operationalization of this tailored definition and specified aims to improve, measure and assure quality of chronic care can be next steps.","preprint_author_corresponding":"Grace Marie V Ku","preprint_author_corresponding_institution":"Institute of Tropical Medicine"},{"preprint_doi":"10.1101\/2024.04.23.24306232","published_doi":"10.1002\/mus.28230","published_journal":"Muscle & Nerve","preprint_platform":"medRxiv","preprint_title":"Mitochondrial genome variants associated with Amyotrophic Lateral Sclerosis and their haplogroup distribution","preprint_authors":"Briones, M. R.; Campos, J. H.; Ferreira, R. C.; Schneper, L.; Santos, I. M.; Antoneli, F.; NYCG ALS Consortium,  ; Broach, J. R.","preprint_category":"genetic and genomic medicine","preprint_date":"2024-04-25","published_date":"2024-08-09","preprint_abstract":"Introduction\/AimsAmyotrophic lateral sclerosis (ALS) may be familial or sporadic, and twin studies have revealed that even sporadic forms have a significant genetic component. Variants in 55 nuclear genes have been associated with ALS and although mitochondrial disfunction is observed in ALS, variants in mitochondrial genomes (mitogenomes) have not yet been tested for association with ALS.\n\nMethodsHere we conducted a genome wide association study (GWAS) in mitogenomes of 1,965 ALS patients and 2,547 controls to test the hypothesis that mitogenome variants are associated with ALS.\n\nResultsWe identified 51 mitogenome variants with p-values <10-7of which 13 variants have odds ratios (OR)>1, in genes RNR1, ND1, CO1, CO3, ND5, ND6 and CYB, while 38 variants have OR<1 in genes RNR1, RNA2, ND1, ND2, CO2, ATP8, ATP6, CO3, ND3, ND4, ND5, ND6 and CYB. The frequencies of haplogroups H, U and L, the most frequent in our ALS dataset, are the same in different onset sites (bulbar, limb, spinal and axial). Also, intra-haplogroup GWAS revealed unique ALS-associated variants in haplogroups L and U.\n\nDiscussionOur study shows that mitogenome variants (SNVs) are associated with ALS and suggests that these SNVs could be included in routine genetic testing for ALS and that mitochondrial replacement therapy would have a potential basis for ALS treatment.","preprint_author_corresponding":"Marcelo RS Briones","preprint_author_corresponding_institution":"Federal University of Sao Paulo, Brazil"},{"preprint_doi":"10.1101\/2023.09.26.23296157","published_doi":"10.2196\/57162","published_journal":"JMIR Medical Informatics","preprint_platform":"medRxiv","preprint_title":"Assessment of Accuracy and Safety of LabTest Checker (LTC-AI)","preprint_authors":"Szumilas, D.; Ochmann, A.; Zieba, K.; Chudek, J.; Bartoszewicz, B.; Kubrak, A.; Makuch, S.; Agrawal, S.; Mazur, G.","preprint_category":"health informatics","preprint_date":"2023-09-26","published_date":"2024-08-14","preprint_abstract":"BackgroundIn recent years, the implementation of artificial intelligence (AI) in healthcare is progressively transforming medical fields, with Clinical Decision Support Systems (CDSS) as a notable application. Laboratory tests are vital for accurate diagnoses, but their increasing reliance presents challenges. The need for effective strategies for managing laboratory test interpretation is evident from the millions of monthly searches on test results significance. The potential role of CDSS in laboratory diagnostics gains significance, however, more research needs to explore this area.\n\nObjectiveThe primary objective of our study was to assess the accuracy and safety of LabTest Checker (LTC), a CDSS designed to support medical diagnoses by analyzing both laboratory test results and patients medical histories\n\nMethodsThis cohort study embraced a prospective data collection approach. A total of 101 patients were enrolled, aged 18 and above, in stable condition, requiring comprehensive diagnosis. A panel of blood laboratory tests was conducted for each participant. Participants utilized LabTest Checker for test result interpretation. Accuracy and safety of the tool were assessed by comparing AI-generated suggestions to experienced doctor (consultant) recommendations, considered the gold standard.\n\nResultsThe system achieved a 74.3% accuracy and 100% sensitivity for emergency safety and 92.3% sensitivity for urgent cases. It potentially reduced unnecessary medical visits by 41.6% and achieved an 82.9% accuracy in identifying underlying pathologies.\n\nConclusionThis study underscores the transformative potential of AI-based CDSS in laboratory diagnostics, contributing to enhanced patient care, efficient healthcare systems, and improved medical outcomes. LabTest Checkers performance evaluation highlights the advancements in AIs role in laboratory medicine.","preprint_author_corresponding":"Jerzy Chudek","preprint_author_corresponding_institution":"Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Reymonta St. 8, 40-027 Katowice, Poland"},{"preprint_doi":"10.1101\/2024.01.24.24301718","published_doi":"10.3389\/fpsyt.2024.1416803","published_journal":"Frontiers in Psychiatry","preprint_platform":"medRxiv","preprint_title":"An International, Cross-Sectional Survey of Psychiatry Researchers and Clinicians: Perceptions of Complementary, Alternative, and Integrative Medicine","preprint_authors":"Ng, J. Y.; Kochhar, J.; Cramer, H.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2024-01-24","published_date":"2024-08-14","preprint_abstract":"BackgroundPsychiatry is a branch of medicine that focuses on mental, behavioural and emotional well-being. Complementary, alternative, and integrative medicine has been an increasingly popular choice for patients with psychiatric disorders, therefore our study aimed to explore the perceptions of psychiatry researchers and clinicians on the use of CAIM.\n\nMethodsWe conducted an online, anonymous, cross-sectional survey for researchers and clinicians who have published their work in psychiatry medical journals that are indexed in MEDLINE. 42,667 researchers and clinicians were sent the link to the survey after extraction of their email addresses from their respective publications. Respondents were asked numerous multiple-choice questions regarding their perceptions on various CAIM therapies, followed by an open-ended question where they could include any additional thoughts.\n\nResultsThe survey was completed by 987 respondents, with a majority identifying as a researcher (n=447, 46.51%), or as both a researcher and a clinician (n=368, 38.29%) within the field of psychiatry. Most respondents (n=629, 78.04%) perceived mind-body therapies such as meditation, biofeedback, hypnosis, and yoga to be the most promising CAIM therapy for the prevention, treatment, and management of psychiatric diseases. Many participants said that they agree (n=285, 38.14%) that most CAIM therapies in general are safe, however, many disagree that CAIM therapies are effective (n=245, 32.93%). Respondents indicated that there is value to conducting research on CAIM therapies (n=356, 47.91%), and that there should be more funding allocated to researching these therapies (n=265, 35.71%). Respondents are also in agreement that clinicians should receive training on CAIM therapies through formal education (n=295, 39.76%) or supplementary education (n=380, 51.28%).\n\nConclusionsThe findings from this study showed that there is great interest and potential in researching CAIM within the field of psychiatry. This information can be used as a basis for further research and to develop tailored educational resources for researchers and clinicians in psychiatry.","preprint_author_corresponding":"Jeremy Y. Ng","preprint_author_corresponding_institution":"University Hospital Tubingen"},{"preprint_doi":"10.1101\/2024.03.06.24303865","published_doi":"10.1126\/sciadv.adp1657","published_journal":"Science Advances","preprint_platform":"medRxiv","preprint_title":"Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh","preprint_authors":"Perez Duque, M.; Mohd Naser, A.; K Paul, K.; Rahman, M.; Shafiul Alam, M.; Mohammad Al-Amin, H.; Ziaur Rahman, M.; Enayet Hossain, M.; C Paul, R.; P Luby, S.; Cauchemez, S.; Vanhomwegen, J.; S Gurley, E.; Salje, H.","preprint_category":"infectious diseases","preprint_date":"2024-03-08","published_date":"2024-08-09","preprint_abstract":"BackgroundJapanese encephalitis virus (JEV) is a major threat to human health. Bangladesh is considering introducing a JEV vaccine, however, the investment case is hampered by a poor understanding of key aspects of JEV ecology, including underlying patterns of infection, the infection fatality ratio, and which host and vectors maintain transmission.\n\nMethodsWe conducted a seroprevalence study in individuals of all ages in Chapai Nawabganj, Bangladesh. We tested blood samples for anti-JEV antibodies using a novel assay that limits cross-reactivity with dengue virus, trapped mosquitoes, and collected information about potential host species. We combined our results with data from a pig census, human case data and healthcare seeking patterns, all from the same region, and used mathematical models to recover risk factors for infection, and underlying probabilities of severe disease and death.\n\nFindingsWe found 14.3% (203\/1455) of participants had antibodies against JEV. We estimated 0.5% of the susceptible population gets infected each year, however, infection risk was spatially heterogeneous, with the presence of pigs in the vicinity being the most important predictor of seropositivity. We identified 10 different known mosquito vectors for JEV. We estimated that 1 in 1,000 infections result in severe disease, 1 in 10,000 result in death, and 76% of severe cases are missed by surveillance systems.\n\nInterpretationJEV infection risk is highly spatially heterogeneous, with the underlying potential of vaccines linked to the distribution of pig-raising communities.\n\nFundingCenters for Disease Control and Prevention (CDC)","preprint_author_corresponding":"Mariana Perez Duque","preprint_author_corresponding_institution":"Pathogen Dynamics Group, Department of Genetics, University of Cambridge, United Kingdom"},{"preprint_doi":"10.1101\/2024.05.01.24306729","published_doi":"10.1016\/j.nbd.2024.106643","published_journal":"Neurobiology of Disease","preprint_platform":"medRxiv","preprint_title":"Alterations in aperiodic and periodic EEG activity in young children with Down syndrome","preprint_authors":"Geiger, M.; Hurewitz, S. R.; Pawlowski, K.; Baumer, N. T.; Wilkinson, C. L.","preprint_category":"neurology","preprint_date":"2024-05-04","published_date":"2024-08-22","preprint_abstract":"Down syndrome is the most common cause of intellectual disability, yet little is known about the neurobiological pathways leading to cognitive impairments. Electroencephalographic (EEG) measures are commonly used to study neurodevelopmental disorders, but few studies have focused on young children with DS. Here we assess resting state EEG data collected from toddlers\/preschoolers with DS (n=29, age 13-48 months old) and compare their aperiodic and periodic EEG features with both age-matched (n=29) and cognitive-matched (n=58) comparison groups. DS participants exhibited significantly reduced aperiodic slope, increased periodic theta power, and decreased alpha peak amplitude. A majority of DS participants displayed a prominent peak in the theta range, whereas a theta peak was not present in age-matched participants. Overall, similar findings were also observed when comparing DS and cognitive-matched groups, suggesting that EEG differences are not explained by delayed cognitive ability.","preprint_author_corresponding":"Carol L Wilkinson","preprint_author_corresponding_institution":"Boston Children\\'s Hospital"},{"preprint_doi":"10.1101\/2024.05.01.24306689","published_doi":"10.1088\/1402-4896\/ad72b4","published_journal":"Physica Scripta","preprint_platform":"medRxiv","preprint_title":"Investigating the Impact of Segregation and Integration on Infection Dynamics: Analysis of a Cholera Model in a Two-Population System","preprint_authors":"El Deeb, O.; Matar, A.","preprint_category":"epidemiology","preprint_date":"2024-05-03","published_date":"2024-08-22","preprint_abstract":"We present a novel dynamic model designed to depict Cholera outbreaks within a two-population framework featuring two environmental reservoirs. The model is designed to emulate the impact of segregation or integration between two populations on the transmission of the disease and infections throughout the entire community, both with and without non-medicinal interventions. This is achieved by allowing infectious individuals to interact with the reservoir of the alternate population at different levels of suppression, in addition to their regular interaction with their own reservoir.\n\nWe find out that increased suppression of cross community interaction reduces the number of infections in the overall population as well as in the population with less contamination and contact. Additionally, we predict significant delays in the occurrence of peak infections, affording public health authorities crucial time for intervention. Lowering cross-immunity interactions also leads to a decrease in bacterial concentrations in environmental reservoirs. Finally, we demonstrate that non-medicinal interventions, including sanitation and water purification, would significantly reduce and delay infections, providing a valuable time frame for implementing additional medicinal measures.","preprint_author_corresponding":"Omar El Deeb","preprint_author_corresponding_institution":"University of Warwick"},{"preprint_doi":"10.1101\/2024.04.08.24305493","published_doi":"10.1016\/j.ijantimicag.2024.107309","published_journal":"International Journal of Antimicrobial Agents","preprint_platform":"medRxiv","preprint_title":"Meta-analysis on safety of standard vs prolonged infusion of beta-lactams","preprint_authors":"Scheetz, M. H.; Schwartz, Z.; Jubrail, R.; Downes, K.; Hong, L.; Fakhri Ravari, A.; Rhodes, N. J.","preprint_category":"infectious diseases","preprint_date":"2024-04-09","published_date":"2024-08-22","preprint_abstract":"BackgroundEfficacy for prolonged infusion beta-lactam dosing schemes has been previously described, but there has been less focus on the safety of standard vs prolonged infusion protocols of beta-lactams. This study explored differences in adverse drug reactions (ADRs) reported for beta-lactams between each of these infusion protocols.\n\nMethodsA systematic review of MEDLINE literature databases via PubMed was conducted and references were compiled. Articles were compiled and assessed with specific inclusion\/exclusion criteria. We included randomized and nonrandomized, prospective, and retrospective cohort studies that reported adverse effects due to either standard (30-60 mins) or prolonged ([&ge;]3 hours) infusions of beta-lactam infusions. Total ADRs between strategies were analyzed by infusion methodology. The most consistently reported ADRs were subject to meta-analysis across studies.\n\nResults13 studies met inclusion\/exclusion criteria with data for 4184 patients. There was insufficient data to systematically analyze neurotoxicity or cytopenias. Eight studies reported on nephrotoxicity outcomes with no significant difference in event rates between standard (n=440\/2117, 20.8%) vs prolonged infusion (n=264\/1284, 20.6%) of beta-lactams (OR=1.09, 95% CI [0.91, 1.30]). Six studies reported on rates of diarrhea with no significant difference in event rates between standard (n=21\/359, 5.8%) vs prolonged infusion (n=25\/330, 7.6%) of beta-lactams (OR=1.33, 95% CI [0.71,2.47).\n\nConclusionProlonged and standard infusion schemes for beta-lactams demonstrated adverse effects at similar rates for both infusion schemes. Future research should focus on improved standardization of adverse effect definitions and a priori aim to study neurotoxicity and cytopenias. Consistent recording of ADRs and standardized definitions of these reactions will be paramount to further study of this subject.","preprint_author_corresponding":"Marc H. Scheetz","preprint_author_corresponding_institution":"Midwestern University"},{"preprint_doi":"10.1101\/2024.03.05.24303709","published_doi":"10.1016\/j.tmrv.2024.150851","published_journal":"Transfusion Medicine Reviews","preprint_platform":"medRxiv","preprint_title":"Balancing donor health and plasma collection: a systematic review of the impact of plasmapheresis frequency","preprint_authors":"D'aes, T.; van den Hurk, K.; Schroyens, N.; Mikkelsen, S.; Severijns, P.; De Buck, E.; O'Leary, P.; Tiberghien, P.; Compernolle, V.; Erikstrup, C.; Van Remoortel, H.","preprint_category":"hematology","preprint_date":"2024-03-06","published_date":"2024-08-22","preprint_abstract":"Most plasma used for manufacturing plasma-derived medicinal products (PDMPs) such as albumin, immunoglobulin (Ig), and clotting factors is obtained from source plasma collected via plasmapheresis, the majority of which is contributed by the United States (US). While the demand for PDMPs continues to rise, it remains unclear whether high-frequency plasmapheresis, such as the twice-weekly plasma donation allowed in the US, may have any (long-term) adverse health effects on the donor.\n\nTo investigate the frequency at which plasma can be donated without harm to the donor, the current systematic review explores the impact of plasma donation frequency on cardiovascular health, protein depletion, and adverse events in healthy plasma donors. We asked the following research question: What is the impact of plasmapheresis frequency (Intervention) on the safety or health (Outcome) of healthy donors (Population)?\n\nSix databases (PubMed, Embase, Web of Science, CINAHL, the Cochrane Library, and Transfusion Evidence Library), two clinical trial registries (ICTRP and clinicaltrials.gov), and the PROSPERO database were searched. Four observational and two experimental studies were included, and one ongoing randomized controlled trial was identified. The results showed that very high-frequency donation (twice per week) may result in a clinically relevant decrease in ferritin and bring IgG levels below the EDQM-defined lower threshold of 6 g\/l. However, the evidence is of low to very low certainty, and solid conclusions are hindered by the healthy donor effect and methodological limitations of the included studies. In order to determine a safe threshold donation frequency that minimizes any possible harmful effect on the donor, more high-quality prospective cohort studies and experimental studies are thus needed. In the meantime, we argue for a precautionary approach and suggest that a sustainable and stable plasma supply may better rely on a large number of voluntary donors donating at a lower frequency (up to two donations per month), rather than on a small number of donors donating at a high frequency.","preprint_author_corresponding":"Hans Van Remoortel","preprint_author_corresponding_institution":"Centre for Evidence-Based Practice, Belgian Red Cross; Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven"},{"preprint_doi":"10.1101\/2024.07.01.24309766","published_doi":"10.1016\/j.jfp.2024.100349","published_journal":"Journal of Food Protection","preprint_platform":"medRxiv","preprint_title":"Inactivation of highly pathogenic avian influenza virus with high temperature short time continuous flow pasteurization and virus detection in bulk milk tanks","preprint_authors":"Spackman, E.; Anderson, N.; Walker, S.; Suarez, D. L.; Jones, D. R.; McCoig, A.; Colonius, T.; Roddy, T.; Chaplinski, N.","preprint_category":"infectious diseases","preprint_date":"2024-07-03","published_date":"2024-08-22","preprint_abstract":"Infections of dairy cattle with clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus (HPAIV) were reported in March 2024 in the U.S. and viable virus was detected at high levels in raw milk from infected cows. This study aimed to determine the potential quantities of infectious HPAIV in raw milk in affected states where herds were confirmed positive by USDA for HPAIV (and therefore were not representative of the entire population), and to confirm that the commonly used continuous flow pasteurization using the FDA approved 72{degrees}C (161{degrees}F) for 15 s conditions for high temperature short time (HTST) processing, will inactivate the virus. Double-blinded raw milk samples from bulk storage tanks from farms (n=275) were collected in four affected states. Samples were screened for influenza A using quantitative real-time RT-PCR (qrRT-PCR) of which 158 (57.5%) were positive and were subsequently quantified in embryonating chicken eggs. Thirty-nine qrRT-PCR positive samples (24.8%) were positive for infectious virus with a mean titer of 3.5 log10 50% egg infectious doses (EID50) per mL. To closely simulate commercial milk pasteurization processing systems, a pilot-scale continuous flow pasteurizer was used to evaluate HPAIV inactivation in artificially contaminated raw milk using the most common legal conditions in the US: 72{degrees}C (161{degrees}F) for 15s. Among all replicates at two flow rates (n=5 at 0.5L\/min; n=4 at 1L\/min), no viable virus was detected. A mean reduction of [&ge;]5.8 {+\/-} 0.2 log10 EID50\/mL occurred during the heating phase where the milk is brought to 72.5{degrees}C before the holding tube. Estimates from heat-transfer analysis support that standard U.S. continuous flow HTST pasteurization parameters will inactivate >12 log10 EID50\/mL of HPAIV, which is ~9 log10 EID50\/mL greater than the mean quantity of infectious virus detected in raw milk from bulk storage tank samples. These findings demonstrate that the milk supply is safe.","preprint_author_corresponding":"Erica Spackman","preprint_author_corresponding_institution":"Exotic and Emerging Avian Viral Disease Research Unit, Southeast Poultry Research Center, US National Poultry Research Center, USDA-Agricultural Research Servic"},{"preprint_doi":"10.1101\/2023.09.13.23295243","published_doi":"10.1016\/j.clinbiomech.2024.106332","published_journal":"Clinical Biomechanics","preprint_platform":"medRxiv","preprint_title":"Real-world gait and turning in individuals scheduled for total knee arthroplasty","preprint_authors":"Boekesteijn, R. J.; Keijsers, N. L. W.; Defoort, K.; Mancini, M.; Bruning, F. J.; El-Gohary, M.; Geurts, A. C. H.; Smulders, K.","preprint_category":"orthopedics","preprint_date":"2023-09-13","published_date":"2024-08-22","preprint_abstract":"ObjectiveTo compare real-world gait and turning between individuals scheduled for total knee arthroplasty (TKA) and healthy controls, using continuous monitoring with inertial measurement units (IMUs).\n\nDesignReal-world gait and turning data were collected for 5-7 days in individuals scheduled for TKA (n=34) and healthy controls in the same age range (n=32) using IMUs on the feet and lower back. Gait and turning parameters were compared between groups using a linear regression model. Data was further analyzed by stratification of gait bouts based on bout length, and turns based on turning angle and turning direction.\n\nResultsDominant real-world gait speed was 0.21 m\/s lower in individuals scheduled for TKA compared to healthy controls. The between-group difference in gait speed was -0.10 m\/s for bouts containing 0-10 strides and -0.15 m\/s for bouts with 160+ strides. Stride time was 0.05 s higher in individuals scheduled for TKA. Step time asymmetry was not different between the groups. Regarding walking activity, individuals scheduled for TKA walked 72 strides\/hour less than healthy controls, and maximum bout length was 316 strides shorter. Irrespective of the size of the turn, turning velocity was lower in individuals scheduled for TKA. Turning velocity did not differ between turns over the affected leg compared to the unaffected leg.\n\nConclusionIndividuals scheduled for TKA showed specific walking and turning limitations in the real-world. Parameters derived from IMUs reflected a rich profile of real-world mobility measures indicative of walking limitation of individuals scheduled for TKA, which may provide a relevant outcome dimension for future studies.","preprint_author_corresponding":"Ramon J. Boekesteijn","preprint_author_corresponding_institution":"Sint Maartenskliniek"},{"preprint_doi":"10.1101\/2024.03.17.24304427","published_doi":"10.1371\/journal.pone.0301304","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Feasibility of individualized home exercise programs for patients with head and neck cancer - study protocol and first results of a  multicentre single-arm intervention trial (OSHO #94)","preprint_authors":"Felser, S.; Rogahn, J.; Glass, A.; Bonke, L. A.; Stru\u0308der, D. F.; Stolle, J.; Schulze, S.; Blaurock, M.; Kriesen, U.; Junghanss, C.; Grosse-Thie, C.","preprint_category":"rehabilitation medicine and physical therapy","preprint_date":"2024-03-19","published_date":"2024-08-22","preprint_abstract":"IntroductionPatients with head and neck cancer (PwHNC) benefit from targeted exercise interventions: symptom relief, compensation for dysfunction, improvement in quality of life (QoL). Data on acceptance physical interventions in PwHNC are rare. The  OSHO #94 trial investigates the short- and medium-term effects of individualized home exercise in PwHNC on QoL, physical activity and functionality. The study includes a feasibility phase in order to evaluate the acceptance (Phase A), followed by a consecutive QoL endpoint Phase B. Here we present the study protocol as well as the feasibility results.\n\nMethods and analysisThis prospective, multicentre, single-arm intervention study includes PwHNC [&ge;]18 years of age in aftercare or palliative care with stable remission under immunotherapy. The study opened in January 01, 2021, with estimated completion by December 31, 2024. The PwHNC receive an individualized home exercise program consisting of mobilization, coordination, strengthening and stretching exercises. This should be carried out at least three times a week over 12 weeks for 15 to 30 minutes, supplemented by aerobic training two to three times a week for 30 minutes (intervention). Once weekly telephone calls with a physiotherapist are performed. Subsequently, there is a 12-week follow-up (FU) without exercise specifications\/contact. Outcomes are measured before and after the intervention and following the FU. Primary outcome of the feasibility phase (Phase A, n = 25) was the determination of the dropout rate during the intervention with a termination cut off if more than 30% PwHNC withdrew premature. The primary outcome of phases A + B (N = 53) are the change in global QoL score from pre- to post-intervention (EORTC QLQ-C30). Secondary outcomes include clinical and patient-reported measures, training details as well as functional diagnostic data (e.g. level of physical activity, training frequency, flexibility, fall risk and aerobic performance).\n\nResults25 PwHNC were enrolled onto the feasibility cohort. Only16% (4\/25 patients) did not complete the study. Therefore, individualized home exercise programs in PwHNC seem feasible recruitment of PwHNC for phase B continued. The dropout rate was adjusted from 30% (N = 60) to 20% (N = 53, calculated sample size n = 42 PwHNC and 20% (n = 11) to dropout).\n\nEthics and disseminationThe study protocol was approved by the Ethics Committee of the University of Rostock, University of Halle-Wittenberg and University of Greifswald. The findings will be disseminated in peer-reviewed journals and academic conferences.\n\nTrial registration German Registry of Clinical Trials DRKS00023883.","preprint_author_corresponding":"Sabine Felser","preprint_author_corresponding_institution":"Rostock University Medical Center: Universitatsmedizin Rostock"},{"preprint_doi":"10.1101\/2024.05.08.24306960","published_doi":"10.1016\/j.clnu.2024.08.016","published_journal":"Clinical Nutrition","preprint_platform":"medRxiv","preprint_title":"Evaluating the efficacy and safety of neonatal chyme reinfusion therapy: A feasibility study using a novel medical device","preprint_authors":"Ludlow, E.; Harrington, T.; Davidson, R.; Davidson, J.; Aikins, K.; O'Grady, G.; Bissett, I.","preprint_category":"nutrition","preprint_date":"2024-05-09","published_date":"2024-08-22","preprint_abstract":"ObjectivesNeonatal and pediatric intestinal failure related to enterostomy is an infrequent but burdensome condition associated with substantial morbidity and mortality. This study presents the development and clinical validation of a novel device to resolve these problems, by formalizing a safe and efficient enterostomy chyme reinfusion technique.\n\nMethodsA novel neonatal chyme reinfusion device was designed and manufactured ( The Insides Neo, The Insides Company, New Zealand), prior to validation in a feasibility study in tertiary neonatal intensive care centres. Neonates with double enterostomy were recruited and commenced on chyme reinfusion therapy using the novel device to test safety, efficacy, tolerability, and usability within nursing workflows. Device and clinical outcomes were recorded along with nursing feedback. Registered under the ANZCTR, identifier no. ACTRN12621000835842p.\n\nResultsTen neonates were recruited across two centres, with a median usage duration of 37.5 (range 12-84) days. Following initiation of therapy, rate of weight gain increased from mean 68.8 {+\/-} 37.4 to 197 {+\/-} 25.0 g\/week (p=0.024). Of the 7\/10 neonates on PN at commencement of therapy, 4\/7 were able to wean and achieve enteral autonomy. All neonates tolerated the device with uniformly positive nursing feedback and minimal time to learn and incorporate the novel device into nursing workflows. There were no device-related adverse events.\n\nConclusionsA novel device was developed and validated to be safe and effective at performing chyme reinfusion therapy in neonates. This device is anticipated to improve the clinical care and outcomes of neonatal patients with double enterostomies.\n\nWhat is Known O_LIChyme reinfusion is widely accepted and is a standard of care in many centres who care for neonates with double enterostomys.\nC_LIO_LIThe manual application of chyme reinfusion has led to low adoption despite the many benefits.\nC_LI\n\nWhat is New O_LIA new device that automates the process of chyme reinfusion that overcomes many of the barriers outlined in the literature.\nC_LIO_LIUniformly positive nursing feedback that streamlines the Neonatal Intensive Care Unit (NICU) workflow.\nC_LI","preprint_author_corresponding":"Ian Bissett","preprint_author_corresponding_institution":"The University of Auckland"},{"preprint_doi":"10.1101\/2023.12.05.23299499","published_doi":"10.1371\/journal.pdig.0000571","published_journal":"PLOS Digital Health","preprint_platform":"medRxiv","preprint_title":"Feasibility characteristics of wrist-worn fitness trackers in health status monitoring for post-COVID patients in remote and rural areas","preprint_authors":"Wiebe, M.; Mackay, M.; Krishnan, R.; Tian, J.; Larsson, J.; Modanloo, S.; Job Mcintosh, C.; Sztym, M.; Elton-Smith, G.; Rose, A.; Ho, C.; Greenshaw, A.; Cao, B.; Chan, A.; Hayward, J.","preprint_category":"health systems and quality improvement","preprint_date":"2023-12-06","published_date":"2024-08-22","preprint_abstract":"IntroductionCommon, consumer-grade biosensors mounted on fitness trackers and smartwatches can measure an array of biometrics that have potential utility in post-discharge medical monitoring, especially in remote\/rural communities. The feasibility characteristics for wrist-worn biosensors are poorly described for post-COVID conditions and rural populations.\n\nMethodsWe prospectively recruited patients in rural communities who were enrolled in an at-home rehabilitation program for post-COVID conditions. They were asked to wear a FitBit Charge 2 device and biosensor parameters were analyzed (e.g. heart rate, sleep, and activity). Electronic patient reported outcome measures (E-PROMS) for mental (bi-weekly) and physical (daily) symptoms were collected using SMS text or email (per patient preference). Exit surveys and interviews evaluated the patient experience.\n\nResultsTen patients were observed for an average of 58 days and half (N=5) were monitored for 8 weeks or more. Five patients (50%) had been hospitalized with COVID (mean stay = 41 days) and 4 (36%) had required mechanical ventilation. As baseline, patients had moderate to severe levels of anxiety, depression, and stress; fatigue and shortness of breath were the most prevalent physical symptoms. Four patients (40%) already owned a smartwatch. In total, 575 patient days of patient monitoring occurred across 10 patients. Biosensor data was usable for 91.3% of study hours and surveys were completed 82.1% and 78.7% of the time for physical and mental symptoms, respectively. Positive correlations were observed between stress and resting heart rate (r=0.360, p<0.01), stress and daily steps (r=0.335, p<0.01), and anxiety and daily steps (r=0.289, p<0.01). There was a trend toward negative correlation between sleep time and physical symptom burden (r=-0.211, p=0.05). Patients reported an overall positive experience and identified the potential for wearable devices to improve medical safety and access to care. Concerns around data privacy\/security were infrequent.\n\nConclusionsWe report excellent feasibility characteristics for wrist-worn biosensors and e-PROMS as a possible substrate for multi-modal disease tracking in post-COVID conditions. Adapting consumer-grade wearables for medical use and scalable remote patient monitoring holds great potential.","preprint_author_corresponding":"Jake Hayward","preprint_author_corresponding_institution":"University of Alberta Faculty of Medicine & Dentistry"},{"preprint_doi":"10.1101\/2024.03.08.24303963","published_doi":"10.1371\/journal.pgph.0003058","published_journal":"PLOS Global Public Health","preprint_platform":"medRxiv","preprint_title":"A dynamic ensemble model for short-term forecasting in pandemic situations","preprint_authors":"Botz, J.; Valderrama, D.; Guski, J.; Fro\u0308hlich, H.","preprint_category":"public and global health","preprint_date":"2024-03-09","published_date":"2024-08-22","preprint_abstract":"During the COVID-19 pandemic, many hospitals reached their capacity limits and could no longer guarantee treatment of all patients. At the same time, governments endeavored to take sensible measures to stop the spread of the virus while at the same time trying to keep the economy afloat. Many models extrapolating confirmed cases and hospitalization rate over short periods of time have been proposed, including several ones coming from the field of machine learning. However, the highly dynamic nature of the pandemic with rapidly introduced interventions and new circulating variants imposed non-trivial challenges for the generalizability of such models.\n\nIn the context of this paper, we propose the use of ensemble models, which are allowed to change in their composition or weighting of base models over time and can thus adapt to highly dynamic pandemic or epidemic situations. In that regard, we also explored the use of secondary metadata - Google searches - to inform the ensemble model. We tested our approach using surveillance data from COVID-19, Influenza, and hospital syndromic surveillance of severe acute respiratory infections (SARI). In general, we found ensembles to be more robust than the individual models. Altogether we see our work as a contribution to enhance the preparedness for future pandemic situations.","preprint_author_corresponding":"Jonas Botz","preprint_author_corresponding_institution":"Fraunhofer SCAI: Fraunhofer-Institut fur Algorithmen und Wissenschaftliches Rechnen SCAI"},{"preprint_doi":"10.1101\/2024.01.18.24301490","published_doi":"10.1371\/journal.pgph.0002885","published_journal":"PLOS Global Public Health","preprint_platform":"medRxiv","preprint_title":"Mapping the Existing Body of Knowledge on New and Repurposed TB Vaccine Implementation: A Scoping Review","preprint_authors":"Buis, J. S. S.; Jerene, D.; Gebhard, A.; Bakker, R.; Majidulla, A.; Kerkhoff, A. D.; Limaye, R.; Pelzer, P. T.","preprint_category":"public and global health","preprint_date":"2024-01-18","published_date":"2024-08-22","preprint_abstract":"There is global consensus on the urgent need for a safe and effective TB vaccine for adults and adolescents to improve global TB control, and encouragingly, several promising candidates have advanced to late-stage trials. Significant gaps remain in understanding the critical factors that will facilitate the successful implementation of new and repurposed TB vaccines in low-and middle-income countries (LMICs), once available. By synthesizing the existing body of knowledge, this review offers comprehensive insights into the current state of research on implementation of these adults and adolescent vaccines. This review explores four key dimensions: (1) epidemiological impact, (2) costing, cost-effectiveness, and\/or economic impact, (3) acceptability, and the (4) feasibility of implementation; this includes implementation strategies of target populations, and health system capabilities. Results indicate that current research primarily consists of epidemiological and costing\/cost-effectiveness\/economic studies in India, China, and South Africa, mainly modelling with M72\/AS01, BCG revaccination, and generic vaccines. Varying endpoints, vaccine efficacies, and vaccination coverages were used. Globally, new, and repurposed TB vaccines are estimated to save millions of lives. Economically, these vaccines also demonstrate promise with expected cost-effectiveness in most countries. Projected outcomes were dependent on vaccine characteristics, target population, implementation strategy, timing of roll out, TB burden\/country context, and vaccination coverage. Potential barriers for vaccine acceptability included TB-related stigma, need for a second dose, and cost, while low pricing, community and civil society engagement and heightened public TB awareness were potential enablers in China, India, and South Africa. Potential implementation strategies considered spanned from mass campaigns to integration within existing vaccine programs and the primary target group studied was the general population, and adults and adolescents. In conclusion, future research must have broader geographical representations to better understand what is needed to inform tailored vaccine programs to accommodate diverse country contexts and population groups to achieve optimal implementation and impact. Furthermore, this review underscores the scarcity of research on acceptability of new and repurposed TB vaccines and their delivery among potential beneficiaries, the most promising implementation strategies, and the health system capabilities necessary for implementation. The absence of this knowledge in these areas emphasizes the crucial need for future research to ensure effective TB vaccine implementation in high burden settings worldwide.","preprint_author_corresponding":"Joeri Sumina  Sumina Buis","preprint_author_corresponding_institution":"KNCV Tuberculosis Foundation: KNCV Tuberculosefonds"},{"preprint_doi":"10.1101\/2023.10.20.23297320","published_doi":"10.1136\/tc-2023-058453","published_journal":"Tobacco Control","preprint_platform":"medRxiv","preprint_title":"Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017-2019 vs 2019-2021","preprint_authors":"Brouwer, A. F.; Jeon, J.; Jimenez-Mendoza, E.; Land, S. R.; Holford, T. R.; Friedman, A. S.; Tam, J.; Mistry, R.; Levy, D. T.; Meza, R.","preprint_category":"epidemiology","preprint_date":"2023-10-21","published_date":"2024-08-22","preprint_abstract":"IntroductionThe use of cigarettes and electronic nicotine delivery system (ENDS) has likely changed since 2019 with the rise of pods and disposables, the outbreak of lung injuries related to vaping THC, flavor bans, and the COVID pandemic. We analyzed patterns of initiation, cessation, and transitions between cigarettes, ENDS, and dual use before and after 2019.\n\nMethodsUsing the Population Assessment of Tobacco and Health (PATH) Study, we applied a multistate transition model to 28,061 adults in Waves 4-5 (2017-19) and 24,751 adults in Waves 5-6 (2019-21), estimating transition rates for initiation, cessation, and switching products for each period overall and by age group.\n\nResultsCigarette initiation among adults who never used either product decreased from 2017-19 to 2019-21, but ENDS initiation did not significantly change. Persistence of ENDS-only use remained high, with 75-80% still using ENDS only after 1 year. Cigarette-only use transitions remained similar, with about 88% remaining, 7% transitioning to non-current use, and 5% transitioning to dual or ENDS-only use. In contrast, dual use to ENDS-only transitions increased from 9.5% (95%CI: 7.3-11.7%) to 20.1% (95%CI: 17.5-22.7%) per year from 2017-19 to 2019-21, decreasing the persistence of dual use. The dual use to cigarette-only transition remained at about 25%. These changes were qualitatively similar across adult age groups, though adults ages 18-24 years exhibited the highest probability of switching from cigarette-only use to dual use and from dual use to ENDS-only use.\n\nConclusionsPersistence of ENDS use among adults remained high in 2019-21, but a larger fraction of dual users transitioned to ENDS-only use compared to 2017-19. Because the fraction of cigarette-only users switching to dual use remained low, the public health implications of the increased dual use to ENDS-only transition are minimal.","preprint_author_corresponding":"Andrew F Brouwer","preprint_author_corresponding_institution":"University of Michigan"},{"preprint_doi":"10.1101\/2023.09.07.23295190","published_doi":"10.1371\/journal.ppat.1012368","published_journal":"PLOS Pathogens","preprint_platform":"medRxiv","preprint_title":"Uncovering the implications of IFN-I in severe COVID-19 neutrophil inflammasome","preprint_authors":"Cabrera, L. E.; Jokiranta, S. T.; Ma\u0308ki, S.; Miettinen, S.; Kant, R.; Kareinen, L.; Sironen, T.; Pietila\u0308, J.-P.; Kantele, A.; Keka\u0308la\u0308inen, E.; Lindgren, H.; Mattila, P.; Kipar, A.; Vapalahti, O.; Strandin, T.","preprint_category":"allergy and immunology","preprint_date":"2023-09-08","published_date":"2024-08-22","preprint_abstract":"The severity of COVID-19 is linked to excessive inflammation. Neutrophils represent a critical arm of the innate immune response and are major mediators of inflammation, but their role in COVID-19 pathophysiology remains poorly understood. We conducted transcriptomic profiling of neutrophils obtained from patients with mild and severe COVID-19, as well as from SARS-CoV-2 infected mice, in comparison to non-infected healthy controls. In addition, we investigated the inflammasome formation potential in neutrophils from patients and mice upon SARS-CoV-2 infection. Transcriptomic analysis of polymorphonuclear cells (PMNs), consisting mainly of mature neutrophils, revealed a striking type I interferon (IFN-I) gene signature in severe COVID-19 patients, contrasting with mild COVID-19 and healthy controls. Notably, low-density granulocytes (LDGs) from severe COVID-19 patients exhibited an immature neutrophil phenotype and lacked this IFN-I signature. Moreover, PMNs from severe COVID-19 patients showed heightened nigericin-induced caspase1 activation, but reduced responsiveness to exogenous inflammasome priming. Furthermore, IFN-I emerged as a priming stimulus for neutrophil inflammasomes, which was confirmed in a COVID-19 mouse model. These findings underscore the crucial role of neutrophil inflammasomes in driving inflammation during severe COVID-19. Altogether, these findings open promising avenues for targeted therapeutic interventions to mitigate the pathological processes associated with the disease.","preprint_author_corresponding":"Luz Eneida Cabrera","preprint_author_corresponding_institution":"University of Helsinki"},{"preprint_doi":"10.1101\/2024.03.21.24304540","published_doi":"10.1080\/21645515.2024.2384189","published_journal":"Human Vaccines & Immunotherapeutics","preprint_platform":"medRxiv","preprint_title":"Equivalence of Freeze-dried and Liquid-frozen Formulations of MVA-BN as Smallpox and Mpox Vaccine","preprint_authors":"Greenberg, R. N.; Schmidt, D.; Reichhardt, D.; Rosch, S.; Vidojkovic, S.; Maclennan, J.; Chen, L. M.; Gruenert, R.; Kreusel, C.; Weidenthaler, H.; Meyer, T.; Chaplin, P. J.","preprint_category":"infectious diseases","preprint_date":"2024-03-22","published_date":"2024-08-22","preprint_abstract":"Orthopox virus-induced diseases such as smallpox and mpox (also known as monkeypox previously) remain a serious public health concern. Modified Vaccinia Ankara Bavarian Nordic (MVA-BN) has been approved in its liquid-frozen (LF) formulation for prevention of smallpox and mpox in the US, Canada and EU. A freeze-dried (FD) formulation might confer additional benefits such as longer shelf life and less reliance on cold chain storage and transport, thus can better meet the potential challenge of large quantity vaccine deployment in emergency situations.\n\nIn a phase 2 clinical trial, 651 vaccinia-naive participants were vaccinated with two doses of MVA-BN LF or FD, 4 weeks apart. The objectives were to compare MVA-BN FD with LF in terms of vaccine-induced immune responses, safety and reactogenicity.\n\nStrong vaccinia-specific humoral and cellular immune responses were induced by both formulations, with peak humoral responses at Week 6 and peak cellular responses at Week 2. At Week 6, geometric means of total antibody titers were 1096 (95% CI 1013, 1186) from the FD group and 877 (95% CI 804, 956) from the LF group, achieving the primary endpoint of non-inferiority of MVA-BN FD compared to MVA-BN LF. At Week 2, geometric means of T cell spot forming units were 449 (95% CI 341, 590) from the FD group and 316 (95% CI 234, 427) from the LF group. Both formulations of MVA-BN were well tolerated, with similar unsolicited AEs and solicited systemic reactions in both groups but slightly higher local reactions in the FD group. No vaccine related serious adverse events (SAEs) or vaccine related AE of special interest were reported.\n\nThe FD formulation of MVA-BN was shown to be equivalent to the LF formulation in immunogenicity, and comparable safety findings were observed from both formulations.\n\nClinical Trial Registration: NCT01668537\n\nHighlightsEquivalence of MVA-BN freeze-dried and liquid-frozen formulations in immunogenicity MVA-BN FD and MVA-BN LF are comparable in clinical safety and reactogenicity Peak T cell responses were observed 2 weeks after the first vaccination","preprint_author_corresponding":"Liddy M Chen","preprint_author_corresponding_institution":"Bavarian Nordic Inc"},{"preprint_doi":"10.1101\/2024.04.24.24306320","published_doi":"10.1016\/j.scitotenv.2024.175687","published_journal":"Science of The Total Environment","preprint_platform":"medRxiv","preprint_title":"Estimating Rates of Change to Interpret Quantitative Wastewater Surveillance of Disease Trends","preprint_authors":"Holcomb, D. A.; Christensen, A.; Hoffman, K.; Lee, A.; Blackwood, A. D.; Clerkin, T.; Gallard-Gongora, J.; Harris, A.; Kotlarz, N.; Mitasova, H.; Reckling, S.; de los Reyes, F. L.; Stewart, J. R.; Guidry, V. T.; Noble, R. T.; Serre, M. L.; Garcia, T. P.; Engel, L. S.","preprint_category":"public and global health","preprint_date":"2024-04-25","published_date":"2024-08-22","preprint_abstract":"BackgroundWastewater monitoring data can be used to estimate disease trends to inform public health responses. One commonly estimated metric is the rate of change in pathogen quantity, which typically correlates with clinical surveillance in retrospective analyses. However, the accuracy of rate of change estimation approaches has not previously been evaluated.\n\nObjectivesWe assessed the performance of approaches for estimating rates of change in wastewater pathogen loads by generating synthetic wastewater time series data for which rates of change were known. Each approach was also evaluated on real-world data.\n\nMethodsSmooth trends and their first derivatives were jointly sampled from Gaussian processes (GP) and independent errors were added to generate synthetic viral load measurements; the range hyperparameter and error variance were varied to produce nine simulation scenarios representing different potential disease patterns. The directions and magnitudes of the rate of change estimates from four estimation approaches (two established and two developed in this work) were compared to the GP first derivative to evaluate classification and quantitative accuracy. Each approach was also implemented for public SARS-CoV-2 wastewater monitoring data collected January 2021 - May 2023 at 25 sites in North Carolina, USA.\n\nResultsAll four approaches inconsistently identified the correct direction of the trend given by the sign of the GP first derivative. Across all nine simulated disease patterns, between a quarter and a half of all estimates indicated the wrong trend direction, regardless of estimation approach. The proportion of trends classified as plateaus (statistically indistinguishable from zero) for the North Carolina SARS-CoV-2 data varied considerably by estimation method but not by site.\n\nDiscussionOur results suggest that wastewater measurements alone might not provide sufficient data to reliably track disease trends in real-time. Instead, wastewater viral loads could be combined with additional public health surveillance data to improve predictions of other outcomes.","preprint_author_corresponding":"David A Holcomb","preprint_author_corresponding_institution":"University of North Carolina at Chapel Hill"},{"preprint_doi":"10.1101\/2024.01.24.24301711","published_doi":"10.7554\/eLife.95901","published_journal":"eLife","preprint_platform":"medRxiv","preprint_title":"Associations of onset age of breast cancer with incident myocardial infarction and heart failure: a prospective cohort study","preprint_authors":"Liang, J.; Pan, Y.; Zhang, W.; Gao, D.; Wang, Y.; Xie, W.; Zheng, F.","preprint_category":"cardiovascular medicine","preprint_date":"2024-01-24","published_date":"2024-08-22","preprint_abstract":"BackgroundThe associations of age at diagnosis of breast cancer with incident myocardial infarction (MI) and heart failure (HF) remain unexamined. Addressing this problem could promote understanding of the cardiovascular impact of breast cancer.\n\nMethodsData were from the UK Biobank. Information on the diagnosis of breast cancer, MI, and HF were collected at baseline and follow-ups (median=12.8 years). The propensity score matching method and Cox proportional hazards models were employed.\n\nResultsA total of 251 277 female participants (mean age: 56.8{+\/-}8.0 years), of whom 16 241 had breast cancer, were included. Among participants with breast cancer, younger age at diagnosis (per 10-year decrease) was significantly associated with elevated risks of MI (HR=1.36, 95%CI: 1.19 to 1.56, P<0.001) and HF (HR=1.31, 95% CI: 1.18 to 1.46, P<0.001). After propensity score matching, breast cancer patients with younger diagnosis ages had significantly higher risks of MI and HF than healthy controls.\n\nConclusionYounger age at diagnosis of breast cancer was associated with higher risks of incident MI and HF, underscoring the necessity to pay additional attention to the cardiovascular health of breast cancer patients diagnosed at younger ages to conduct timely interventions to attenuate the subsequent risks of incident cardiovascular diseases.","preprint_author_corresponding":"Fanfan Zheng","preprint_author_corresponding_institution":"Chinese Academy of Medical Sciences & Peking Union Medical College"},{"preprint_doi":"10.1101\/2024.01.08.24300986","published_doi":"10.1183\/23120541.00026-2024","published_journal":"ERJ Open Research","preprint_platform":"medRxiv","preprint_title":"Priorities and barriers for research related to primary ciliary dyskinesia","preprint_authors":"Goutaki, M.; Lam, Y. T.; Rubbo, B.; Chalmers, J. D.; Kouis, P.; Marsh, G.; Papon, J.-F.; Raidt, J.; Robinson, P.; Behan, L.; Lucas, J. S.","preprint_category":"respiratory medicine","preprint_date":"2024-01-09","published_date":"2024-08-22","preprint_abstract":"BackgroundDespite advances in primary ciliary dyskinesia (PCD) research, many questions remain; diagnosis is complex and no disease specific therapies exist. Using a mixed-methods approach, we aimed to identify priorities for clinical and epidemiological research and explore barriers to research.\n\nMethodsTo obtain rich, relevant, diverse data, we performed in-depth semi-structured interviews with PCD specialists selected using purposive sampling. We transcribed, coded, and analysed interview data using thematic analysis. Based on interview themes we identified, we developed an anonymous survey and circulated it widely through the BEAT-PCD network.\n\nResultsWe interviewed 28 participants from 15 countries across different disciplines and expertise levels. The main themes identified as priorities for PCD research were improving diagnosis, understanding prevalence, and disease course; phenotypic variability; disease monitoring; treatment strategies; clinical trial endpoints; and neglected research areas. In total, 136 participants (49% paediatric pulmonologists) from 36 countries completed the survey. Most commonly reported barriers for research were low awareness about PCD and difficulties securing funding--in more than one-third of cases, participants reported undertaking predominantly unfunded research. Research questions ranked highest included priorities related to further improving diagnosis, treating PCD, managing upper and lower airway problems, and studying clinical variability and disease prognosis.\n\nConclusionWe need to overcome barriers of limited funding and low awareness and promote collaborations between centres, disciplines, experts, and patients to address PCD priorities effectively. Our results contribute to the ongoing efforts of guiding the use of existing limited research resources and setting up a roadmap for future research activities.\n\nTake home messageOur study defined PCD research priorities including improving diagnosis, treatments, managing upper and lower airway disease, and understanding prognosis. Key barriers identified include low disease awareness and limited funding opportunities.","preprint_author_corresponding":"Myrofora Goutaki","preprint_author_corresponding_institution":"University of Bern"},{"preprint_doi":"10.1101\/2024.03.08.24303910","published_doi":"10.1183\/23120541.00218-2024","published_journal":"ERJ Open Research","preprint_platform":"medRxiv","preprint_title":"Definition of sinonasal and otologic exacerbation in patients with primary ciliary dyskinesia - an expert consensus","preprint_authors":"Goutaki, M.; Lam, Y. T.; Anagiotos, A.; Armengot, M.; Burgess, A.; Campbell, R.; Carlier, M.; Caversaccio, N.; Chadha, N. K.; Demir, B.; Dheyauldeen, S. A. D.; Gunaydin, O.; Harris, A.; Hayun, I.; Inal-Ince, D.; Levi, E.; Lopez Fernandez, T.; Lucas, J. S.; Maitre, B.; Poirrier, A.-L. M.; Schofield, L.; Takeuchi, K.; van Gogh, C.; Wolter, N. E.; Papon, J.-F.","preprint_category":"otolaryngology","preprint_date":"2024-03-09","published_date":"2024-08-22","preprint_abstract":"BackgroundRecurrent infections of the nose, sinuses, and ears are common problems for people with primary ciliary dyskinesia (PCD). While pulmonary exacerbations in PCD are defined, there is no definition for Ear-Nose-Throat (ENT) exacerbations, a potential outcome for research and clinical trials.\n\nMethodsWe set up an expert panel of 24 ENT specialists, respiratory physicians, other healthcare professionals, and patients to develop consensus definitions of sinonasal and otologic exacerbations in children and adults with PCD for research settings. We reviewed the literature and used a modified Delphi approach with four electronic surveys.\n\nResultsBoth definitions are based on a combination of major and minor criteria, requiring three major or two major and at least two minor criteria each. Major criteria for a sinonasal exacerbation are: 1) reported acute increase in nasal discharge or change in colour; 2) reported acute pain or sensitivity in the sinus regions; 3) mucopurulent discharge on examination. Minor criteria include: reported symptoms; examination signs; docto[r]s decision to treat; improvement after at least 14-days. Major criteria for the otologic exacerbation are: 1) reported acute ear pain or sensitivity, 2) reported acute ear discharge, 3) ear discharge on examination, 4) signs of otitis media in otoscopy. Minor criteria are: reported acute hearing problems; signs of acute complication; docto[r]s decision to treat.\n\nConclusionThese definitions might offer a useful outcome measure for PCD research in different settings. They should be validated in future studies and trials together with other potential outcomes, to assess their usability.","preprint_author_corresponding":"Myrofora Goutaki","preprint_author_corresponding_institution":"University of Bern"},{"preprint_doi":"10.1101\/2023.11.09.23298162","published_doi":"10.1183\/23120541.00474-2024","published_journal":"ERJ Open Research","preprint_platform":"medRxiv","preprint_title":"One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study","preprint_authors":"Leavy, O. C.; Russell, R. J.; Harrison, E. M.; Lone, N. I.; Kerr, S.; Docherty, A. B.; Sheikh, A.; Richardson, M.; Elneima, O.; Greening, N. J.; Harris, V. C.; Houchen-Wolloff, L.; McAuley, H. J. C.; Saunders, R. M.; Sereno, M.; Shikotra, A.; Singapuri, A.; Aul, R.; Beirne, P.; Bolton, C. E.; Brown, J. S.; Choudhury, G.; Diar Bakerly, N.; Easom, N.; Echevarria, C.; Fuld, J.; Hart, N.; Hurst, J. R.; Jones, M.; Parekh, D.; Pfeffer, P.; Rahman, N. M.; Rowland-Jones, S.; Shah, A. M.; Wootton, D. G.; Jolley, C.; Thompson, A. R.; Chalder, T.; Davies, M. J.; De Soyza, A.; Geddes, J. R.; Greenhalf, W.","preprint_category":"infectious diseases","preprint_date":"2023-11-10","published_date":"2024-08-22","preprint_abstract":"BackgroundIn patients with COVID-19 requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during acute COVID-19 would be associated with improved health-related quality of life (HRQoL) one year after discharge.\n\nMethodsAdults admitted to hospital between February 2020 and March 2021 for COVID-19 and meeting current guideline recommendations for dexamethasone treatment were included using two prospective UK cohort studies. HRQoL, assessed by EQ-5D-5L utility index, pre-hospital and one year after discharge were compared between those receiving corticosteroids or not after propensity weighting for treatment. Secondary outcomes included patient reported recovery, physical and mental health status, and measures of organ impairment. Sensitivity analyses were undertaken to account for survival and selection bias.\n\nFindingsIn 1,888 participants included in the primary analysis, 1,149 received corticosteroids. There was no between-group difference in EQ-5D-5L utility index at one year (mean difference 0.004, 95% CI: -0.026 to 0.034, p = 0.77). A similar reduction in EQ-5D-5L was seen at one year between corticosteroid exposed and non-exposed groups (mean (SD) change -0.12 (0.22) vs -0.11 (0.22), p = 0.32). Overall, there were no differences in secondary outcome measures. After sensitivity analyses modelled using a larger cohort of 109,318 patients admitted to hospital with COVID-19, EQ-5D-5L utility index at one year remained similar between the two groups.\n\nInterpretationSystemic corticosteroids for acute COVID-19 have no impact on the large reduction in HRQoL one year after hospital discharge. Treatments to address this are urgently needed.\n\nTake home messageSystemic corticosteroids given for acute COVID-19 do not affect health-related quality of life or other patient reported outcomes, physical and mental health outcomes, and organ function one year after hospital discharge","preprint_author_corresponding":"Rachael A Evans","preprint_author_corresponding_institution":"The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK"},{"preprint_doi":"10.1101\/2024.02.06.24302127","published_doi":"10.1093\/ageing\/afae181","published_journal":"Age and Ageing","preprint_platform":"medRxiv","preprint_title":"Process evaluation of a New psychosocial goal-setting and manualised support intervention for Independence in Dementia (NIDUS-Family)","preprint_authors":"Wyman, D. L.; Butler, L. T.; Morgan-Trimmer, S.; Bright, P.; Barber, J.; Budgett, J.; Walters, K.; Lang, I.; Rapaport, P.; Banks, S.; Palomo, M.; Orgeta, V.; Livingston, G.; Rockwood, K.; Lord, K.; Manthorpe, J.; Dow, B.; Hoe, J.; Cooper, C.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2024-02-07","published_date":"2024-08-06","preprint_abstract":"IntroductionWe report a process evaluation embedded within a UK Randomised Controlled Trial (RCT), which demonstrated that New Interventions for independence in Dementia Study (NIDUS)-Family (a manualised, multimodal psychosocial intervention), was effective relative to usual care, on the primary outcome of Goal Attainment Scaling (GAS) over one year. We aimed to test and refine a hypothesised theory of change model delineating key causal assumptions for impact mechanisms.\n\nMethodsIn 2021-22, intervention-arm dyads completed an acceptability questionnaire developed to test causal assumptions. We interviewed dyads and their intervention facilitators, purposively selected for diverse follow-up GAS scores and sociodemographic diversity. Matching observational data were collected from intervention session recordings, using a checklist developed to test causal assumptions. We thematically analysed data, then integrated qualitative and quantitative data.\n\nResults174\/204 (85.3%) dyads allocated to NIDUS-Family, fully completed the intervention, 18 partially completed it, while 12 received none. 47\/192 (24.5%) of carers receiving any sessions completed the acceptability questionnaire. 27\/58 (47%) dyads purposively selected, and 9\/10 facilitators participated in qualitative interviews; and we observed 12 sessions. We identified four themes: A)  Someone to talk to helps dyads feel supported; B)  NIDUS-Family helps carers change their perspective; C)  Personalisation helps people living with dementia maintain their identity; and D)  Small steps help dyads move forward.\n\nConclusionKey causal pathway mechanisms were: regular sessions with a consistent facilitator providing space to discuss priorities, supporting carers to consider new perspectives and approaches to personalising care; and planning small actionable steps towards goals. Findings will support NIDUS-Family implementation.","preprint_author_corresponding":"Danielle Laura Wyman","preprint_author_corresponding_institution":"Anglia Ruskin University"},{"preprint_doi":"10.1101\/2024.03.17.24304341","published_doi":"10.1016\/j.jbiomech.2024.112266","published_journal":"Journal of Biomechanics","preprint_platform":"medRxiv","preprint_title":"Patient-specific compliant simulation framework informed by 4DMRI-extracted Pulse Wave Velocity: Application post-TEVAR","preprint_authors":"Girardin, L.; Diaz-Zuccarini, V.; Balabani, S.; von Tengg-Kobligk, H.; Lind, N.","preprint_category":"cardiovascular medicine","preprint_date":"2024-03-18","published_date":"2024-08-22","preprint_abstract":"We introduce a new computational framework that makes use of the Pulse Wave Velocity (PWV) extracted exclusively from 4D flow MRI (4DMRI) to inform patient-specific compliant computational fluid dynamics (CFD) simulations of a Type-B aortic dissection (TBAD), post-thoracic endovascular aortic repair (TEVAR). From 4DMRI and brachial pressure, a 3D inlet velocity profile (IVP), dynamic outlet boundary, and reconstructed thoracic aortic geometry are obtained. A moving boundary method (MBM) is applied to simulate aortic wall displacement. The aortic wall stiffness was estimated through two methods: one relying on area-based distensibility and the other utilising regional pulse wave velocity (RPWV) distensibility, further fine-tuned to align with in vivo values. Predicted pressures and outlet flow rates were within 2.3% of target values. RPWV-based simulations were more accurate in replicating in vivo hemodynamic compared to the area-based ones. RPWVs were closely predicted in most regions, with the exception being the endograft, and systolic flow reversal ratios (SFRR) were accurately captured, while a difference of above 60% on in-plane rotational flow (IRF) between the simulations. Significant disparities between the wall shear stress (WSS)-based indices were observed between the two approaches, especially the endothelial cell activation potential (ECAP). At the isthmus, the RPWV-driven simulation indicated a mean ECAP>1.4Pa-1 (critical threshold), indicating areas potentially prone to thrombosis. In contrast, the area-based simulation did not depict this. RPWV-driven simulation results agree well with 4DMRI measurements, emphasising that RPWV simulations are accurate in simulating haemodynamics, consequently facilitating a comprehensive assessment of surgery decision-making and potential complications, such as thrombosis and aortic growth.","preprint_author_corresponding":"Vanessa Diaz-Zuccarini","preprint_author_corresponding_institution":"University College London"},{"preprint_doi":"10.1101\/2023.11.29.23299196","published_doi":"10.1007\/s12028-024-02087-y","published_journal":"Neurocritical Care","preprint_platform":"medRxiv","preprint_title":"Quantitative and radiological assessment of post-cardiac arrest comatose patients with diffusion-weighted magnetic resonance imaging","preprint_authors":"Van Roy, S.; Hsu, L.; Ho, J.; Scirica, B.; Fischer, D.; Snider, S.; Lee, J. W.","preprint_category":"neurology","preprint_date":"2023-11-29","published_date":"2024-08-22","preprint_abstract":"BackgroundAlthough MR imaging, particularly diffusion weighted imaging, has increasingly been utilized as part of a multimodal approach to prognostication in patients comatose after cardiac arrest, the performance of quantitative analysis of apparent diffusion coefficient (ADC) maps, as compared to standard radiologist impression, has not been well characterized. This retrospective study evaluated quantitative ADC analysis to the identification of anoxic brain injury by diffusion abnormalities on standard clinical MRI reports.\n\nMethodsThe cohort included 204 previously described comatose patient post-cardiac arrest. Clinical outcome was assessed by 1) 3-6 month cerebral performance category (CPC); 2) Coma recovery to following commands. Radiological evaluation was obtained from clinical reports and characterized as diffuse, cortex only, deep gray matter structures only, or no injury. Quantitative analysis of ADC maps were obtained in specific regions of interest (ROI), whole cortex, and whole brain. A subgroup analysis of 172 was performed after eliminating images with artifacts and pre-existing lesions.\n\nResultsRadiological assessment outperformed quantitative assessment over all evaluated regions (AUC 0.80 for radiological interpretation, 0.70 for occipital region, the best-performing ROI, p=0.11); agreement was substantial for all regions. Radiological assessment still outperformed quantitative analysis in the subgroup analysis, though by smaller margins, and with substantial to near-perfect agreement. When assessing for coma recovery only, the difference was no longer significant (AUC 0.83 vs 0.81, p=0.70).\n\nDiscussionAlthough quantitative analysis eliminates interrater differences in the interpretation of abnormal diffusion imaging and avoids bias from other prediction modalities, clinical radiologist interpretation has a higher predictive value for outcome. This difference appears to be driven by poor scan quality, foreign body artifacts, and pre-existing stroke and white matter disease. Quantitative analysis is comparable to clinical interpretation after eliminating such scans. Further research is required into improving quantitative imaging techniques to account for such variability.","preprint_author_corresponding":"Jong Woo Lee","preprint_author_corresponding_institution":"Brigham and Women\\'s Hospital"},{"preprint_doi":"10.1101\/2024.05.01.24306620","published_doi":"10.3389\/fpubh.2024.1426489","published_journal":"Frontiers in Public Health","preprint_platform":"medRxiv","preprint_title":"Transnational adoptees in healthcare: barriers, resources, and needs","preprint_authors":"Strand, M.; Hillerberg, N.","preprint_category":"public and global health","preprint_date":"2024-05-02","published_date":"2024-08-22","preprint_abstract":"BackgroundAfter decades of research output, it is well established that transnational adoptees--i.e., individuals who are placed for adoption outside their country of birth--exhibit an increased risk of various negative mental health outcomes. Even so, there is a lack of suggestions for preventive measures or treatment interventions targeting the transnational adoptee population in the literature.\n\nObjectiveTo explore experiences, opinions, and needs among adult transnational adoptees in Sweden concerning healthcare in general and mental healthcare in particular.\n\nMethodsSixty-six adult transnational adoptees residing in Sweden, born in 15 different non-European countries, were recruited for individual in-depth interviews about their experiences and opinions regarding psychosocial support and healthcare. The interview data were analyzed employing a codebook thematic analysis approach.\n\nResultsThree overarching themes were identified: a) barriers to adequate treatment, b) helpful resources in dealing with health-related issues, and c) health-related needs and suggestions for the development of adequate support. Identified barriers include a lack of insight into and interest in adoptee health, colorblindness and unwillingness to address racism, expectations of gratitude, steep financial costs, lack of support from adoptive parents, and mistrust of support structures that involve adoptive parents or adoption organizations. Participants also describe helpful resources, such as the community of fellow transnational adoptees. Health-related needs and suggestions include more well-defined and easily accessible structures of support, improved knowledge and competence, a broader psychotherapeutic repertoire that better addresses adoption-related themes, improved support in situations that can be particularly stressful for adoptees (such as during pregnancy and as new parents), routine follow-up during childhood and adolescence, and education targeting adoptive parents. The need for greater attention to the well-being of children of transnational adoptees is also highlighted.\n\nImplicationsBased on these findings, a number of recommendations can be made. For example, knowledge about adoptee health should be strengthened, and psychotherapeutic competence in addressing issues related to racism should become a priority. After over 20 years of discussion, one or more national research and knowledge hubs on transnational adoption should be created. Moreover, economic resources should be made available to support transnational adoptees in accessing adequate treatment.","preprint_author_corresponding":"Mattias Strand","preprint_author_corresponding_institution":"Karolinska Institutet"},{"preprint_doi":"10.1101\/2024.05.23.24307850","published_doi":"10.1136\/bmjopen-2024-085819","published_journal":"BMJ Open","preprint_platform":"medRxiv","preprint_title":"HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)","preprint_authors":"Egger, M.; Sauermann, M.; Loosli, T.; Hossmann, S.; Riedo, S.; Beerenwinkel, N.; Jaquet, A.; Minga, A.; Ross, J.; Giandhari, J.; Kouyos, R.; Lessells, R. J.","preprint_category":"hiv aids","preprint_date":"2024-05-24","published_date":"2024-08-22","preprint_abstract":"IntroductionHIV drug resistance poses a challenge to the United Nations goal of ending the HIV\/AIDS epidemic. The integrase strand transfer inhibitor (InSTI) dolutegravir, which has a higher resistance barrier, was endorsed by the World Health Organization in 2019 for first-, second-, and third-line antiretroviral therapy (ART). This multiplicity of roles of dolutegravir in ART may facilitate the emergence of dolutegravir resistance.\n\nMethods and analysisDTG RESIST is a multicentre longitudinal study of adults and adolescents living with HIV in sub-Saharan Africa, Asia, and South and Central America who experienced virologic failure on dolutegravir-based ART. At the time of virologic failure whole blood will be collected and processed to prepare plasma or dried blood spots. Laboratories in Durban, Mexico City and Bangkok will perform genotyping. Analyses will focus on (i) individuals who experienced virologic failure on dolutegravir, and (ii) on those who started or switched to such a regimen and were at risk of virologic failure. For population (i), the outcome will be any InSTI drug resistance mutations, and for population (ii) virologic failure defined as a viral load >1000 copies\/mL. Phenotypic testing will focus on non-B subtype viruses with major InSTI resistance mutations. Bayesian evolutionary models will explore and predict treatment failure genotypes. The study will have intermediate statistical power to detect differences in resistance mutation prevalence between major HIV-1 subtypes; ample power to identify risk factors for virologic failure and limited power for analysing factors associated with individual InSTI drug resistance mutations.\n\nEthics and disseminationThe research protocol was approved by the Biomedical Research Ethics Committee at the University of KwaZulu-Natal, South Africa, and the Ethics Committee of the Canton of Bern, Switzerland. All sites participate in IeDEA and have obtained ethics approval from their local ethics committee to conduct the additional data collection.\n\nRegistrationNCT06285110\n\nStrengths and limitations of this study DTG RESIST is a large international study to prospectively examine emergent dolutegravir resistance in diverse settings characterised by different HIV-1 subtypes, provision of ART, and guidelines on resistance testing.\n Embedded within the International epidemiology Databases to Evaluate AIDS (IeDEA), DTG RESIST will benefit from harmonized clinical data across participating sites and expertise in clinical, epidemiological, biological, and computational fields.\n Procedures for sequencing and assembling genomes from different HIV-1 strains will be developed at the heart of the HIV epidemic, by the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), in Durban, South Africa. Phenotypic testing, Genome Wide Association Study (GWAS) methods and Bayesian evolutionary models will explore and predict treatment failure genotypes.\n A significant limitation is the absence of genotypic resistance data from participants before they started dolutegravir treatment, as collecting and bio-banking pre-treatment samples was not feasible at most IeDEA sites. Consistent and harmonized data on adherence to treatment are also lacking.\n The distribution of HIV-1 subtypes across different sites is uncertain, which may limit the statistical power of the study in analysing patterns and risk factors for dolutegravir resistance. The results from GWAS and Bayesian modelling analyses will be preliminary and hypothesis-generating.","preprint_author_corresponding":"Matthias Egger","preprint_author_corresponding_institution":"University of Bern: Universitat Bern"},{"preprint_doi":"10.1101\/2023.09.11.23295348","published_doi":"10.1007\/s44200-024-00057-5","published_journal":"Artery Research","preprint_platform":"medRxiv","preprint_title":"Flow-mediated dilatation: learning curve study with a novice operator","preprint_authors":"Dhar, A. S.; Fisk, M.; McEniery, C. M.; Cseh, D.","preprint_category":"cardiovascular medicine","preprint_date":"2023-09-12","published_date":"2024-08-22","preprint_abstract":"IntroductionBrachial artery flow-mediated dilatation (FMD) is commonly measured to assess endothelial function in experimental and clinical research studies. However, attaining reproducible results can be challenging, especially among inexperienced operators. Until now, no detailed learning curve study of novice operators has been published.\n\nMethodsWe assessed the learning curve of FMD measurement in one novice operator. Following a one-week basic training period, the operator performed duplicate measurements on 6-8 individuals per week, for six weeks. The operator followed the recommendations of the most recent FMD measurement guideline. Duplex ultrasound was used for the simultaneous and continuous measurement of brachial artery diameter and local blood flow velocity. Following a 1-minute recording of baseline diameter (D), FMD was measured after a 5-minute period of occlusion of the proximal forearm vessels. Inter-session coefficient of variation (CV) values for D and FMD were calculated for each week.\n\nResultsThe majority of participants did not have any cardiovascular disease history. The number of volunteers assessed each week were the following: 8, 7, 7, 6, 7, 7 individuals, from week 1 to week 6. CV values for both D and FMD exhibited a decreasing trend over the training period, ending at 1.73% for D and 14.24% for FMD at week 6. The CV values at week 6 were within the range outlined in the most recent FMD guideline for proficiency.\n\nConclusionsWithin a reasonable timeframe, and with careful adherence to measurement guidelines, the attainment of sound reproducibility in FMD measurements by a novice operator is feasible.","preprint_author_corresponding":"Domonkos Cseh","preprint_author_corresponding_institution":"Division of Experimental Medicine and Immunotherapeutics, University of Cambridge"},{"preprint_doi":"10.1101\/2023.08.02.23293545","published_doi":"10.1002\/nop2.2249","published_journal":"Nursing Open","preprint_platform":"medRxiv","preprint_title":"A qualitative exploration to inform an oral health training for disability care workers in Burkina Faso","preprint_authors":"Pold, A.; Kientega, D. F.; Gare, J. V.; Lorenz, M.","preprint_category":"nursing","preprint_date":"2023-08-04","published_date":"2024-08-22","preprint_abstract":"IntroductionSignificant inequalities in oral health needs exist among people with intellectual and developmental disability in low-income settings such as Burkina Faso.\n\nAimTo explore enablers and barriers to the creation of an oral health training for caregivers of children with disabilities at specialized centres in Ouagadougou.\n\nMethodThis was a formative study informed by the Theoretical Domains Framework (TDF) using qualitative methods comprising observations at five centres for disability and semi-structured interviews with 14 caregivers.\n\nResultsA successful training facilitation to caregivers must account for resources available in centres, part of the training must be dedicated to healthy diets and provide ideas for lowering sugar consumption and the training must empower caregivers with practical skills and tools to manage regular toothbrushing and identification of child oral health needs.\n\nDiscussionThese observations and interviews enabled us to gather valuable and unique perspectives into the everyday functioning of centres for disability, and the professional and personal role of caregivers working with children with disabilities in Ouagadougou.\n\nImplications for practiceTeams planning oral health promotion activities in low resourced settings for vulnerable population groups can benefit from the methodology and results of this research for ensuring their interventions are appropriate and relevant.\n\nRelevance statementThis is a unique field study conducted in a scarcely researched area of caregiving practices for children with disabilities in a low-income country, Burkina Faso. Results from the disability centre observations and interviews with local caregivers are of great value to any team planning health projects in similar low-resourced settings. Psychiatric and mental health nursing practices are highly context-dependent, thus using proposed qualitative methods can help to ensure that planned interventions are appropriate and relevant.\n\nAccessible summaryWhat is known on the subject?\n\nO_LIPeople with disabilities often suffer from oral disease and lack opportunities to access oral care, especially in low-income countries such as Burkina Faso.\nC_LIO_LITheir caregivers and nurses lack training in oral health, necessary resources, and motivation to take care of oral hygiene and diet.\nC_LI\n\nWhat the paper adds to existing knowledge?O_LIThis paper provides a detailed description of the everyday activities and functioning of disability care centres in Ouagadougou, Burkina Faso and insider perspectives related to the struggles, joys, and motivation of carers in performing their work activities.\nC_LIO_LIThis paper adds new knowledge about the reality of disability care in Burkina Faso and gives practical information to teams planning health promotion activities in similar contexts, focusing primarily on oral health promotion and training.\nC_LI\n\nWhat are the implications for practice?O_LIDedicating effort to improving the oral health of people with disabilities depends largely on nurses and carers having necessary resources including materials, practical skills, time and support to be empowered in their duties.\nC_LIO_LIResults from the disability centre observations and interviews with local caregivers are of great value to any team planning health projects in similar low-resourced settings with mental health nurses or carers.\nC_LI","preprint_author_corresponding":"Ave Pold","preprint_author_corresponding_institution":"Charite Universitatsmedizin Berlin, Institute of Tropical Medicine and International Health"},{"preprint_doi":"10.1101\/2024.03.04.24303692","published_doi":"10.1093\/pnasnexus\/pgae338","published_journal":"PNAS Nexus","preprint_platform":"medRxiv","preprint_title":"Influenza virus shedding and symptoms: Dynamics and implications from a multi-season household transmission study","preprint_authors":"Morris, S. E.; Nguyen, H. Q.; Grijalva, C. G.; Hanson, K. E.; Zhu, Y.; Biddle, J. E.; Meece, J. K.; Halasa, N. B.; Chappell, J. D.; Mellis, A. M.; Reed, C.; Biggerstaff, M.; Belongia, E. A.; Talbot, H. K.; Rolfes, M. A.","preprint_category":"epidemiology","preprint_date":"2024-03-04","published_date":"2024-08-22","preprint_abstract":"Isolation of symptomatic infectious persons can reduce influenza transmission. However, virus shedding that occurs without symptoms will be unaffected by such measures. Identifying effective isolation strategies for influenza requires understanding the interplay between individual virus shedding and symptom presentation. From 2017-2020, we conducted a case-ascertained household transmission study using influenza real-time reverse transcription quantitative PCR (RT-qPCR) testing of nasal swabs and daily symptom diary reporting for up to 7 days after enrollment ([&le;]14 days after index onset). We assumed real-time RT-qPCR cycle threshold (Ct) values were indicators of quantitative virus shedding and used symptom diaries to create a score that tracked influenza-like-illness (ILI) symptoms (fever, cough, or sore throat). We fit phenomenological nonlinear mixed-effects models stratified by age and vaccination status and estimated two quantities influencing isolation effectiveness: shedding before symptom onset and shedding that might occur once isolation ends. We considered different isolation end points (including 24 hours after fever resolution or 4 days after symptom onset) and assumptions about the infectiousness of Ct shedding trajectories. Of the 116 household contacts with [&ge;]2 positive tests for longitudinal analyses, 105 (91%) experienced [&ge;]1 ILI symptom. On average, children <5 years experienced greater peak shedding, longer durations of shedding, and elevated ILI symptom scores compared with other age groups. Most individuals (63\/105) shed <10% of their total shed virus before symptom onset, and shedding after isolation varied substantially across individuals, isolation end points, and infectiousness assumptions. Our results can inform strategies to reduce transmission from symptomatic individuals infected with influenza.\n\nSignificance StatementIndividuals infected with influenza are encouraged to avoid contact with others for a period following symptom onset. This action should reduce the likelihood of onward transmission if infectious virus shedding is associated with symptom presentation. We modeled influenza virus shedding and symptom dynamics in participants of a multi-season household transmission study. On average, children <5 years shed more virus for longer durations and experienced elevated influenza-like-illness symptoms compared with older age groups. Most shedding took place after symptom onset, and estimated shedding that might remain after a period of avoiding contact with others depended on how the end of this period was defined. Our results can help inform strategies to reduce transmission from symptomatic individuals infected with influenza.","preprint_author_corresponding":"Sinead E Morris","preprint_author_corresponding_institution":"Centers for Disease Control and Prevention; Goldbelt Professional Services"},{"preprint_doi":"10.1101\/2024.06.06.24308477","published_doi":"10.1093\/rheumatology\/keae447","published_journal":"Rheumatology","preprint_platform":"medRxiv","preprint_title":"Incidence of Chronic Recurrent Multifocal Osteomyelitis in Children and Adolescents in the UK and Republic of Ireland","preprint_authors":"Chia, D. T.; Toms, A. P.; Sanghrajka, A.; Ramanan, A.; Killeen, O. G.; Ilea, C.; Mahmood, K.; Compeyrot-Lacassagne, S.; Bailey, K.; Martin, N.; Armon, K.; Suo, C.","preprint_category":"rheumatology","preprint_date":"2024-06-07","published_date":"2024-08-22","preprint_abstract":"ObjectivesChronic Recurrent Multifocal Osteomyelitis (CRMO), also known as chronic nonbacterial osteomyelitis (CNO), is a rare autoinflammatory condition affecting the bones in children and teenagers. The actual incidence of CRMO remains uncertain. The objective of this study is to identify the incidence of CRMO in children and young people under the age of 16 years in the United Kingdom (UK) and Republic of Ireland (ROI). We also aim to delineate the demographics, clinical presentation, investigations, initial management and healthcare needs for children and adolescents with CRMO.\n\nMethodsWe conducted monthly surveys among all paediatric consultants and paediatric orthopaedic surgeons to identify patients newly diagnosed with CRMO between October 2020 and November 2022. A standardised questionnaire was sent to reporting clinicians to collect further information.\n\nResultsOver the surveillance period, 288 patients were reported, among which, 165 confirmed and 20 probable cases were included in the analysis. The highest incidences were among 8-10 year-olds. A two-to-one female-to-male difference in incidence was observed, and male patients were more likely to present with multifocal disease. A negative correlation was observed between reporting clavicular and leg pain. Investigation-wise, 80.0% of patients were reported to have undergone whole-body MRI and 51.1% had bone biopsies. The most common initial treatments were NSAIDs (93.9%) and bisphosphonates (44.8%).\n\nConclusionThis study estimates an average annual CRMO incidence of 0.65 cases per 100,000 children and adolescents in the UK and ROI. These findings establish a crucial baseline for ongoing research and improvement in the care of individuals with CRMO.\n\nKey MessagesO_LIThe estimated annual incidence of CRMO is 0.65 per 100,000 children and adolescents aged <16.\nC_LIO_LITwo-fold higher incidence in females to males was found, with the highest incidence in 8-10 year-olds.\nC_LIO_LIMale patients are more likely to present with multifocal disease compared with females.\nC_LI","preprint_author_corresponding":"Chenqu Suo","preprint_author_corresponding_institution":"Department of Paediatrics, University of Cambridge, Cambridge, UK"},{"preprint_doi":"10.1101\/2023.12.27.23300593","published_doi":"10.1161\/CIRCEP.124.013015","published_journal":"Circulation: Arrhythmia and Electrophysiology","preprint_platform":"medRxiv","preprint_title":"Clinical Implications of Atrial Fibrillation Provoked by Acetylcholine","preprint_authors":"Shibata, K.; Wakabayashi, K.; Ikeda, N.; Ishinaga, T.; Kusakabe, Y.; Masaki, A.; Aizawa, N.; Suguru, S.; Furuya, T.; Nakamura, Y.; Sato, C.; Nishikura, T.; Shiigai, M.; Mutou, M.; Honye, J.; Tanno, K.","preprint_category":"cardiovascular medicine","preprint_date":"2023-12-30","published_date":"2024-08-22","preprint_abstract":"BackgroundThe coronary spasm provocation test using acetylcholine (ACh) is useful for diagnosing vasospastic angina (VSA). Paroxysmal atrial fibrillation (PAF) during ACh testing is frequent and usually transient. However, the clinical implications of PAF provoked by ACh is unknown. Deterioration of the left atrial (LA) reservoir strain is associated with new-onset of atrial fibrillation (AF) and fibrosis of the left atrium; additionally, ACh shortens the action potential duration and facilitates AF in the fibrotic atria in the human AF model. Hence, this study aimed to investigate the relationship between LA function and occurrence of AF during the ACh test.\n\nMethodsWe studied a consecutive cohort of 100 patients (60.1{+\/-}14.5 years, 39 women) without history of AF who underwent the ACh test in our centers from 2015 to 2022. Echocardiographic data were available for all the patients. PAF was defined as lasting >30 s during the ACh test. Based on the occurrence of AF during the ACh test, the patients were divided into two groups: provoked PAF group (n=29) vs. non AF group (n=71). LA function was assessed via two-dimensional speckle-tracking echocardiography. Occurrences of spontaneous AF were recorded as clinical events during long-term follow-up.\n\nResultsThe observation period was 675 (114.5-1789.5) days, and 65 patients (65%) were tested positive in the ACh test and diagnosed with VSA. LA volume index was similar between provoked PAF and non AF groups (26.9{+\/-}7.4 mL\/m2 vs. 27.1{+\/-}8.5 mL\/m2, p=0.89). In contrast, LA reservoir (27.6{+\/-}5.2% vs. 34.8{+\/-}6.8%, p<0.001) and conduit (13.4{+\/-}5.1% vs. 18.4{+\/-}6.2%, p<0.001) strain were significantly lower in provoked PAF group than in non AF group. The provoked PAF group had a lower LA booster strain (14.1{+\/-}5.6% vs. 16.4{+\/-}6.3%, p=0.093) than non AF group. A multiple regression analysis showed that LA reservoir strain was independently associated with the provoked PAF during ACh test (OR 0.81, 95% CI: 0.72-0.91, p<0.001). In the provoked PAF group, spontaneous AF occurred in three patients (10.3%), one of whom was treated with pulmonary vein isolation, whereas there were no events of PAF in the non AF group.\n\nConclusionThe occurrence of PAF during the ACh test suggests dysfunction of left atria and may predict future PAF.","preprint_author_corresponding":"Kohei Wakabayashi","preprint_author_corresponding_institution":"Showa University Koto-Toyosu Hospital"},{"preprint_doi":"10.1101\/2024.03.24.24304597","published_doi":"10.1371\/journal.pone.0301564","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Relevance of Mediterranean diet as a nutritional strategy in diminishing COVID-19 risk: A systematic review","preprint_authors":"Halim, C.; Howen, M.; Fitrisubroto, A. A. N. b.; Pratama, T.; Harahap, I. R.; Ganesh, L. J.; Siahaan, A. M. P.","preprint_category":"nutrition","preprint_date":"2024-03-25","published_date":"2024-08-21","preprint_abstract":"BackgroundMediterranean Diet has been reported to possess immunomodulatory and anti-inflammatory properties. These properties are closely associated with the immunopathogenesis of COVID-19.\n\nObjectiveThe present systematic review aimed to determine the association between Mediterranean Diet and COVID-19, COVID-19 symptoms, and COVID-19 severity.\n\nMethodsThe protocol for this systematic review was registered in International Prospective Register of Systematic Reviews (PROSPERO) with identification number CRD42023451794. The literature search was conducted through Pubmed, Proquest, and Google Scholar on August 2023. The inclusion criteria were studies with a population of human subjects, reported the association between Mediterranean diet adherence with risk of COVID-19 infection, COVID-19 symptoms, or COVID-19 severity, and full text must be available in English. The exclusion criteria were reviews, editorials, letters, replies, systematic reviews, meta-analyses, studies on animals, and duplicates. Risk of bias in included studies was assessed using Newcastle Ottawa Scale (NOS). Data was synthesized narratively. Each study was compared and a structured summary was developed.\n\nResultsAfter selection process, 6 articles were included, with a sample size of 55,489 patients. All studies were observational studies and assessed Mediterranean diet adherence using food frequency questionnaires (FFQ), with scoring system varied between each study. Four studies found a significant correlation between increased adherence to Mediterranean Diet and reduced COVID-19 risk, while one study indicated non-significant association. One study reported a significant association between higher adherence to Mediterranean Diet and COVID-19 symptoms, but three studies reported non-significant association. One study found that individuals with higher adherence to Mediterranean Diet had reduced likelihood of developing severe COVID-19, however, two studies yielded inconclusive findings.\n\nLimitationsAll studies used self-administrated food frequency questionnaires (FFQs), which were prone to biased responses, such as recall and estimation bias.\n\nDiscussionLower trends of odds ratios (ORs) were consistently observed in higher Mediterranean diet adherence. In every outcome of the included studies, ORs ranged between 0.06-0.992, however, differing levels of significance were reported in each outcome.\n\nConclusionOverall analyses suggest that high adherence to Mediterranean Diet is a protective factor against COVID-19, with unclear benefits against COVID-19 symptoms and severity.\n\nPrimary Funding SourceThe author(s) received no specific funding for this work.","preprint_author_corresponding":"Andre  Marolop Pangihutan Siahaan","preprint_author_corresponding_institution":"Universitas Sumatera Utara Fakultas Kedokteran"},{"preprint_doi":"10.1101\/2024.05.10.24307195","published_doi":"10.1080\/19490976.2024.2391505","published_journal":"Gut Microbes","preprint_platform":"medRxiv","preprint_title":"Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease","preprint_authors":"Prins, F. M.; Hidding, I. J.; Klaassen, M. A. Y.; Collij, V.; Schultheiss, J. P. D.; Uniken Venema, W. T. C.; Bangma, A.; Aardema, J. B.; Jansen, B. H.; Mares, W. G. N.; Witteman, B. J. M.; Festen, E. A. M.; Dijkstra, G.; Visschedijk, M. C.; Fidder, H. H.; Vich Vila, A.; Oldenburg, B.; Gacesa, R.; Weersma, R. K.","preprint_category":"gastroenterology","preprint_date":"2024-05-10","published_date":"2024-08-21","preprint_abstract":"IntroductionThe complexity of Inflammatory Bowel Diseases (IBD) presents challenges for the management of these diseases. Predicting treatment outcomes remains difficult, leading to suboptimal outcomes and high costs. Emerging evidence suggests the potential of the gut microbiome in predicting response to biologic treatments. In this prospective study we aimed to predict treatment response to vedolizumab and ustekinumab in 79 IBD patients by integrating clinical data, gut microbiome profiles and fecal metabolites and validating these findings in a replication cohort of 47 IBD patients.\n\nMethodsTreatment response was defined as either continuation or discontinuation of the biologic at six months. We performed whole genome metagenomic shotgun sequencing on the baseline fecal samples to detect microbial and functional profiles. Additionally, over 1000 metabolites were captured through untargeted metabolomic profiling. Baseline diversity, dissimilarity and differential abundance analyses compared responder and non-responder groups. The prediction tool CoDaCoRe was used to identify predictive log-ratio biomarkers. We tested our identified ratios in an external cohort and attempted to replicate the microbiome-based signals of previous studies. Finally, we used a neural-network framework to model the relationship between metabolites and microbes, comparing these clusters in responders and non-responders and tested our approach with different definitions of response.\n\nResultsWe identified seven metabolites to be differentially abundant between responders and non-responders (FDR < 0.05). However, no significant differences in bacterial species and pathways were detected at baseline between responders and non-responders. Our prediction analysis indicated only marginal predictive utility of the gut microbiome and fecal metabolites for treatment response, when compared to a clinical model using fecal calprotectin, disease duration and disease activity, among other factors (AUC only clinical features: 0.71{+\/-}0.13, AUC microbial and clinical features: 0.73{+\/-}0.12). The main predictive features of these models were the disease activity and previous anti-TNF use combined with high abundance of Phocaeicola vulgatus, Bacteroides uniformis and Alistipes onderdonkii, and the low abundance of Ruminococcus gnavus and Faecalibacterium prausnitzii. Testing our identified ratio of 10 species in an external cohort of 47 IBD patients reinforced the lack of predictive power of the microbiome. No replication of previously published predictive signals of the microbiome was observed. Additionally, we identified 2 metabolite clusters and 1 microbiome cluster associated with response, and observed that predictors were highly dependent on the definition of response.\n\nConclusionWhile previous studies of similar size have shown that microbial features can predict response to either vedolizumab (VedoNet), or vedolizumab, ustekinumab and anti-TNF, our comprehensive study found no significant differences in the gut microbiome at baseline between responders and non-responders among IBD patients treated with ustekinumab or vedolizumab. Microbial features added no predictive power to drug response in our IBD patient cohort or an independent replication cohort. Addition of metabolite features did not improve predictive power. These findings suggest minimal impact of the pre-treatment gut microbiome on treatment outcomes with these medications in IBD patients with long term chronic disease. Generalizability beyond initial study cohorts is limited, leaving predictors for individualized IBD-medication selection unidentified, but based on this work, likely do not lie in the fecal microbiome.","preprint_author_corresponding":"Rinse K Weersma","preprint_author_corresponding_institution":"University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, The Netherlands; University of Groningen, Universit"},{"preprint_doi":"10.1101\/2023.04.20.23288894","published_doi":"10.1161\/JAHA.123.033648","published_journal":"Journal of the American Heart Association","preprint_platform":"medRxiv","preprint_title":"Menopausal vasomotor symptoms and subclinical atherosclerotic cardiovascular disease - a population-based study","preprint_authors":"Nilsson, S.; Qvick, A.; Henriksson, M.; Sederholm Lawesson, S.; Spetz Holm, A.-C.; Leander, K.","preprint_category":"cardiovascular medicine","preprint_date":"2023-04-24","published_date":"2024-08-21","preprint_abstract":"BACKGROUNDMenopausal vasomotor symptoms (VMS) have been associated with subclinical and manifest atherosclerotic cardiovascular disease (ASCVD) but have not been studied in relation to image-detected coronary atherosclerosis. We assessed the association between VMS and subclinical ASCVD in peri- and postmenopausal women, considering a wide range of cardiovascular related risk factors that could potentially influence the relationship.\n\nMETHODSThis cross-sectional population-based study was conducted on a subset of participants from the Swedish CArdioPulmonary BioImage Study (SCAPIS), including women 50-65 years of age. The women underwent comprehensive cardiovascular assessments and completed an extensive questionnaire, which included questions about current and previous menopause-related symptoms. VMS was assessed on a 4-point scale and analyzed in relation to subclinical ASCVD, detected via coronary computed tomography angiography (CCTA), coronary artery calcium score (CACS) and carotid ultrasound using logistic regression analyses.\n\nRESULTSOf 2995 women included, 14.2% reported previous or on-going severe VMS (n=425), 18.1% moderate VMS (n=543), and 67.7% no or mild VMS (n=2027). Women who had ever experienced severe VMS, but not those with ever moderate VMS, had higher prevalence of CCTA-detected coronary atherosclerosis (34.1 vs 27.8%, p=0.017), but not segmental involvement score (SIS) >3 (4.5 vs 5.1%, p=0.332), CACS>100 (5.8 vs 6.8%, p=0.166) or any carotid plaque (47.6% vs 46.6%, p=249) than women with never or ever mild VMS. Using the same reference, ever severe but not moderate VMS was significantly associated with CCTA-detected coronary atherosclerosis, odds ratio (OR) after multivariable adjustment 1.33, 95% CI 1.02-1.72. This association was only present for durations of severe VMS of more than 5 years (multivariable adjusted OR 1.53 95% CI 1.09-2.14) or when the onset of severe VMS occurred before menopause (multivariable adjusted OR 1.60 95% CI 1.06-2.42). Additional adjustment for menopausal hormone therapy strengthened the associations whereas additional adjustment for physical activity did not. No significant association with SIS>3, CACS>100, nor with any carotid plaque was observed.\n\nCONCLUSIONSPrevious or on-going severe but not moderate VMS were significantly associated with CCTA-detected coronary atherosclerosis, independent of a broad range of cardiovascular risk factors. No corresponding associations was observed for SIS>3, CACS>100 or carotid atherosclerosis.","preprint_author_corresponding":"Sigrid Nilsson","preprint_author_corresponding_institution":"Department of Obstetrics and Gynecology, and Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"preprint_doi":"10.1101\/2023.11.22.23298875","published_doi":"10.1371\/journal.pntd.0011810","published_journal":"PLOS Neglected Tropical Diseases","preprint_platform":"medRxiv","preprint_title":"The risk and risk factors of chikungunya virus infection and rheumatological sequelae in a cohort of U.S. Military Health System beneficiaries: implications for the vaccine era","preprint_authors":"Pollett, S.; Hsieh, H.-C.; Lu, D.; Grance, M.; Nowak, G.; Lanteri, C.; Tribble, D.; Burgess, T.","preprint_category":"infectious diseases","preprint_date":"2023-11-23","published_date":"2024-08-05","preprint_abstract":"BackgroundUnderstanding the risk of chikungunya virus (CHIKV) infection and rheumatic sequelae across populations, including travelers and the military, is critical. We leveraged the electronic medical records of about 9.5 million U.S. Military Health System (MHS) beneficiaries to identify the risk of post-CHIKV rheumatic sequelae.\n\nMethodology\/Principal FindingsMHS beneficiary CHIKV infections diagnosed 2014-2018 were identified from the Disease Reporting System internet, TRICARE Encounter Data Non-Institutional, and Comprehensive Ambulatory\/Professional Encounter Record systems. Non-CHIKV controls were matched (1:4) by age, gender, beneficiary status, and encounter date. The frequency of comorbidities and incident rheumatic diagnoses through 2020 were derived from International Classification of Diseases codes and compared between cases and controls. Logistic regression models estimated the association of CHIKV infection with rheumatic sequelae and risk factors for post-CHIKV sequelae. 195 CHIKV cases were diagnosed between July 2014 and December 2018. The mean age was 42 years, and 43.6% were active duty. 63\/195 (32.3%) of CHIKV cases had an incident rheumatic diagnosis, including arthralgia, polyarthritis, polymyalgia rheumatica, and\/or rheumatoid arthritis, compared to 156\/780 (20.0%) of controls (p < 0.001). CHIKV infection remained associated with rheumatic sequelae (aOR = 1.911, p = 0.002) after adjusting for prior rheumatic disease and demography. Those with rheumatic CHIKV sequelae had a median 7 healthcare encounters (IQR 3-15). Among CHIKV infections, we found no association between post-CHIKV rheumatic sequelae and demography, service characteristics, or comorbidities.\n\nConclusions\/SignificanceCHIKV infection is uncommon but associated with rheumatic sequelae among MHS beneficiaries, with substantial healthcare requirements in a proportion of cases with such sequelae. No demographic, clinical, or occupational variables were associated with post-CHIKV rheumatic sequelae, suggesting that prediction of these complications is challenging in MHS beneficiaries. These findings are important context for future CHIKV vaccine decision making in this and other populations.\n\nAuthor summaryWe examined U.S. Military Health System (MHS) electronic medical records during to identify the likelihood of rheumatic complications after chikungunya virus (CHIKV) infection. Overall, CHIKV infections were rare in the MHS, with 195 cases found in the records between 2014 and 2018 (a period which encompassed the peak of the CHIKV epidemic in the Americas). Of these, about 32% received a rheumatic diagnosis after infection, including arthralgia, polyarthritis, polymyalgia rheumatica, and rheumatoid arthritis. Patients who had a rheumatic diagnosis had on average 7 healthcare encounters for their post-CHIKV rheumatic complication, and a quarter had more than 15 healthcare encounters. We did not find any demographic, clinical, or occupational characteristics associated with developing rheumatic complications after CHIKV, suggesting that predicting rheumatic complications from CHIKV may be challenging in MHS beneficiaries. These findings may provide important context for decisions about implementing an approved chikungunya vaccine to military servicemembers and other MHS beneficiaries.","preprint_author_corresponding":"Simon Pollett","preprint_author_corresponding_institution":"Uniformed Services University of the Health Sciences"},{"preprint_doi":"10.1101\/2024.02.26.24303361","published_doi":"10.1016\/j.cortex.2024.07.007","published_journal":"Cortex","preprint_platform":"medRxiv","preprint_title":"Establishing and evaluating the gradient of item naming difficulty in post-stroke aphasia and semantic dementia","preprint_authors":"Noerkaer, E.; Halai, A. D.; Woollams, A.; Lambon Ralph, M. A.; Schumacher, R.","preprint_category":"neurology","preprint_date":"2024-02-27","published_date":"2024-08-10","preprint_abstract":"Anomia is a common consequence following brain damage and a central symptom in semantic dementia (SD) and post-stroke aphasia (PSA), for instance. Picture naming tests are often used in clinical assessments and experience suggests that items vary systematically in their difficulty. Despite clinical intuitions and theoretical accounts, however, the existence and determinants of such a naming difficulty gradient remain to be empirically established and evaluated. Seizing the unique opportunity of two large-scale datasets of semantic dementia and post-stroke aphasia patients assessed with the same picture naming test, we applied an Item Response Theory (IRT) approach and we (a) established that an item naming difficulty gradient exists, which (b) partly differs between patient groups, and is (c) related in part to a limited number of psycholinguistic properties - frequency and familiarity for SD, frequency and word length for PSA. Our findings offer exciting future avenues for new, adaptive, time-efficient, and patient-tailored approaches to naming assessment and therapy.","preprint_author_corresponding":"Rahel Schumacher","preprint_author_corresponding_institution":"MRC Cognition and Brain Sciences Unit, University of Cambridge; Neurocenter, Luzerner Kantonsspital, Lucerne"},{"preprint_doi":"10.1101\/2024.01.13.24301070","published_doi":"10.1038\/s44321-024-00115-0","published_journal":"EMBO Molecular Medicine","preprint_platform":"medRxiv","preprint_title":"Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction","preprint_authors":"Li, X.; Liu, T.; Bacchiocchi, A.; Li, M.; Cheng, W.; Wittkop, T.; Mendez, F.; Wang, Y.; Tang, P.; Yao, Q.; Bosenberg, M. W.; Sznol, M.; Yan, Q.; Faham, M.; Weng, L.; Halaban, R.; Jin, H.; Hu, Z.","preprint_category":"oncology","preprint_date":"2024-01-13","published_date":"2024-08-20","preprint_abstract":"While whole genome sequencing (WGS) of cell-free DNA (cfDNA) holds enormous promise for molecular residual disease (MRD) detection, its performance is limited by WGS error rate. Here we introduce AccuScan, an efficient cfDNA WGS technology that enables genome-wide error correction at single read level, achieving an error rate of 4.2x10-7, which is about two orders of magnitude lower than a read-centric de-noising method. When applied to MRD detection, AccuScan demonstrated analytical sensitivity down to 10-6 circulating tumor allele fraction at 99% sample level specificity. In colorectal cancer, AccuScan showed 90% landmark sensitivity for predicting relapse. It also showed robust MRD performance with esophageal cancer using samples collected as early as 1 week after surgery, and predictive value for immunotherapy monitoring with melanoma patients. Overall, AccuScan provides a highly accurate WGS solution for MRD, empowering circulating tumor DNA detection at parts per million range without high sample input nor personalized reagents.\n\nOne Sentence SummaryAccuScan showed remarkable ultra-low limit of detection with a short turnaround time, low sample requirement and a simple workflow for MRD detection.","preprint_author_corresponding":"Ruth Halaban","preprint_author_corresponding_institution":"Yale University School of Medicine"},{"preprint_doi":"10.1101\/2023.03.14.23287262","published_doi":"10.1016\/j.isci.2024.110654","published_journal":"iScience","preprint_platform":"medRxiv","preprint_title":"Serum lipidome associates with neuroimaging features in patients with traumatic brain injury","preprint_authors":"Thomas, I.; Newcombe, V. F. J.; Dickens, A. M.; Richter, S.; Posti, J. P.; Maas, A. I. R.; Tenovuo, O.; Hyotylainen, T.; Buki, A.; Menon, D. K.; Oresic, M.","preprint_category":"neurology","preprint_date":"2023-03-20","published_date":"2024-08-03","preprint_abstract":"Acute traumatic brain injury (TBI) is associated with substantial metabolic abnormalities, both centrally and in the periphery. We have previously reported extensive changes in the circulating metabolome resulting from TBI, including changes proportional to disease severity and associated with patient outcomes. The observed metabolome changes in TBI likely reflect several pathophysiological mechanisms supporting the concept that TBI is a systemic disease after the primary injury. However, one of the main metabolic changes we have observed following a TBI are changes in lipids, including the structural lipids that are known to be present in the myelin in the brain.\n\nHere, we conducted a study to investigate the relationship between traumatic microstructural changes in white matter seen on magnetic resonance imaging (MRI) and quantitative lipidomic changes in the blood in a subset of patients with TBI recruited to the MRI sub-study of the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study.\n\nIn total, there were 103 patients who had both a magnetic resonance imaging (MRI) scan and serum samples available for analysis. From serum, 201 known lipids were quantified. Diffusion tensor fitting generated fractional anisotropy (FA) and mean diffusivity (MD) maps for the MRI scans, in addition to volumetric data. Association matrices and partial correlation networks were built to elucidate the connections between the lipid groups and the maps.\n\nWe found that there are distinct directions of associations between the neuroimage data (FA and MD sets) and the concentrations of circulating lipids after injury. The FA and MD values were in inverse relationship with the severity of TBI (higher MD values, lower FA). We also observed that the lipid associations to FA and MD show different metabolic signatures. Lysophosphatidylcholines (LPC) associate mostly with FA while sphingomyelins (SM) associate with MD. Only phosphatidylcholines(PC) have strong associations with both as well as with the volumetric data. Finally, we found that the lipid changes are not associated with the number of regions with abnormalities.\n\nIn conclusion, we have identified groups of lipids which assocate with specific MRI imaging metrics following TBI. There appears to be consistent patterns of lipid changes associating with the specific microstructure changes in the CNS white matter. There is also a pattern of lipids with regional specficity, suggesting that blood-based lipidomics may provide an insight into the underlying disease mechanisms in TBI.","preprint_author_corresponding":"Matej Oresic","preprint_author_corresponding_institution":"Orebro University"},{"preprint_doi":"10.1101\/2023.11.16.23298633","published_doi":"10.1093\/aje\/kwae288","published_journal":"American Journal of Epidemiology","preprint_platform":"medRxiv","preprint_title":"Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals","preprint_authors":"Ortiz-Brizuela, E.; Carabali, M.; Jiang, C.; Merckx, J.; Talbot, D.; Schnitzer, M. E.","preprint_category":"epidemiology","preprint_date":"2023-11-16","published_date":"2024-08-14","preprint_abstract":"The test-negative design (TND) is a popular method for evaluating vaccine effectiveness (VE). A \"classical\" TND study includes symptomatic individuals tested for the disease targeted by the vaccine to estimate VE against symptomatic infection. However, recent applications of the TND have attempted to estimate VE against infection by including all tested individuals, regardless of their symptoms. In this article, we use directed acyclic graphs and simulations to investigate potential biases in TND studies of COVID-19 VE arising from the use of this \"alternative\" approach, particularly when applied during periods of widespread testing. We show that the inclusion of asymptomatic individuals can potentially lead to collider stratification bias, uncontrolled confounding by health and healthcare-seeking behaviors (HSBs), and differential outcome misclassification. While our focus is on the COVID-19 setting, the issues discussed here may also be relevant in the context of other infectious diseases. This may be particularly true in scenarios where there is either a high baseline prevalence of infection, a strong correlation between HSBs and vaccination, different testing practices for vaccinated and unvaccinated individuals, or settings where both the vaccine under study attenuates symptoms of infection and diagnostic accuracy is modified by the presence of symptoms.","preprint_author_corresponding":"Mireille E. Schnitzer","preprint_author_corresponding_institution":"Universite de Montreal"},{"preprint_doi":"10.1101\/2024.04.08.24305414","published_doi":"10.1016\/j.cmpbup.2024.100160","published_journal":"Computer Methods and Programs in Biomedicine Update","preprint_platform":"medRxiv","preprint_title":"Predicting chronic kidney disease progression using small pathology datasets and explainable machine learning models","preprint_authors":"Reddy, S.; Roy, S.; Choy, K. W.; Sharma, S.; Dwyer, K. M.; Manapragada, C.; Nakisa, B.","preprint_category":"health informatics","preprint_date":"2024-04-10","published_date":"2024-08-08","preprint_abstract":"Chronic kidney disease (CKD) poses a major global public health burden, with approximately 7 million affected. Early identification of those in whom disease is likely to progress enables timely therapeutic interventions to delay advancement to kidney failure. This study developed explainable machine learning models leveraging pathology data to accurately predict CKD trajectory, targeting improved prognostic capability even in early stages using limited datasets. Key variables used in this study include age, gender, most recent estimated glomerular filtration rate (eGFR), mean eGFR, and eGFR slope over time prior to incidence of kidney failure. Supervised classification modelling techniques included decision tree and random forest algorithms selected for interpretability. Internal validation on an Australian tertiary centre cohort (n=706; 353 with kidney failure and 353 without) achieved exceptional predictive accuracy, with the area under the receiver operating characteristic curve (ROC-AUC) reaching 0.94 and 0.98 on the binary task of predicting kidney failure for decision tree and random forest, respectively. To address the inherent class imbalance, centroid-cluster-based under-sampling was applied to the Australian dataset. To externally validate the performance of the model, we applied the model to a dataset (n=597 adults) sourced from a Japanese CKD registry. To overcome risks of overfitting on small sample sizes, transfer learning was subsequently employed by fine-tuned machine learning models on 15% of the external dataset (n=89) before evaluating the remaining 508 patients. This external validation demonstrated performant results with an ROC-AUC of 0.88 for the decision tree and 0.93 for the random forest model. Decision tree model analysis revealed the most recent eGFR and eGFR slope as the most informative variables for prediction in the Japanese cohort, aligning with the underlying pathophysiology. The research highlights the utility of deploying explainable machine learning techniques to forecast CKD trajectory even in the early stages utilising limited real-world datasets.","preprint_author_corresponding":"Sandeep Reddy","preprint_author_corresponding_institution":"Deakin University"},{"preprint_doi":"10.1101\/2023.11.14.23298472","published_doi":"10.1080\/00952990.2024.2377256","published_journal":"The American Journal of Drug and Alcohol Abuse","preprint_platform":"medRxiv","preprint_title":"Psychometric Properties and Longitudinal Measurement Invariance of the Spanish Version of the Alcohol Expectancies Questionnaire Short Form among Young Adult Binge Drinkers","preprint_authors":"Gonzalez Ponce, B. M.; Pilatti, A.; Rivarola Montejano, G.; Bravo, A. J.; Fernandez Calderon, F.","preprint_category":"health policy","preprint_date":"2023-11-14","published_date":"2024-08-19","preprint_abstract":"BackgroundLongitudinal Measurement Invariance (LMI) is critically important to evaluate changes in the alcohol expectancies over time. However, few studies have yet explored the longitudinal properties of the Spanish EQ-SF.\n\nObjectivesTo examine the reliability, sources of validity (structural and concurrent validity), and LMI of the Spanish short version of the Alcohol Expectancy Questionnaire in a sample of young adults who engage in binge drinking.\n\nMethodsThe participants (n = 279; Mean age = 21.33, SD = 2.15; 48.4% female) completed the Spanish EQ-SF, and two months later they completed this measure again, along with measures to alcohol use, drinking motives, and protective behavioral strategies (PBS). Confirmatory Factor Analysis was used to identify which of two proposed models provided the best-fitting factor structure. We aimed to determine whether the best-fitting model was invariant across assessments and to evaluate the predictive validity and reliability of the scores.\n\nResultsOur findings revealed that the eight-factor intercorrelated model provided the best fit. This model was invariant across assessments, providing evidence for longitudinal measurement invariance. Moreover, the scores showed adequate reliability (.68 to .90) and predictive validity (i.e., positive alcohol expectancies were positively related to alcohol use and drinking motives and negatively related to PBS).\n\nConclusionOur results support the reliability, validity, and temporal invariance of the EQ-SF scores among Spanish young adults with binge drinking patterns. The evidence supports the suitability of this measure for accurately assessing changes in alcohol expectancies over time in interventions aimed at preventing binge drinking in young adults.","preprint_author_corresponding":"Bella M. Gonzalez Ponce","preprint_author_corresponding_institution":"Univerisity of Huelva"},{"preprint_doi":"10.1101\/2024.03.20.24304583","published_doi":"10.1038\/s41598-024-69660-5","published_journal":"Scientific Reports","preprint_platform":"medRxiv","preprint_title":"Enhancing COVID-19 Forecasting Precision through the Integration of Compartmental Models, Machine Learning and Variants","preprint_authors":"Baccega, D.; Castagno, P.; Fernandez Anta, A.; Sereno, M.","preprint_category":"epidemiology","preprint_date":"2024-03-24","published_date":"2024-08-19","preprint_abstract":"Predicting epidemic evolution is essential for informed decision-making and guiding the implementation of necessary countermeasures. Computational models are vital tools that provide insights into illness progression and enable early detection, proactive intervention, and targeted preventive measures.\n\nThis paper introduces Sybil, a framework that integrates machine learning and variant-aware compartmental models, leveraging a fusion of data-centric and analytic methodologies. To validate and evaluate Sybils forecasts, we employed COVID-19 data from two European countries. The dataset included the number of new and recovered cases, fatalities, and variant presence over time. We evaluate the forecasting precision of Sybil in periods in which there is a change in the trend of the pandemic evolution or a new variant appears. Results demonstrate that Sybil outperforms a conventional data-centric approach, being able to forecast accurately the changes in the trend, the magnitude of these changes, and the future prevalence of new variants.","preprint_author_corresponding":"Daniele Baccega","preprint_author_corresponding_institution":"University of Turin"},{"preprint_doi":"10.1101\/2024.05.22.24307733","published_doi":"10.1371\/journal.pmed.1004416","published_journal":"PLOS Medicine","preprint_platform":"medRxiv","preprint_title":"Point-of-care C-reactive protein measurement by community health workers safely reduces antimicrobial use among children with respiratory illness: results from a stepped wedge cluster-randomized trial in rural Uganda","preprint_authors":"Ciccone, E. J.; Hu, D.; Preisser, J. S.; Cassidy, C. A.; Kabugho, L.; Emmanuel, B.; Kibaba, G.; Mwebembezi, F.; Juliano, J. J.; Mulogo, E. M.; Boyce, R. M.","preprint_category":"infectious diseases","preprint_date":"2024-05-22","published_date":"2024-08-19","preprint_abstract":"BackgroundAcute respiratory illness (ARI) is one of the most common reasons children receive antibiotic treatment. Measurement of C-reaction protein (CRP) to identify children at high risk for bacterial infection has been shown to reduce unnecessary antibiotic use among children with ARI in a range of clinical settings. Yet in many resource-constrained contexts, patients seek care outside the formal health sector, often from lay community health workers (CHW). The objective of this study was to determine the impact of CRP measurement on antibiotic use among children under 5 years of age presenting with febrile ARI to CHW in rural western Uganda.\n\nMethods and FindingsWe conducted a stepped wedge cluster randomized trial comparing a clinical algorithm that included CRP measurement by CHW to guide antibiotic treatment decisions (STAR Sick Child Job Aid [SCJA]) with the Integrated Community Care Management (iCCM) SCJA currently in use by CHW in the region. Children under 5 years presenting to CHW in 15 villages in Bugoye sub-county with fever and cough were eligible. The CHW conducted follow-up assessments 7 days after the initial visit. Our primary outcome was the proportion of children who were given or prescribed an antibiotic at the initial visit. Our secondary outcomes were (1) persistent fever on Day 7, (2) development of pre-specified danger signs, (3) unexpected visits to the CHW, (4) hospitalizations, (5) deaths, (6) lack of perceived improvement per the childs caregiver on Day 7, and (7) clinical failure, which was a composite outcome of persistence of fever on Day 7, development of danger signs, hospitalization, or death.\n\nThe 65 participating CHW enrolled 1,280 children, 1,220 (95.3%) of whom had sufficient data to be included in this analysis; 48% (587\/1,220) and 52% (633\/1,220) were enrolled during control (iCCM SCJA) and intervention periods (STAR SCJA), respectively. The observed percentage of children who were given or prescribed antibiotics at the initial visit was 91.8% (539\/587) in the control periods as compared to 70.8% (448\/633) during the intervention periods (prevalence difference -21.0%; 95% CI: (-30.4%, - 11.7%). The odds of antibiotic prescription by the CHW were over 80% lower in the intervention as compared to the control periods (OR 0.18, 95% CI (0.07-0.45)). There was no difference in frequency of clinical failure or lack of perceived improvement by the caregiver between groups. There were no unexpected visits to the CHW or deaths in either group.\n\nConclusionsIncorporating CRP measurement into iCCM algorithms for evaluation of children with febrile ARI by CHW in rural Uganda decreased antibiotic use without negatively affecting clinical outcomes. These findings support expanded access to simple, point-of-care diagnostics to improve antibiotic stewardship in rural, resource-constrained settings where individuals with limited medical training provide a substantial proportion of care.","preprint_author_corresponding":"Emily  J. Ciccone","preprint_author_corresponding_institution":"The University of North Carolina at Chapel Hill School of Medicine"},{"preprint_doi":"10.1101\/2023.12.26.23300560","published_doi":"10.1371\/journal.pgph.0002818","published_journal":"PLOS Global Public Health","preprint_platform":"medRxiv","preprint_title":"A Scoping Review of Deaf Awareness Programs in Health Professional Education","preprint_authors":"Terry, J.; Meara, R.","preprint_category":"medical education","preprint_date":"2023-12-29","published_date":"2024-08-19","preprint_abstract":"Deaf awareness aims to promote understanding about Deaf and hard of hearing people, with the goal of reducing barriers between Deaf and hearing populations; and is particularly pertinent for health professional students as they need to learn to communicate effectively with a range of population groups. This scoping review aims to provide an overview of literature examining Deaf awareness programs provided to health professional students during their initial training. We searched four medical and public health databases and registers using terms related to Deaf awareness. We used the PRISMA-ScR reporting standards checklist for scoping reviews. We identified 10,198 citations, with 15 studies included in the final review. Searches were performed during August to September 2022, and April 2023. Studies were included provided they examined Deaf awareness content or programs within health professional education. Data were extracted by two independent reviewers who screened all abstracts using Rayyan software, followed by discussion to achieve knowledge synthesis and agreement. In all, a total of 15 articles from six countries were identified across health professional student disciplines including pharmacy, nursing, audiology, inter-professional and medical programs. The review found sparse evidence of research into Deaf awareness programs delivered to health professional students, with delivery often solely to small groups of students, indicating why so few students can access information about how to communicate effectively with Deaf and hard of hearing patients during their initial training programs. This scoping reviewed showed evidence of promising benefits for health professional students undertaking Deaf and hard of hearing awareness programs during their undergraduate education. The importance of communicating with Deaf and hard of hearing patients and attaining Deaf cultural competencies for health professional students should be investigated in future research.","preprint_author_corresponding":"Julia Terry","preprint_author_corresponding_institution":"Swansea University"},{"preprint_doi":"10.1101\/2023.10.19.23297222","published_doi":"10.1371\/journal.pone.0301857","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Physical activity in adult users of inpatient mental health services: a scoping review","preprint_authors":"Tew, G.; Peckham, E.; Ker, S.; Smith, J.; Hodgson, P.; Machaczek, K.; Faires, M.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2023-10-19","published_date":"2024-08-19","preprint_abstract":"People with severe mental illness engage in considerably less physical activity than those without. They also experience premature mortality of around 10-25 years. A large proportion of these premature deaths are attributed to modifiable behaviours, including physical activity. The inpatient environment provides an opportunity to support people to become more physically active; however, there is limited evidence on which interventions are most successful and what contextual factors affect their delivery. A scoping review was conducted to help understand the extent and type of evidence in this area and identify research gaps. We included studies of physical activity in adult inpatient mental health services published in peer-reviewed journals. Reviews, meta-analyses, and papers focusing on eating disorder populations were excluded. We searched the MEDLINE, CINAHL, PsycINFO, ASSIA and Web of Science databases for relevant studies published in English. We extracted data on study design, participant characteristics, intervention and control conditions, key findings, and research recommendations. We used a descriptive analytical approach and results are presented in tables and figures. Of 27,286 unique records screened, 210 reports from 182 studies were included. Sixty-one studies reported on correlates of physical activity, and 139 studies reported on physical activity interventions. Most intervention studies used a single-group, pre-post design (40%) and included fewer than 100 participants (86%). Ninety percent of interventions delivered physical activity directly to participants, and 50% included group-based sessions. The duration, type, frequency and intensity of sessions varied. Mental health was the most commonly reported outcome (64%), whereas physical activity was rarely an outcome (13%). Overall, there is a modest but growing body of research on physical activity in adult users of inpatient mental health services. More high-quality trials are needed to advance the field, and future research should target neglected intervention types, outcomes, populations and settings.","preprint_author_corresponding":"Garry Tew","preprint_author_corresponding_institution":"York St John University"},{"preprint_doi":"10.1101\/2023.06.08.23291105","published_doi":"10.1111\/resp.14817","published_journal":"Respirology","preprint_platform":"medRxiv","preprint_title":"Ventilation heterogeneity is increased in adults exposed to coal mine fire-related PM2.5","preprint_authors":"McCrabb, T.; Borg, B.; Gao, C. X.; Smith, C. L.; Brown, D.; Ikin, J.; Makar, A.; Lane, T. J.; Abramson, M. J.; Thompson, B.","preprint_category":"respiratory medicine","preprint_date":"2023-06-12","published_date":"2024-08-19","preprint_abstract":"Background and ObjectivesThe Hazelwood Health Study was set up to study long term health effects of a mine fire that blanketed residents of the Latrobe Valley with smoke for 45 days in 2014. The Respiratory Stream specifically assessed the impact of fine particulate matter <2.5m diameter (PM2.5) exposure from mine fire smoke on lung health. The multiple breath nitrogen washout (MBW) test assesses ventilation heterogeneity, which may detect early airways dysfunction not identified using standard tests such as spirometry. This analysis assessed the association of PM2.5 exposure with measures of ventilation heterogeneity.\n\nMethodsExposed (Morwell) and unexposed (Sale) participants were recruited 3.5-4 years after the fire from those who had participated in an Adult Survey. MBW was performed to measure lung clearance index (LCI), functional residual capacity (FRC), acinar (Sacin) and conductive (Scond) ventilation heterogeneity. PM2.5 exposure was estimated with emission and chemical transport models. Multivariate linear regression models were fitted controlling for confounders.\n\nResultsWe recruited 519 participants. MBW tests were conducted on 504 participants with 479 acceptable test results (40% male; 313 exposed, 166 unexposed). Exposure to mine fire-related PM2.5 was associated with increasing Scond ({beta}=2.15\/kL, 95%CI: 0.67-3.63, p=0.006), which was comparable to the estimated effect on Scond of 7.9 years of aging. No other MBW outcomes were significant.\n\nConclusionsIncreasing exposure to PM2.5 was associated with increased ventilation heterogeneity in the conductive region of the lungs 4 years after the event.","preprint_author_corresponding":"Michael J Abramson","preprint_author_corresponding_institution":"School of Public Health and Preventive Medicine, Monash University"},{"preprint_doi":"10.1101\/2023.10.18.23297231","published_doi":"10.1161\/JAHA.123.033111","published_journal":"Journal of the American Heart Association","preprint_platform":"medRxiv","preprint_title":"Measuring Frailty Using Self-Report or Automated Tools to Identify Risk of Cardiovascular Events and Mortality: The Million Veteran Program","preprint_authors":"Qazi, S.; Seligman, B.; Preis, S. R.; Rane, M.; Djousse, L.; Gagnon, D. R.; Wilson, P. W. F.; Gaziano, J. M.; Driver, J. A.; Cho, K.; Orkaby, A. R.","preprint_category":"cardiovascular medicine","preprint_date":"2023-10-24","published_date":"2024-08-19","preprint_abstract":"BackgroundFrailty, a syndrome of physiologic vulnerability, increases cardiovascular disease (CVD) risk. Whether in person or automated frailty tools are ideal for identifying CVD risk remains unclear. We calculated three distinct frailty scores and examined their associations with mortality and CVD events in the Million Veteran Program (MVP).\n\nMethodsMVP is a prospective cohort of U.S. Veterans that has enrolled nearly one million Veterans. We included participants aged [&ge;]50 years who enrolled from 2011-2018. Frailty was calculated using three tools: two frailty indices (FI) based on the accumulation of deficits theory, the 36-item MVP-FI using self-reported answers to questionaries, and the 31-item VA-FI developed using claims data. Finally, we calculated the 3-item Study of Osteoporotic Fractures Fried physical frailty score from self-report. The primary outcomes were CVD and all-cause mortality. Multivariable-adjusted Cox proportional hazards models (adjusted for age, sex, smoking, statin use, antihypertensive use, hyperlipidemia, and survey year). Secondary outcomes were myocardial infarction (MI), stroke, and heart failure (HF).\n\nResultsAmong 190,688 MVP participants (mean age 69 {+\/-}9 years, 94% male, 85% white), there were 33,233 (17%) all-cause and 10,115 (5%) CVD deaths. Using MVP-FI, 29% were robust, 42% pre-frail, and 29% frail. Frailty prevalence increased by age group, from 27% in 50-59-year-olds to 42% in age[&ge;]90 years. Follow-up duration was 6{+\/-}2 years. Using the MVP-FI, pre-frail and frail Veterans had a higher incidence of both all-cause mortality (pre-frail: HR=1.66, 95%CI: 1.61-1.72; frail: 3.05, 2.95-3.16) and CVD death (pre-frail: 1.76, 1.65-1.88; frail: 3.65, 3.43-3.90), as compared to robust individuals. These findings remained significant among Veterans [&ge;] 50 years. Findings were similar for CVD events. When frailty was measured using the VA-FI and SOF results were concordant.\n\nConclusionIrrespective of frailty measure used, frailty is associated with a higher risk of all-cause mortality and CVD events. Further study of frailty in individuals <60 years old is warranted.","preprint_author_corresponding":"Saadia Qazi","preprint_author_corresponding_institution":"Brigham & Women\\'s Hospital"},{"preprint_doi":"10.1101\/2023.11.10.23298311","published_doi":"10.1093\/jamia\/ocae213","published_journal":"Journal of the American Medical Informatics Association","preprint_platform":"medRxiv","preprint_title":"Development of Portable Electronic Health Record Based Algorithms to Identify Individuals with Diabetic Retinopathy","preprint_authors":"Breeyear, J. H.; Mitchell, S. L.; Nealon, C. L.; Hellwege, J. N.; Charest, B.; Khakaria, A.; Halladay, C. W.; Yang, J.; Garriga, G. A.; Wilson, O. D.; Hung, A. M.; Reaven, P. D.; Meigs, J. B.; Rhee, M. K.; Sun, Y.; Lynch, M. G.; Sobrin, L.; Brantley, M. A.; Sun, Y. V.; Wilson, P. W.; Iyengar, S. K.; Peachey, N. S.; Phillips, L. S.; Edwards, T. L.; Giri, A.","preprint_category":"endocrinology","preprint_date":"2023-11-15","published_date":"2024-08-19","preprint_abstract":"ObjectivesTo develop, validate and implement algorithms to identify diabetic retinopathy (DR) cases and controls from electronic health care records (EHR)s. Methods: We developed and validated EHR-based algorithms to identify DR cases and individuals with type I or II diabetes without DR (controls) in three independent EHR systems: Vanderbilt University Medical Center Synthetic Derivative (VUMC), the VA Northeast Ohio Healthcare System (VANEOHS), and Massachusetts General Brigham (MGB). Cases were required to meet one of three criteria: 1) two or more dates with any DR ICD-9\/10 code documented in the EHR, or 2) at least one affirmative health-factor or EPIC code for DR along with an ICD9\/10 code for DR on a different day, or 3) at least one ICD-9\/10 code for any DR occurring within 24 hours of an ophthalmology exam. Criteria for controls included affirmative evidence for diabetes as well as an ophthalmology exam.\n\nResultsThe algorithms, developed and evaluated in VUMC through manual chart review, resulted in a positive predictive value (PPV) of 0.93 for cases and negative predictive value (NPV) of 0.97 for controls. Implementation of algorithms yielded similar metrics in VANEOHS (PPV=0.94; NPV=0.86) and lower in MGB (PPV=0.84; NPV=0.76). In comparison, use of DR definition as implemented in Phenome-wide association study (PheWAS) in VUMC, yielded similar PPV (0.92) but substantially reduced NPV (0.48). Implementation of the algorithms to the Million Veteran Program identified over 62,000 DR cases with genetic data including 14,549 African Americans and 6,209 Hispanics with DR.\n\nConclusions\/DiscussionWe demonstrate the robustness of the algorithms at three separate health-care centers, with a minimum PPV of 0.84 and substantially improved NPV than existing high-throughput methods. We strongly encourage independent validation and incorporation of features unique to each EHR to enhance algorithm performance for DR cases and controls.","preprint_author_corresponding":"Ayush Giri","preprint_author_corresponding_institution":"Vanderbilt University Medical Center; VA Tennessee Valley Healthcare System"},{"preprint_doi":"10.1101\/2023.05.04.23289509","published_doi":"10.1186\/s12889-024-19598-0","published_journal":"BMC Public Health","preprint_platform":"medRxiv","preprint_title":"Concordance of weight status between mothers and children: A secondary analysis of the Pakistan Demographic and Health Survey VII","preprint_authors":"Alam, F.; Ali, M. K.; Patel, S. A.; Iqbal, R.","preprint_category":"public and global health","preprint_date":"2023-05-05","published_date":"2024-08-19","preprint_abstract":"Familial concordance of nutritional status is an emerging field of study that may guide the development of interventions that operate beyond the individual and within the family context. Little published data exist for concordance of nutritional status within Pakistani households. We assessed the associations between weight status of mothers and their children in a nationally representative sample of households in Pakistan using Demographic and Health Survey data. Our analysis included 3465 mother-child dyads, restricting to children under-five years of age with body mass index (BMI) information on their mothers. We used linear regression models to assess the associations between maternal BMI category (underweight, normal weight, overweight, obese) and childs weight-for-height z-score (WHZ), accounting for socio-demographic characteristics of mothers and children. We assessed these relationships in all children under-five and also stratified by age of children (younger than 2 years and 2 to 5 years). In all children under-five and in children 2 to 5 years, maternal BMI was positively associated with childs WHZ, while there was no association between maternal BMI and child WHZ for children under-two. The findings indicate that the weight status of mothers is positively associated with that of their children. These associations have implications for interventions aimed at healthy weights of families.","preprint_author_corresponding":"Romaina Iqbal","preprint_author_corresponding_institution":"Aga Khan University"},{"preprint_doi":"10.1101\/2024.04.08.24305483","published_doi":"10.1186\/s12950-024-00402-0","published_journal":"Journal of Inflammation","preprint_platform":"medRxiv","preprint_title":"Evidence of aberrant anti-Epstein-Barr virus antibody response, though no viral reactivation, in people with post-stroke fatigue","preprint_authors":"Mouat, I. C.; Zhu, J.; Aslan, A.; McColl, B. W.; Allan, S. M.; Smith, C. J.; Buckwalter, M. S.; McCulloch, L.","preprint_category":"cardiovascular medicine","preprint_date":"2024-04-10","published_date":"2024-08-12","preprint_abstract":"BACKGROUNDFatigue is a common complication of stroke that has a significant impact on quality of life. The biological mechanisms that underly post-stroke fatigue are currently unclear, however, reactivation of latent viruses and their impact on systemic immune function have been increasingly reported in other conditions where fatigue is a predominant symptom. Epstein-Barr virus (EBV) in particular has been associated with fatigue, including in long-COVID and myalgic encephalomyelitis\/chronic fatigue syndrome, but has not yet been explored within the context of stroke.\n\nAIMSWe performed an exploratory analysis to determine if there is evidence of a relationship between EBV reactivation and post-stroke fatigue.\n\nMETHODSIn a chronic ischemic stroke cohort (>6 months post-stroke), we assayed circulating EBV by qPCR and measured the titres of anti-EBV antibodies by ELISA in patients with high fatigue (FACIT-F <40) and low fatigue (FACIT-F >41). Statistical analysis between two-groups were performed by t-test when normally distributed according to the Shapiro-Wilk test, by Mann-Whitney test when the data was not normally distributed, and by Fishers exact test for categorical data.\n\nRESULTSWe observed a similar incidence of viral reactivation between people with low versus high levels of post-stroke fatigue (5 of 22 participants (24%) versus 6 of 22 participants (27%)). Although the amount of circulating EBV was similar between the groups, we observed an altered antibody response against EBV antigens in participants with high fatigue, with reduced IgM against the Viral Capsid Antigen (VCA; 2.244 {+\/-} 0.926 vs 3.334 {+\/-} 2.68; P = 0.031). Total IgM levels were not different between groups indicating this effect was specific to EBV (3.23 x 105 {+\/-} 4.44 x 104 high fatigue versus 4.60 x 105 {+\/-} 9.28 x 104 low fatigue; P= 0.288).\n\nCONCLUSIONSThese findings indicate that EBV is not more prone to reactivation during chronic stroke recovery in those with post-stroke fatigue. However, the dysregulated antibody response to EBV may be suggestive of viral reactivation at an earlier stage after stroke and warrants further investigation.","preprint_author_corresponding":"Laura McCulloch","preprint_author_corresponding_institution":"Centre for Inflammation Research, Institute for Regeneration and Repair South, University of Edinburgh, UK"},{"preprint_doi":"10.1101\/2024.05.03.24306807","published_doi":"10.1016\/j.expneurol.2024.114913","published_journal":"Experimental Neurology","preprint_platform":"medRxiv","preprint_title":"Data-driven prediction of spinal cord injury recovery: an exploration of current status and future perspectives","preprint_authors":"Hakansson, S.; Tuci, M.; Bolliger, M.; Curt, A.; Jutzeler, C.; Bru\u0308ningk, S.","preprint_category":"health informatics","preprint_date":"2024-05-04","published_date":"2024-08-02","preprint_abstract":"Spinal Cord Injury (SCI) presents a significant challenge in rehabilitation medicine, with recovery outcomes varying widely among individuals. Machine learning (ML) is a promising approach to enhance the prediction of recovery trajectories, but its integration into clinical practice requires a thorough understanding of its efficacy and applicability. We systematically reviewed the current literature on data-driven models of SCI recovery prediction. The included studies were evaluated based on a range of criteria assessing the approach, implementation, input data preferences, and the clinical outcomes aimed to forecast. We observe a tendency to utilize routinely acquired data, such as International Standards for Neurological Classification of SCI (ISNCSCI), imaging, and demographics, for the prediction of functional outcomes derived from the Spinal Cord Independence Measure (SCIM) III and Functional Independence Measure (FIM) scores with a focus on motor ability. Although there has been an increasing interest in data-driven studies over time, traditional machine learning architectures, such as linear regression and tree-based approaches, remained the overwhelmingly popular choices for implementation. This implies ample opportunities for exploring architectures addressing the challenges of predicting SCI recovery, including techniques for learning from limited longitudinal data, improving generalizability, and enhancing reproducibility. We conclude with a perspective, highlighting possible future directions for data-driven SCI recovery prediction and drawing parallels to other application fields in terms of diverse data types (imaging, tabular, sequential, multimodal), data challenges (limited, missing, longitudinal data), and algorithmic needs (causal inference, robustness).","preprint_author_corresponding":"Samuel H\u00e5kansson","preprint_author_corresponding_institution":"ETH Zurich"},{"preprint_doi":"10.1101\/2023.08.25.23294216","published_doi":"10.1186\/s12904-024-01542-z","published_journal":"BMC Palliative Care","preprint_platform":"medRxiv","preprint_title":"Non-invasive technology to assess hydration status in advanced cancer to explore relationships between fluid status and symptoms: an observational study using bioelectrical impedance analysis","preprint_authors":"Nwosu, A. C.; Stanley, S.; Mayland, C. R.; Mason, S.; McDougall, A.; Ellershaw, J.","preprint_category":"palliative medicine","preprint_date":"2023-08-25","published_date":"2024-08-19","preprint_abstract":"BackgroundOral fluid intake decreases in people with advanced cancer, especially when they approach the dying phase of their illness. There is inadequate evidence to support hydration assessment and decision making in the dying phase of illness. Bioelectrical impedance analysis (BIA) and vector analysis (BIVA) are validated methods of hydration assessment, with research demonstrating that hydration status is associated with specific symptoms, and survival in advanced cancer. However, further research is needed to better understand the relationships between hydration status and clinical outcomes in advanced cancer, particularly at the end-of-life.\n\nAimTo evaluate hydration status and its associations with clinical outcomes in advanced cancer patients, and those in the last week of life.\n\nMaterials and methodsAn observational study of people with advanced cancer in three centres. Advance consent methodology was used to conduct hydration assessments in the dying. Total body water was estimated using the BIA Impedance index (Height - H (m)2\/Resistance - R (Ohms)). We used backward regression to identify factors (signs, symptoms, quality of life) that predict H2\/R. Participants in the last 7 days of life were further assessed with BIA to assess hydration changes, and its relationship with clinical outcomes.\n\nResults125 people participated (males n=74 (59.2%), females, n=51 (40.8%). BIVA demonstrated that baseline hydration status was normal in 58 (46.4%),  more-hydrated in 52 (41.6%) and  less hydrated in 13 (10.4%). Regression analysis demonstrated that less hydration (lower H2\/R) was associated with female sex (Beta = -0.371, p<0.001), increased anxiety (Beta = - 0.135, <0.001), increased severity of physical signs (dry mouth, dry axilla, sunken eyes - Beta = -0.204, p<0.001), and increased breathlessness (Beta = -0.180, p<0.014).  More hydration (higher H2\/R) was associated with oedema (Beta= 0.514, p<0.001) and increased pain (Beta = 0.156, p=0.039). Eighteen participants (14.4%) were in the last week of life. For dying participants, hydration status (H2\/R) was not significantly different compared to baseline (n= 18, M= 49.55, SD= 16.00 vs. M= 50.96, SD= 12.13; t(17)= 0.636, p = 0.53) and was not significantly associated with agitation (rs = -0.847, p = 0.740), pain (rs = 0.306, p = 0.232) or respiratory tract secretions (rs = -0.338, p = 0.185).\n\nConclusionsIn advanced cancer, hydration status was associated with specific physical signs and symptoms. No significant associations between survival and hydration status were recorded. In the dying phase, hydration status did not significantly change compared to baseline, and was not associated with symptoms. Further work can use BIA\/BIVA to standardise the process to identify clinically relevant outcomes for hydration studies, to establish a core outcome set to evaluate how hydration affects symptoms and quality of life in cancer.\n\nKey messageWe used bioelectrical impedance analysis (a non-invasive body composition assessment tool) to evaluate associations between hydration status and clinical outcomes in people with cancer. Hydration status was significantly associated with biological sex, physical signs, symptoms and psychological outcomes. In the dying phase, hydration status did not significantly change compared to baseline, and hydration status was not significantly associated with survival. The development of a standardised core outcome set for cancer hydration studies, to evaluate how hydration affects symptoms, quality of life and outcomes in cancer patients, will help to establish a meaningful evidence base for clinical practice.","preprint_author_corresponding":"Amara Callistus Nwosu","preprint_author_corresponding_institution":"Lancaster University, Lancaster, UK;  Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK; Marie Curie Hospice Liverpool, Liverpool, UK."},{"preprint_doi":"10.1101\/2023.12.11.23299797","published_doi":"10.1002\/jrsm.1739","published_journal":"Research Synthesis Methods","preprint_platform":"medRxiv","preprint_title":"Development of the Individual Participant Data (IPD) Integrity Tool for assessing the integrity of randomised trials using individual participant data","preprint_authors":"Hunter, K. E.; Aberoumand, M.; Libesman, S.; Sotiropoulos, J. X.; Williams, J. G.; Li, W.; Aagerup, J.; Mol, B. W.; Wang, R.; Barba, A.; Shrestha, N.; Webster, A. C.; Seidler, A. L.","preprint_category":"public and global health","preprint_date":"2023-12-13","published_date":"2024-08-19","preprint_abstract":"IntroductionIncreasing concerns about integrity in medical research have prompted the development of tools to detect untrustworthy studies. Existing tools focus on evaluating aggregate or published data, though some trustworthiness issues may only be detected upon scrutiny of individual participant data (IPD). To address this, we developed the IPD Integrity Tool for detecting integrity issues in randomised controlled trials with IPD available. This manuscript describes the development of this tool.\n\nMethodsWe conducted a literature review to collate and map existing integrity items. These were discussed with an expert advisory group, and agreed items were included in a standardised tool and automated where possible. We piloted this tool in two IPD meta-analyses, and conducted preliminary validation checks on 13 datasets with and without known integrity issues in a blinded manner.\n\nResultsThe literature review identified 120 integrity items: 54 could be conducted at the publication or aggregate data (AD) level, 48 required IPD, and 18 were possible with aggregate data, but more comprehensive with IPD. Based on these items, an initial reduced tool was developed in a consensus process involving 13 advisors with different backgrounds (countries, profession, education). This initial tool included 11 items across four domains for AD, and 12 items across 8 domains requiring IPD. The tool was iteratively refined throughout piloting on two IPD meta-analyses including a total of 116 trials (73 with IPD, and 43 with only AD available), and preliminary validation using an additional 13 datasets. All five studies with known integrity issues were accurately identified during validation. The final version of the tool included seven domains with 13 items for AD and eight domains with 18 items requiring IPD.\n\nConclusionsThe quality of evidence informing health care relies on trustworthy data. This manuscript describes the development of a tool to enable researchers, editors, and other stakeholders to detect integrity issues in randomised trials using IPD. Detailed instructions on the application of this tool will be published subsequently.","preprint_author_corresponding":"Kylie E Hunter","preprint_author_corresponding_institution":"NHMRC Clinical Trials Centre, University of Sydney"},{"preprint_doi":"10.1101\/2023.06.06.23291063","published_doi":"10.7759\/cureus.67155","published_journal":"Cureus","preprint_platform":"medRxiv","preprint_title":"'One more tool in the tool belt': A qualitative interview study investigating patient and clinician opinions on the integration of psychometrics into routine testing for disorders of gut-brain interaction","preprint_authors":"Law, M.; Bartlett, E.; Sebaratnam, G.; Pickering, I.; Simpson, K.; Keane, C.; Daker, C.; Gharibans, A.; O'Grady, G.; Andrews, C. N.; Calder, S.","preprint_category":"gastroenterology","preprint_date":"2023-06-10","published_date":"2024-08-19","preprint_abstract":"BackgroundPsychological comorbidities are common in patients with disorders of gut-brain interaction (DGBIs) and are often linked with poorer patient outcomes. Likewise, extensive research has shown a bidirectional association between psychological factors and gastrointestinal symptoms, termed the gut-brain axis. Consequently, assessing and managing mental wellbeing, in an integrated care pathway, may lead to improvements in symptoms and quality of life for some patients. This study aimed to explore patients and gastroenterology clinicians opinions on integrating psychometrics into routine DGBI testing.\n\nMethodsSemi-structured interviews were conducted with 16 patients with a gastroduodenal DGBI and 19 clinicians who see and treat these patients. Interviews were transcribed verbatim and analysed using inductive, reflexive thematic analysis.\n\nResultsThree key clinician themes were developed: (1) psychology as part of holistic care, emphasising the importance of a multidisciplinary approach; (2) the value of psychometrics in clinical practice, highlighting their potential for screening and expanding management plans; and (3) navigating barriers to utilising psychometrics, addressing the need for standardisation and external handling to maintain the therapeutic relationship. Four key patient themes were also developed: (1) the utility of psychometrics in clinical care, reflecting the perceived benefits; (2) openness to psychological management, indicating patients willingness to explore psychological treatment options; (3) concerns with psychological integration, addressing potential stigma and fear of labelling; and (4) the significance of clinician factors, emphasising the importance of clinician bedside manner, knowledge, and collaboration.\n\nConclusionsThe themes generated from the interviews indicated that patients and clinicians see value in integrating psychometrics into routine DGBI testing. Despite potential barriers, psychometrics would advance the understanding of a patients condition and facilitate holistic and multidisciplinary management. Recommendations for navigating challenges were provided, and considering these, patients and clinicians supported the use of psychometrics as mental health screening tools for patients with gastroduodenal DGBIs.","preprint_author_corresponding":"Stefan Calder","preprint_author_corresponding_institution":"The University of Auckland"},{"preprint_doi":"10.1101\/2023.07.01.23292113","published_doi":"10.1016\/j.bbi.2024.08.025","published_journal":"Brain, Behavior, and Immunity","preprint_platform":"medRxiv","preprint_title":"Maternal prenatal immune activation associated with brain tissue microstructure and metabolite concentrations in newborn infants","preprint_authors":"Spann, M.; Bansal, R.; Aydin, E.; Pollatou, A.; Alleyne, K.; Bennett, M.; Sawardekar, S.; Cheng, B.; Lee, S.; Monk, C.; Peterson, B.","preprint_category":"pediatrics","preprint_date":"2023-07-03","published_date":"2024-08-18","preprint_abstract":"ImportanceFew translational human studies have assessed the association of prenatal maternal immune activation with altered brain development and psychiatric risk in newborn offspring.\n\nObjectiveTo identify the effects of maternal immune activation during the 2nd and 3rd trimesters of pregnancy on newborn brain metabolite concentrations, tissue microstructure, and longitudinal motor development.\n\nDesignProspective longitudinal cohort study conducted from 2012 - 2017.\n\nSettingColumbia University Irving Medical Center and Weill Cornell Medical College.\n\nParticipants76 nulliparous pregnant women, aged 14 to 19 years, were recruited in their 2nd trimester, and their children were followed through 14 months of age.\n\nExposureMaternal immune activation indexed by maternal interleukin-6 and C-reactive protein in the 2nd and 3rd trimesters of pregnancy.\n\nMain Outcomes and MeasuresThe main outcomes included (1) newborn metabolite concentrations, measured as N-acetylaspartate, creatine, and choline using Magnetic Resonance Spectroscopy; (2) newborn fractional anisotropy and mean diffusivity measured using Diffusion Tensor Imaging; and (3) indices of motor development assessed prenatally and postnatally at ages 4- and 14-months.\n\nResultsMaternal interleukin-6 and C-reactive protein levels in the 2nd or 3rd trimester were significantly positively associated with the N-acetylaspartate, creatine, and choline concentrations in the putamen, thalamus, insula, and anterior limb of the internal capsule. Maternal interleukin-6 was associated with fractional anisotropy in the putamen, insula, thalamus, precuneus, and caudate, and with mean diffusivity in the inferior parietal and middle temporal gyrus. C-reactive protein was associated with fractional anisotropy in the thalamus, insula, and putamen. Regional commonalities were found across imaging modalities, though the direction of the associations differed by immune marker. In addition, a significant positive association was observed between offspring motor development and both maternal interleukin-6 and C-reactive protein (in both trimesters) prenatally and 4- and 14-months of age.\n\nConclusions and RelevanceUsing a healthy sample, these findings demonstrate that levels of maternal immune activation in mid- to late pregnancy associate with tissue characteristics in newborn brain regions primarily supporting motor integration\/coordination and behavioral regulation and may lead to alterations in motor development.\n\nKey PointsO_ST_ABSQuestionC_ST_ABSWhat are the associations of prenatal maternal immune activation (MIA) with newborn brain microstructure, metabolite concentrations, and longitudinal motor development?\n\nFindingsIn this longitudinal cohort study we recruited 76 adolescent and young adult pregnant women and assessed maternal interleukin (IL)-6 and C-reactive protein (CRP) levels in the 2nd and 3rd trimesters. These pro-inflammatory markers were significantly associated with brain microstructure and metabolite concentrations in newborns, and longitudinal motor development (prenatally, 4- and 14-months of age).\n\nMeaningThis study suggests that prenatal exposure to MIA has an influence on brain microstructure, metabolite concentration and motor development in offspring.","preprint_author_corresponding":"Marisa Spann","preprint_author_corresponding_institution":"Vagelos College of Physicians and Surgeons, Columbia University, New York, NY"},{"preprint_doi":"10.1101\/2024.03.20.24304636","published_doi":"10.1080\/09638288.2024.2390648","published_journal":"Disability and Rehabilitation","preprint_platform":"medRxiv","preprint_title":"Development and content validation of a questionnaire identifying patients' functional priorities and abilities after hip or knee arthroplasty","preprint_authors":"Karimijashni, M.; Westby, M.; Ramsay, T.; Beaule, P.; Poitras, S.","preprint_category":"orthopedics","preprint_date":"2024-03-22","published_date":"2024-08-18","preprint_abstract":"BackgroundTo develop a self-report questionnaire evaluating functional priorities after hip or knee arthroplasty and evaluate patients understanding of its items and conceptual relevance.\n\nMethodsA self-report questionnaire was first developed based on the International Classification of Functioning, Disability, and Health (ICF) core set for osteoarthritis (OA). In the second stage, two research physiotherapists thoroughly reviewed and refined the questionnaire, and another physiotherapist conducted cognitive think-aloud interviews with 18 patients to assess the face and content validity of the questionnaire.\n\nResultsAll categories and corresponding activities of ICF core set for OA were used to develop the questionnaire. Several questionnaire issues were identified and addressed. Most challenges were related to comprehension, followed by item ordering and visual elements. Patients identified ambiguous wording which we subsequently simplified. Ten activities of the core set were excluded due to lack of face validity, two activities were added, and four activities were modified.\n\nConclusion and implicationThe findings suggest that the ICF core set for OA needs to be adjusted for patients undergoing hip or knee arthroplasty and highlight the feasibility of applying a modified core set to assess functional priorities after hip or knee arthroplasty.","preprint_author_corresponding":"Stephane Poitras","preprint_author_corresponding_institution":"University of Ottawa, Faculty of Health Sciences"},{"preprint_doi":"10.1101\/2024.06.04.24308419","published_doi":"10.1016\/j.cdnut.2024.104439","published_journal":"Current Developments in Nutrition","preprint_platform":"medRxiv","preprint_title":"Meal Protein Quality Score: A novel tool to evaluate protein quantity and quality of meals","preprint_authors":"Grootswagers, P.; Hoejlund Christensen, S.; Timmer, M.; Riley, W.; de Groot, L.; Tetens, I.","preprint_category":"nutrition","preprint_date":"2024-06-04","published_date":"2024-08-17","preprint_abstract":"BackgroundThe recent shift towards increased plant-based protein consumption has necessitated the development of new tools to evaluate the quality and quantity of protein in meals, especially given the changing dietary guidelines and the adoption of plant-centric menus in healthcare and other settings.\n\nObjectiveTo develop and test the feasibility of the Meal Protein Quality Score (MPQS), a novel metric that assesses the protein quality and quantity in meals based on essential amino acid (EAA) content, digestibility and requirements, with a focus on optimizing protein intake for vulnerable populations, particularly older adults.\n\nMethodsThe MPQS integrates digestibility-adjusted EAA intake with total protein consumed in a meal, that together with the EAA requirements provide a score from 0 to 100 to reflect EAA coverage adequacy. The score was tested for feasibility by applying it to recipe data from real life hospital meals, and to dietary data from the NU-AGE trial, involving detailed seven-day food records from 252 non-vegan participants analyzed over multiple meal moments.\n\nResultsThe analyses revealed that the higher the content of plant-protein in a meal, the lower the meal protein quality. Also, breakfast meals scored lowest on protein quality, mainly due to low contents of protein overall, and of lysine and methionine. The MPQS effectively highlighted the difference in protein quality between plant-based and animal-based meals, and across different meal types.\n\nConclusionThe MPQS appears to be a practical tool that facilitates the assessment of meal-based protein quality. The MPQS can be used to guide dietary transitions towards plant-rich diets, ensuring that such shifts do not compromise protein adequacy for at-risk populations. The score allows for guidance in meal-planning, leading to improvements in plant-rich meal formulation to meet both individual and public health nutritional needs.","preprint_author_corresponding":"Pol Grootswagers","preprint_author_corresponding_institution":"Wageningen University"},{"preprint_doi":"10.1101\/2023.11.02.23297956","published_doi":"10.1016\/j.ebiom.2024.105279","published_journal":"eBioMedicine","preprint_platform":"medRxiv","preprint_title":"1H-NMR metabolomics-guided DNA methylation mortality predictors","preprint_authors":"Bizzarri, D.; Reinders, M. J. T.; Kuiper, L. M.; Beekman, M.; Deelen, J.; van Meurs, J. B. J.; van Dongen, J.; Pool, R.; Boomsma, D. I.; Ghanbari, M.; Franke, L.; BIOS Consortium,  ; BBMRI-NL Consortium,  ; Slagboom, P. E.; van den Akker, E. B.","preprint_category":"epidemiology","preprint_date":"2023-11-03","published_date":"2024-08-17","preprint_abstract":"1H-NMR metabolomics and DNA methylation in blood are widely known biomarkers predicting age-related physiological decline and mortality yet exert mutually independent mortality and frailty signals. Leveraging multi-omics data in four Dutch population studies (N=5238) we investigated whether the mortality signal captured by 1H-NMR metabolomics could guide the construction of novel DNA methylation-based mortality predictors. Hence, we trained DNA methylation-based surrogates for 64 metabolomic analytes and found that analytes marking inflammation, fluid balance, or HDL\/VLDL metabolism could be accurately reconstructed using DNA-methylation assays. Interestingly, a previously reported multi-analyte score indicating mortality risk (MetaboHealth) could also be accurately reconstructed. Sixteen of our derived surrogates, including the MetaboHealth surrogate, showed significant associations with mortality, independent of other relevant covariates. Finally, adding our novel surrogates to previously established DNA-methylation markers, such as GrimAge, showed significant improvement for predicting all-cause mortality, indicating that our metabolic analyte-derived surrogates potentially represent novel mortality signal.","preprint_author_corresponding":"Erik B. van den Akker","preprint_author_corresponding_institution":"Leiden University Medical Center"},{"preprint_doi":"10.1101\/2023.10.03.23295921","published_doi":"10.1097\/AJP.0000000000001237","published_journal":"The Clinical Journal of Pain","preprint_platform":"medRxiv","preprint_title":"Pediatric Neural Changes to Physical and Emotional Pain After Intensive Interdisciplinary Pain Treatment: A Pilot Study","preprint_authors":"Lepping, R. J.; Hoffart, C. M.; Bruce, A. S.; Taylor, J. M.; Mardis, N. J.; Lim, S.-L.; Wallace, D. P.","preprint_category":"pediatrics","preprint_date":"2023-10-04","published_date":"2024-08-13","preprint_abstract":"Brain areas activated during pain can contribute to enhancing or reducing the pain experience, showing a potential connection between chronic pain and the neural response to pain in adolescents and youth. This study examined changes in brain activation associated with experiencing physical pain, and the observation of physical and emotional pain in others, by using functional magnetic resonance imaging (fMRI) before and after intensive interdisciplinary pain treatment (IIPT). Eighteen youth (age 14 to 18) with widespread chronic pain completed fMRI testing before and after IIPT to assess changes in brain activation in response to physical and emotional pain. Broadly, brain activation changes were observed in frontal, somatosensory, and limbic regions. These changes suggest improvements in descending pain modulation via thalamus and caudate, and the different pattern of brain activation after treatment suggests better discrimination between physical and emotional pain. Brain activation changes were also correlated with improvements in clinical outcomes of catastrophizing (reduced activation in right caudate, right mid-cingulate, and postcentral gyrus) and pain-related disability (increased activation in precentral gyrus, left hippocampus, right middle occipital cortex, and left superior frontal gyrus). These changes support interpretation that reduced brain protective responses to pain were associated with treatment-related improvements. This pilot study highlights the need for larger trials designed to better understand the brain mechanisms involved in pediatric widespread pain treatment.\n\nPerspectiveThis study examined changes in brain response to pain in youth experiencing chronic pain participating in intensive interdisciplinary pain treatment (IIPT). The novelty in this pilot study is the longitudinal neuroimaging findings in conjunction with established, clinically relevant behavioral and self-report measures of pain.","preprint_author_corresponding":"Dustin P Wallace","preprint_author_corresponding_institution":"Pain Management, Department of Pediatrics, Children\\'s Mercy Hospital, Kansas City, MO, USA; Center for Children\\'s Healthy Lifestyles & Nutrition, Kansas City,"},{"preprint_doi":"10.1101\/2024.03.12.24304183","published_doi":"10.1136\/lupus-2024-001214","published_journal":"Lupus Science & Medicine","preprint_platform":"medRxiv","preprint_title":"Effects of Systemic Lupus Erythematosus on the Brain: A Systematic Review of Structural MRI Findings and their Relationships with Cognitive Dysfunction","preprint_authors":"Valdes Cabrera, D.; El Tal, T.; Mohamed, I.; Arciniegas, S. E.; Fevrier, S.; Ledochowski, J.; Knight, A. M.","preprint_category":"neurology","preprint_date":"2024-03-14","published_date":"2024-08-17","preprint_abstract":"BackgroundCognitive dysfunction (CD) is highly prevalent in systemic lupus erythematosus (SLE), yet the underlying mechanisms are poorly understood. Neuroimaging utilizing advanced magnetic resonance imaging (MRI) metrics may yield mechanistic insights. We conducted a systematic review of neuroimaging studies to investigate the relationship between structural and diffusion MRI metrics and CD in SLE.\n\nMethodsWe systematically searched several databases between January 2000 and October 2023 according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Retrospective, and prospective studies were screened for search criteria keywords (including structural or diffusion MRI, cognitive function, and SLE) to identify peer-reviewed articles reporting advanced structural MRI metrics and evaluating CD in human patients with SLE.\n\nResultsEighteen studies (8 structural MRI, 9 diffusion MRI, and 1 with both modalities) were included; sample sizes ranged from 11 to 120 participants with SLE. Neurocognitive assessments and neuroimaging techniques, parameters, and processing differed across articles. The most frequently affected cognitive domains were memory, psychomotor speed, and attention; while abnormal structural and\/or diffusion MRI metrics were found more consistently in the hippocampus, corpus callosum, and frontal cortex of patients with SLE, with and without clinically diagnosed CNS involvement.\n\nConclusionAdvanced structural MRI analysis can identify total and regional brain abnormalities associated with CD in patients with SLE, with potential to enhance clinical assessment. Future collaborative, longitudinal studies of neuroimaging in SLE are needed to better characterize CD, with focus on harmonized neurocognitive assessments, neuroimaging acquisitions and post-processing analyses, and improved clinical characterization of SLE cohorts.","preprint_author_corresponding":"Diana Valdes Cabrera","preprint_author_corresponding_institution":"Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, Canada"},{"preprint_doi":"10.1101\/2024.04.23.24306261","published_doi":"10.1136\/bmjopen-2023-083251","published_journal":"BMJ Open","preprint_platform":"medRxiv","preprint_title":"A factorial randomised controlled trial to examine the potential effect of a text-message based intervention on reducing adolescent susceptibility to e-cigarette use: A study protocol","preprint_authors":"Barnes, C.; Turon, H.; McCrabb, S.; Mantach, S.; Duffy, M.; Groombridge, D.; Hodder, R. K.; Meharg, D.; Robinson, E.; Bialek, C.; Wallace, S.; Leigh, L.; Wolfenden, L.","preprint_category":"public and global health","preprint_date":"2024-04-24","published_date":"2024-08-17","preprint_abstract":"IntroductionAdolescent e-cigarette use, globally and within Australia, has increased in recent years. In response, public health agencies have called for the development of education and communication programmes targeting adolescents. Despite such recommendations, few rigorous evaluations of such interventions currently exist. The main objective of this study is to examine the potential effect of a text-message intervention targeting parents and adolescents on adolescent susceptibility to e-cigarette use (e.g. intentions towards using e-cigarettes). Secondary objectives are to: (1) examine the effect of the intervention on adolescent e-cigarette and combustible tobacco use; and (2) examine the acceptability of the intervention.\n\nMethods and analysisA randomised controlled trial employing a 2x2 factorial design will be conducted with parent-adolescent dyads (aged 12-15 years). Dyads will be randomly allocated to one of four arms: Arm 1 - a text-message intervention delivered to adolescents only; Arm 2 - a text- message intervention delivered to the parents of adolescents only; Arm 3 - a text-message intervention delivered to both the parents and adolescents; and Arm 4 - an information only control, consisting of an e-cigarette factsheet provided to parents only. Participant recruitment commenced in April 2023 with the aim to recruit 120 parent-adolescent dyads. Data collection to assess study outcomes will occur at baseline, 6-, 12- and 24-months post the commencement of the intervention. The primary endpoint will be 6-month follow-up. The primary outcome will be adolescent susceptibility to e-cigarette use, assessed using validated items. Analyses of trial outcomes will be undertaken under an intention-to-treat framework, with all participants included in the analysis in the group they were allocated.\n\nEthics and disseminationEthics approval has been obtained from the University of Newcastle Human Research Ethics Committee (H-2022-0340). Findings will be disseminated in peer-reviewed journals and at conferences.\n\nTrial registrationProspectively registered with Australia New Zealand Clinical Trials Registry (ACTRN12623000079640).\n\nSTRENGTHS AND LIMITATIONSO_LIThis study will employ a rigorous factorial randomised controlled trial design to test the effectiveness of a text-message based intervention;\nC_LIO_LIThis study will contribute to the limited existing evidence base, with no randomised controlled trials aiming to prevent adolescent e-cigarette use currently published yet several underway;\nC_LIO_LISelection bias may occur if adolescents who are highly susceptible to e-cigarette use refuse to participate in the study.\nC_LI","preprint_author_corresponding":"Courtney Barnes","preprint_author_corresponding_institution":"University of Newcastle"},{"preprint_doi":"10.1101\/2022.07.05.22277258","published_doi":"10.1186\/s12889-024-19734-w","published_journal":"BMC Public Health","preprint_platform":"medRxiv","preprint_title":"Age at separation, residential mobility, and depressive symptoms among twins in late adolescence and young adulthood: a FinnTwin12 cohort study","preprint_authors":"Wang, Z.; Whipp, A. M.; Heinonen-Guzejev, M.; Kaprio, J.","preprint_category":"epidemiology","preprint_date":"2022-07-07","published_date":"2024-08-17","preprint_abstract":"ObjectivesLeaving the parental home at an early age represents a major life event for an adolescent and may predispose them to poor mental health. This study aims to examine the effect of age at separation and residential mobility (from residential records) on depressive symptoms among twins in late adolescence and young adulthood. Age at separation of twins in a twin pair was used as a proxy indicator for the age of leaving the parental home\n\nMethodsThe participants (n=3055) are from the FinnTwin12 cohort. Residential mobility consisted of the number and total distance of moves before age 17. First, we used linear regression to assess the association of age at separation and residential mobility with log-transformed General Behavior Inventory (GBI) scores at age 17 and in young adulthood. Then, the mixed model for repeated measures (MMRM) was used to visualize the GBI scores trajectory and test the associations, controlling for \"baseline\" state.\n\nResultsIn the adjusted linear regression, compared to twins separated before age 17, twins who separated in the later three groups all were significantly lower on log-transformed GBI scores at age 17. The two groups of twins who separated after age 19.5 scored lower GBIs in young adulthood. Compared to twins who never moved before age 17, moving twice led to a lower GBI score. In MMRM, twins who separated later all had lower GBI scores in young adulthood. Twins who moved twice or more had lower GBI scores in young adulthood.\n\nConclusionThe current study provides valid evidence of the family influence on depressive symptoms in later adolescence and young adulthood. A strong association between residential mobility and depressive symptoms was affirmed, although further research is still needed in the future.","preprint_author_corresponding":"Jaakko Kaprio","preprint_author_corresponding_institution":"Institute for Molecular Medicine, University of Helsinki"},{"preprint_doi":"10.1101\/2024.05.01.24306655","published_doi":"10.1038\/s41598-024-69772-y","published_journal":"Scientific Reports","preprint_platform":"medRxiv","preprint_title":"Patients Recovering from COVID-19 who Presented Anosmia During their Acute Episode have Behavioral, Functional, and Structural Brain Alterations","preprint_authors":"Kausel, L.; Figueroa-Vargas, A.; Zamorano, F.; Stecher, X.; Aspe-Sanchez, M.; Carvajal-Paredes, P.; Marquez-Rodriguez, V.; Martinez-Molina, M. P.; Roman, C.; Soto-Fernandez, P.; Valdebenito-Oyarzo, G.; Manterola, C.; Uribe, R.; Silva, C.; Henriquez-Ch, R.; Aboitiz, F.; Polania, R.; Guevara, P.; Munoz Venturelli, P.; Soto-Icaza, P.; Billeke, P.","preprint_category":"neurology","preprint_date":"2024-05-03","published_date":"2024-08-17","preprint_abstract":"Patients recovering from COVID-19 commonly exhibit cognitive and brain alterations, yet the specific neuropathological mechanisms and risk factors that underlie these alterations remain elusive. Given the significant global incidence of COVID-19, identifying factors that can distinguish individuals at risk of developing medium or long-term brain alterations is crucial for prioritizing follow-up care. Here, we report findings from a sample of 100 patients who were affected by a respiratory infection during the COVID-19 pandemic. This sample comprised 73 adults with a mild to moderate SARS-CoV-2 infection (who did not require invasive ventilatory assistance) and 27 with infections attributed to other agents and no history of COVID-19. The participants underwent cognitive screening, a decision-making task to measure cognitive flexibility, and magnetic resonance imaging evaluations. We assessed two clinical factors during infection: the presence of anosmia and the requirement for hospitalization due to respiratory symptoms. Groups did not differ in age or cognitive performance, but clinical factors differentially affected task performance. Patients who presented anosmia during the acute episode exhibited more impulsive changes in alternatives after a shift in probabilities in the decision-making task, while patients who required hospitalization showed more perseverative choices. Interestingly, the presence of anosmia during SARS-CoV-2 infection correlated with several brain measures, including decreases in functional activity during the decision-making task, thinning of cortical thickness in parietal regions, and loss in white matter integrity in corticospinal tracts and parietal-thalamic fasciculi, among others. These results suggest that anosmia could be a risk factor for developing brain alterations after SARS-CoV-2 infection and may serve to identify at-risk populations for follow-up.","preprint_author_corresponding":"Pablo Billeke","preprint_author_corresponding_institution":"Universidad del Desarrollo"},{"preprint_doi":"10.1101\/2024.05.17.24307546","published_doi":"10.1016\/j.ajcnut.2024.08.008","published_journal":"The American Journal of Clinical Nutrition","preprint_platform":"medRxiv","preprint_title":"Effects of prenatal small-quantity lipid-based nutrient supplements on pregnancy, birth and infant outcomes: a systematic review and meta-analysis of individual participant data from randomized controlled trials in low- and middle-income countries","preprint_authors":"Dewey, K. G.; Wessells, K. R.; Arnold, C. D.; Adu-Afarwuah, S.; Arnold, B. F.; Ashorn, P.; Ashorn, U.; Garces, A.; Huybregts, L.; Krebs, N. F.; Lartey, A.; Leroy, J. L.; Maleta, K.; Matias, S. L.; Moore, S. E.; Mridha, M. K.; Okronipa, H.; Stewart, C. P.","preprint_category":"nutrition","preprint_date":"2024-05-17","published_date":"2024-08-16","preprint_abstract":"BackgroundUndernutrition during pregnancy increases the risk of giving birth to a small vulnerable newborn. Small-quantity lipid-based nutrient supplements (SQ-LNS) contain both macro- and micronutrients and can help prevent nutritional deficiencies during pregnancy and lactation.\n\nObjectivesWe examined effects of SQ-LNS provided to pregnant women, compared to a) iron and folic acid or standard of care (IFA\/SOC) or b) multiple micronutrient supplements (MMS), and identified characteristics that modified effects of SQ-LNS on birth outcomes.\n\nMethodsWe conducted a 2-stage meta-analysis of individual participant data from 4 randomized controlled trials of SQ-LNS provided to pregnant women (n = 5,273). We generated study-specific and subgroup estimates of SQ-LNS compared with IFA\/SOC or MMS and pooled the estimates. In sensitivity analyses, we examined whether results differed depending on methods for gestational age dating, birth anthropometry, or study design.\n\nResultsSQ-LNS (vs IFA\/SOC) increased birth weight (mean difference: +49g; 95% CI: 26, 71g), duration of gestation (+0.12 wk; 95% CI: 0.01, 0.24 wk), and all birth anthropometric z-scores (+0.10-0.13 SD); it reduced risk of low birthweight by 11%, newborn stunting by 17%, newborn wasting by 11%, and small head size by 11%. Only 2 trials compared SQ-LNS and MMS; birth outcomes did not differ except for a marginal increase in head circumference for gestational age (+0.11; 95% CI: -0.01, 0.23). Effect estimates for SQ-LNS vs IFA\/SOC were greater among female infants and among women with body mass index < 20 kg\/m2, inflammation, malaria, or household food insecurity. Effect estimates for SQ-LNS vs MMS were greater among female infants, first-born infants, and women < 25 y.\n\nConclusionsSQ-LNS had positive impacts on multiple outcomes compared to IFA\/SOC, but further research directly comparing SQ-LNS and MMS is needed. Targeting SQ-LNS to vulnerable subgroups may be worth considering. Analysis registered at www.crd.york.ac.uk\/PROSPERO (CRD42021283391).","preprint_author_corresponding":"Kathryn G Dewey","preprint_author_corresponding_institution":"University of California, Davis"},{"preprint_doi":"10.1101\/2023.12.26.23300110","published_doi":"10.1056\/NEJMoa2314132","published_journal":"New England Journal of Medicine","preprint_platform":"medRxiv","preprint_title":"An accurate and rapidly calibrating speech neuroprosthesis","preprint_authors":"Card, N. S.; Wairagkar, M.; Iaccobacci, C.; Hou, X.; Singer-Clark, T.; Willett, F. R.; Kunz, E. M.; Fan, C.; Vahdati Nia, M.; Deo, D. R.; Choi, E. Y.; Glasser, M. F.; Hochberg, L. R.; Henderson, J. M.; Shahlaie, K.; Brandman, D. M.; Stavisky, S. D.","preprint_category":"neurology","preprint_date":"2023-12-26","published_date":"2024-08-14","preprint_abstract":"Brain-computer interfaces can enable rapid, intuitive communication for people with paralysis by transforming the cortical activity associated with attempted speech into text on a computer screen. Despite recent advances, communication with brain-computer interfaces has been restricted by extensive training data requirements and inaccurate word output. A man in his 40s with ALS with tetraparesis and severe dysarthria (ALSFRS-R = 23) was enrolled into the BrainGate2 clinical trial. He underwent surgical implantation of four microelectrode arrays into his left precentral gyrus, which recorded neural activity from 256 intracortical electrodes. We report a speech neuroprosthesis that decoded his neural activity as he attempted to speak in both prompted and unstructured conversational settings. Decoded words were displayed on a screen, then vocalized using text-to-speech software designed to sound like his pre-ALS voice. On the first day of system use, following 30 minutes of attempted speech training data, the neuroprosthesis achieved 99.6% accuracy with a 50-word vocabulary. On the second day, the size of the possible output vocabulary increased to 125,000 words, and, after 1.4 additional hours of training data, the neuroprosthesis achieved 90.2% accuracy. With further training data, the neuroprosthesis sustained 97.5% accuracy beyond eight months after surgical implantation. The participant has used the neuroprosthesis to communicate in self-paced conversations for over 248 hours. In an individual with ALS and severe dysarthria, an intracortical speech neuroprosthesis reached a level of performance suitable to restore naturalistic communication after a brief training period.","preprint_author_corresponding":"Nicholas S Card","preprint_author_corresponding_institution":"University of California, Davis"},{"preprint_doi":"10.1101\/2023.12.06.23299587","published_doi":"10.1016\/j.biopsych.2024.07.024","published_journal":"Biological Psychiatry","preprint_platform":"medRxiv","preprint_title":"Brain-charting autism and attention deficit hyperactivity disorder reveals distinct and overlapping neurobiology","preprint_authors":"Bedford, S. A.; Lai, M.-C.; Lombardo, M. V.; Chakrabarti, B.; Ruigrok, A.; Suckling, J.; Anagnostou, E.; Lerch, J. P.; Taylor, M.; Nicolson, R.; Stelios, G.; Crosbie, J.; Schachar, R.; Kelley, E.; Jones, J.; Arnold, P. D.; Courchesne, E.; Pierce, K.; Eyler, L. T.; Campbell, K.; Carter Barnes, C.; Seidlitz, J.; Alexander-Bloch, A. F.; Bullmore, E. T.; Baron-Cohen, S.; Bethlehem, R. A.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2023-12-07","published_date":"2024-08-14","preprint_abstract":"BackgroundAutism and attention deficit hyperactivity disorder (ADHD) are heterogeneous neurodevelopmental conditions with complex underlying neurobiology. Despite overlapping presentation and sex-biased prevalence, autism and ADHD are rarely studied together, and sex differences are often overlooked. Normative modelling provides a unified framework for studying age-specific and sex-specific divergences in neurodivergent brain development.\n\nMethodsHere we use normative modelling and a large, multi-site neuroimaging dataset to characterise cortical anatomy associated with autism and ADHD, benchmarked against models of typical brain development based on a sample of over 75,000 individuals. We also examined sex and age differences, relationship with autistic traits, and explored the co-occurrence of autism and ADHD (autism+ADHD).\n\nResultsWe observed robust neuroanatomical signatures of both autism and ADHD. Overall, autistic individuals showed greater cortical thickness and volume localised to the superior temporal cortex, whereas individuals with ADHD showed more global effects of cortical thickness increases but lower cortical volume and surface area across much of the cortex. The autism+ADHD group displayed a unique pattern of widespread increases in cortical thickness, and certain decreases in surface area. We also found evidence that sex modulates the neuroanatomy of autism but not ADHD, and an age-by-diagnosis interaction for ADHD only.\n\nConclusionsThese results indicate distinct cortical differences in autism and ADHD that are differentially impacted by age, sex, and potentially unique patterns related to their co-occurrence.","preprint_author_corresponding":"Saashi A. Bedford","preprint_author_corresponding_institution":"University of Cambridge"},{"preprint_doi":"10.1101\/2024.04.19.24306060","published_doi":"10.1016\/j.prevetmed.2024.106314","published_journal":"Preventive Veterinary Medicine","preprint_platform":"medRxiv","preprint_title":"Systematic Review of Knowledge, Attitudes, and Practices of Dairy Farmers and Consumers Towards Bovine Tuberculosis in Low- and Middle-Income Countries.","preprint_authors":"Van Der Zwan, A.; Campbell, P. T.; Shi, N.; De Bortoli, N.; Villanueva Cabezas, J. P.","preprint_category":"epidemiology","preprint_date":"2024-04-19","published_date":"2024-08-14","preprint_abstract":"BackgroundBovine Tuberculosis (bTB), caused by Mycobacterium bovis, is a neglected zoonotic disease primarily associated with cattle. The incidence of bTB is highest in low-income settings with high cattle density and unpasteurised dairy consumption. Smallholder dairy farming has been steadily growing in low- and middle-income countries (LMICs) with limited professional support for adequate bTB surveillance and risk mitigation. Several studies have explored the knowledge, attitudes, and practices (KAP) of milk value chains stakeholders towards bTB in LMICs, but this evidence has not been collated and synthesised.\n\nMethodologyWe conducted a systematic review to determine what is known, believed, and done in relation to bTB among dairy producers and consumers in LMICs. We performed a systematic search of studies in OVID Medline, Scopus and CABI on 11 September 2023. KAP data were summarised using narrative synthesis and forest plots.\n\nResultsWe retrieved 2763 articles, retaining 51 for the review. Only studies from Africa (n=38) and Asia (n=13) met the eligibility criteria. Most populations reported awareness of human tuberculosis and knew it could be treated, but there was limited awareness of bTB and its zoonotic potential. Knowledge of bTB transmission routes and bTB mitigation varied and risky practices were also variable across populations. Inconsistencies in study design and survey tools suggest some results may have mid- to high risk of bias.\n\nConclusionsAwareness of bTB is surprisingly low among African and Asian populations with high bTB exposure risk, possibly due to the long-standing divide between animal and human health messages that has obscured the One Health implications of bTB. Addressing bTB in LMICs requires a structural One Health approach and standard KAP survey tools to adequately explore the socio-cultural, political, and economic processes and drivers favouring bTB spread and persistence.","preprint_author_corresponding":"Juan Pablo Villanueva Cabezas","preprint_author_corresponding_institution":"The Peter Doherty Institute for Infection and Immunity"},{"preprint_doi":"10.1101\/2023.07.17.23292587","published_doi":"10.1016\/j.bpsgos.2024.100376","published_journal":"Biological Psychiatry Global Open Science","preprint_platform":"medRxiv","preprint_title":"Predicting prenatal depression and assessing model bias using machine learning models","preprint_authors":"Huang, Y.; Alvernaz, S.; Kim, S. J.; Maki, P.; Dai, Y.; Penalver Bernabe, B.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2023-07-18","published_date":"2024-08-14","preprint_abstract":"Perinatal depression (PND) is one of the most common medical complications during pregnancy and postpartum period, affecting 10-20% of pregnant individuals. Black and Latina women have higher rates of PND, yet they are less likely to be diagnosed and receive treatment. Machine learning (ML) models based on Electronic Medical Records (EMRs) have been effective in predicting postpartum depression in middle-class White women but have rarely included sufficient proportions of racial and ethnic minorities, which contributed to biases in ML models for minority women. Our goal is to determine whether ML models could serve to predict depression in early pregnancy in racial\/ethnic minority women by leveraging EMR data. We extracted EMRs from a hospital in a large urban city that mostly served low-income Black and Hispanic women (N=5,875) in the U.S. Depressive symptom severity was assessed from a self-reported questionnaire, PHQ-9. We investigated multiple ML classifiers, used Shapley Additive Explanations (SHAP) for model interpretation, and determined model prediction bias with two metrics, Disparate Impact, and Equal Opportunity Difference. While ML model (Elastic Net) performance was low (ROCAUC=0.67), we identified well-known factors associated with PND, such as unplanned pregnancy and being single, as well as underexplored factors, such as self-report pain levels, lower levels of prenatal vitamin supplement intake, asthma, carrying a male fetus, and lower platelet levels blood. Our findings showed that despite being based on a sample mostly composed of 75% low-income minority women (54% Black and 27% Latina), the model performance was lower for these communities. In conclusion, ML models based on EMRs could moderately predict depression in early pregnancy, but their performance is biased against low-income minority women.","preprint_author_corresponding":"Beatriz Penalver Bernabe","preprint_author_corresponding_institution":"University of Illinois Chicago"},{"preprint_doi":"10.1101\/2024.01.17.23300238","published_doi":"10.1016\/j.bpsgos.2024.100375","published_journal":"Biological Psychiatry Global Open Science","preprint_platform":"medRxiv","preprint_title":"Alcohol Use Disorder-Associated DNA Methylation in the Nucleus Accumbens and Dorsolateral Prefrontal Cortex","preprint_authors":"White, J. D.; Minto, M. S.; Willis, C.; Quach, B. C.; Han, S.; Tao, R.; Deep-Soboslay, A.; Zillich, L.; Clark, S. L.; van den Oord, E. J.; Hyde, T. M.; Mayfield, R. D.; Webb, B. T.; Johnson, E. O.; Kleinman, J. E.; Bierut, L. J.; Hancock, D. B.","preprint_category":"addiction medicine","preprint_date":"2024-01-17","published_date":"2024-08-14","preprint_abstract":"BackgroundAlcohol use disorder (AUD) has a profound public health impact. However, understanding of the molecular mechanisms underlying the development and progression of AUD remain limited. Here, we interrogate AUD-associated DNA methylation (DNAm) changes within and across addiction-relevant brain regions: the nucleus accumbens (NAc) and dorsolateral prefrontal cortex (DLPFC).\n\nMethodsIllumina HumanMethylation EPIC array data from 119 decedents of European ancestry (61 cases, 58 controls) were analyzed using robust linear regression, with adjustment for technical and biological variables. Associations were characterized using integrative analyses of public gene regulatory data and published genetic and epigenetic studies. We additionally tested for brain region-shared and -specific associations using mixed effects modeling and assessed implications of these results using public gene expression data.\n\nResultsAt a false discovery rate [&le;] 0.05, we identified 53 CpGs significantly associated with AUD status for NAc and 31 CpGs for DLPFC. In a meta-analysis across the regions, we identified an additional 21 CpGs associated with AUD, for a total of 105 unique AUD-associated CpGs (120 genes). AUD-associated CpGs were enriched in histone marks that tag active promoters and our strongest signals were specific to a single brain region. Of the 120 genes, 23 overlapped with previous genetic associations for substance use behaviors; all others represent novel associations.\n\nConclusionsOur findings identify AUD-associated methylation signals, the majority of which are specific within NAc or DLPFC. Some signals may constitute predisposing genetic and epigenetic variation, though more work is needed to further disentangle the neurobiological gene regulatory differences associated with AUD.","preprint_author_corresponding":"Julie D White","preprint_author_corresponding_institution":"GenOmics and Translational Research Center, RTI International"},{"preprint_doi":"10.1101\/2024.03.04.24303508","published_doi":"10.3389\/fpsyt.2024.1427365","published_journal":"Frontiers in Psychiatry","preprint_platform":"medRxiv","preprint_title":"Multichannel tDCS with Advanced Targeting for Major Depressive Disorder: A Tele-Supervised At-Home Pilot Study","preprint_authors":"Ruffini, G.; Salvador, R.; Cappon, D.; Castaldo, F.; Baleeiro, T.; Pascual-Leone, A.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2024-03-04","published_date":"2024-08-15","preprint_abstract":"IntroductionProof-of-principle human studies suggest that transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex (DLPFC) may improve depression severity. This open-label multicenter study tested remotely supervised multichannel tDCS delivered at home in patients (N=35) with major depressive disorder (MDD). The primary aim was to assess the feasibility and safety of our protocol. As an exploratory aim, we evaluated therapeutic efficacy: the primary efficacy measure was the median percent change from baseline to the end of the 4-week post-treatment follow-up period in the observer-rated Montgomery-Asberg Depression Mood Rating Scale (MADRS).\n\nMethodsParticipants received 37 at-home stimulation sessions (30 minutes each) of specifically designed multichannel tDCS targeting the left DLPFC administered over eight weeks (4 weeks of daily treatments plus 4 weeks of taper), with a follow-up period of 4 weeks following the final stimulation session. The stimulation montage (electrode positions and currents) was optimized by employing computational models of the electric field generated by multichannel tDCS using available structural data from a similar population (group optimization). Conducted entirely remotely, the study employed the MADRS for assessment at baseline, at weeks 4 and 8 during treatment, and at 4-week follow-up visits.\n\nResults34 patients (85.3% women) with a mean age of 59 years, a diagnosis of MDD according to DSM-5 criteria, and a MADRS score [&ge;]20 at the time of study enrolment completed all study visits. At baseline, the mean time since MDD diagnosis was 24.0 (SD 19.1) months. Concerning compliance, 85% of the participants (n=29) completed the complete course of 37 stimulation sessions at home, while 97% completed at least 36 sessions. No detrimental effects were observed, including suicidal ideation and\/or behavior. The study observed a median MADRS score reduction of 64.5% (48.6, 72.4) 4 weeks post-treatment (Hedges g = -3.1). We observed a response rate ([&ge;] 50% improvement in MADRS scores) of 72.7% (n=24) from baseline to the last visit 4 weeks post-treatment. Secondary measures reflected similar improvements.\n\nConclusionsThese results suggest that remotely supervised and supported multichannel home-based tDCS is safe and feasible, and antidepressant efficacy motivates further appropriately controlled clinical studies.","preprint_author_corresponding":"Giulio Ruffini","preprint_author_corresponding_institution":"Neuroelectrics"},{"preprint_doi":"10.1101\/2024.01.30.24302013","published_doi":"10.1177\/13524585241243157","published_journal":"Multiple Sclerosis Journal","preprint_platform":"medRxiv","preprint_title":"Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for Multiple Sclerosis.","preprint_authors":"Montobbio, N.; Carmisciano, L.; Signori, A.; Ponzano, M.; Schiavetti, I.; Bovis, F.; Sormani, M. P.","preprint_category":"neurology","preprint_date":"2024-01-31","published_date":"2024-08-15","preprint_abstract":"BackgroundThe lack of standardized disability progression evaluation in multiple sclerosis (MS) hinders reproducibility of clinical study results, due to heterogeneous and poorly reported criteria.\n\nObjectivesTo demonstrate the impact of using different parameters when evaluating MS progression, and to introduce an automated tool for reproducible outcome computation.\n\nMethodsRe-analyzing BRAVO clinical trial data (NCT00605215), we examined the fluctuations in computed treatment effect on confirmed disability progression (CDP) and progression independent of relapse activity (PIRA) when varying different parameters. These analyses were conducted using the msprog package for R, which we developed as a tool for CDP assessment from longitudinal data, given a set of criteria that can be specified by the user.\n\nResultsThe BRAVO study reported a hazard ratio (HR) of 0.69 (95%CI:0.46-1.02) for CDP. Using the different parameter configurations, the resulting treatment effect on CDP varied considerably, with HRs ranging from 0.59 (95%CI:0.41-0.86) to 0.72 (95%CI:0.48-1.07). The treatment effect on PIRA varied from an HR=0.62 (95%CI:0.41-0.93) to an HR=0.65 (95%CI:0.40-1.04).\n\nConclusionsThe adoption of an open-access tool validated by the research community, with clear parameter specification and standardized output, could greatly reduce heterogeneity in CDP estimation and promote repeatability of study results.","preprint_author_corresponding":"Maria Pia Sormani","preprint_author_corresponding_institution":"Department of Health Sciences (DISSAL), University of Genova, Genova, Italy"},{"preprint_doi":"10.1101\/2024.04.29.24306520","published_doi":"10.1002\/pds.5887","published_journal":"Pharmacoepidemiology and Drug Safety","preprint_platform":"medRxiv","preprint_title":"The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia","preprint_authors":"Zoega, H.; Falster, M. O.; Gillies, M. B.; Litchfield, M.; Camacho, X.; Bruno, C.; Daniels, B.; Donnolley, N.; Havard, A.; Schaffer, A. L.; Chambers, G.; Degenhardt, L.; Dobbins, T.; Gisev, N.; Ivers, R.; Jorm, L.; Liu, B.; Vajdic, C. M.; Pearson, S.-A.","preprint_category":"public and global health","preprint_date":"2024-04-30","published_date":"2024-08-15","preprint_abstract":"The Medicines Intelligence (MedIntel) Data Platform is an anonymised linked data resource designed to generate real-world evidence on prescribed medicine use, safety, costs and cost-effectiveness in Australia. The platform comprises Medicare-eligible people who are [&ge;]18 years and residing in New South Wales (NSW), Australia, any time during 2005-2020, with linked data on dispensed prescription medicines (Pharmaceutical Benefits Scheme), health service use (Medicare Benefits Schedule), emergency department visits (NSW Emergency Department Data Collection), hospitalisations (NSW Admitted Patient Data Collection), cancer notifications (NSW Cancer Registry), fact and cause of death (National Death Index). Data are currently available to 2022, with approval to update the cohort and data collections annually.\n\nThe platform includes 7.4 million unique people across all years, covering 36.9% of the Australian adult population; the overall population increased from 4.8M in 2005 to 6.0M in 2020. As of 1 January 2019 (the last pre-pandemic year), the cohort had a mean age of 48.7 years (51.1% female), with most people (4.4M, 74.7%) residing in a major city. In 2019, 4.4M people (73.3%) were dispensed a medicine, 1.2M (20.5%) were hospitalised, 5.3M (89.4%) had a GP or specialist appointment, and 54 003 people died. Anti-infectives were the most prevalent medicines dispensed to the cohort in 2019 (43.1%), followed by nervous system (32.2%) and cardiovascular system medicines (30.2%).\n\nThe MedIntel Data Platform creates opportunities for national and international research collaborations and enables us to address contemporary clinically- and policy-relevant research questions about quality use of medicines and health outcomes in Australia and globally.\n\nFive Key PointsO_LIThe Medicines Intelligence (MedIntel) Data Platform is a purpose-built, real-world data resource designed to generate evidence on prescribed medicine use, safety, costs and cost-effectiveness in Australia\nC_LIO_LIThis is a whole of population anonymised linkage of medicine and health records of Medicare-eligible adults ([&ge;]18 years) residing in Australias most populous state, New South Wales, from 2005 onwards\nC_LIO_LIThe platform comprised 7.4M unique people across all years, representing 36.9% of the Australian adult population; the population increased from 4.8M in 2005 to 6.0M in 2020\nC_LIO_LIAs of 1 January 2019 (the last pre-pandemic year), the cohort had a mean age of 48.7 years (51.1% female), with most people (4.4M, 74.7%) residing in a major city\nC_LIO_LIThe MedIntel Data Platform creates unique research opportunities for national and international research collaborations exploring population-level medicine use and outcomes\nC_LI\n\nPlain Language SummaryThe Medicines Intelligence (MedIntel) Data Platform is a new linked data resource established to generate evidence on prescribed medicine use, safety, costs, and cost-effectiveness in Australia. It adheres to best practice privacy principles, with no identifying information available to researchers. The platform comprises Medicare-eligible people who are [&ge;]18 years and residing in New South Wales (NSW), Australia, any time during 2005-2020, with linked data on dispensed prescription medicines, Medicare services, emergency department visits, hospitalisations, cancer notifications, and deaths. In total, the platform includes 7.4 million unique people across all years, covering 36.9% of the Australian adult population. As of 1 January 2019 (the last pre-pandemic year), the cohort had a mean age of 48.7 years (51.1% female), with most people (4.4M, 74.7%) residing in a major city. In 2019, 4.4M people (73.3%) were dispensed a medicine (most commonly anti-infective, nervous system, and cardiovascular medicines), 1.2M (20.5%) were hospitalised, 5.3M (89.4%) had a GP or specialist appointment, and 54 003 people died. Data are available until 2022 with approval for annual updates. This platform creates opportunities for national and international research collaborations and enables us to address important questions about quality use of medicines and health outcomes.","preprint_author_corresponding":"Sallie-Anne Pearson","preprint_author_corresponding_institution":"School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Australia"},{"preprint_doi":"10.1101\/2024.01.31.24302094","published_doi":"10.1038\/s41433-024-03303-x","published_journal":"Eye","preprint_platform":"medRxiv","preprint_title":"Intraocular pressure, primary open-angle glaucoma and the risk of retinal vein occlusion: a Mendelian randomization mediation analysis","preprint_authors":"Katsimpris, A.; Baumeister, S.-E.; Voulgari, N. A.; Baurecht, H.; Kandarakis, S.; Nolde, M.","preprint_category":"ophthalmology","preprint_date":"2024-02-01","published_date":"2024-08-15","preprint_abstract":"BackgroundThe etiological connection between intraocular pressure (IOP) and the risk of retinal vein occlusion (RVO) remains elusive, particularly regarding whether this risk emanates from the direct influence of elevated intraocular pressure (IOP), irrespective of the presence of primary open-angle glaucoma (POAG), or if it arises as a consequence of the sequelae of POAG. Therefore, we conducted a Mendelian Randomization (MR) mediation analysis to elucidate the mediating role of POAG in the association between IOP and RVO.\n\nMethodsWe identified 47 single-nucleotide polymorphisms (SNPs) associated with IOP (P-value < 5x10-8) leveraging data from a genome-wide association study (GWAS) (N = 97,653) obtained from the UK Biobank and 50 SNPs associated with POAG (P-value < 5x10-8) from a GWAS meta-analysis (16,677 cases and 199,580 controls). We related these SNPs with RVO using a GWAS of 775 RVO cases and 376,502 controls from FinnGen. By utilizing univariable and multivariable MR analyses we calculated the total effect of IOP on RVO and estimated the degree to which POAG mediates this association.\n\nResultsMR analyses showed that higher IOP is associated with higher RVO risk (odds ratio of RVO per 1 mmHg increase in IOP: 1.53; 95% confidence interval: 1.04 to 2.26; p-value = 0.03). Moreover, our MR mediation analysis suggested that 91.6% of the total effect of IOP on RVO risk was mediated through POAG. The primary results were consistent with estimates of pleiotropy-robust MR methods.\n\nConclusionOur findings suggest that higher IOP increases the risk of RVO and that the majority of this effect is mediated through POAG.","preprint_author_corresponding":"Andreas Katsimpris","preprint_author_corresponding_institution":"Princess Alexandra Eye Pavilion, University of Edinburgh, Edinburgh, UK"},{"preprint_doi":"10.1101\/2024.02.15.24302809","published_doi":"10.1371\/journal.pntd.0012409","published_journal":"PLOS Neglected Tropical Diseases","preprint_platform":"medRxiv","preprint_title":"Demographic characteristics and clinical features of patients presenting with different forms of cutaneous leishmaniasis, in Lay Gayint, Northern Ethiopia","preprint_authors":"Yizengaw, E.; Gashaw, B.; Yimer, M.; Takele, Y.; Nibret, E.; Yismaw, G.; Cruz Cervera, E.; Ejigu, K.; Tamiru, D.; Munshea, A.; Muller, I.; Weller, R.; Cotton, J. A.; Chapman, L. A.; Kropf, P.","preprint_category":"epidemiology","preprint_date":"2024-02-18","published_date":"2024-08-15","preprint_abstract":"Cutaneous leishmaniasis (CL) is a neglected tropical disease caused by Leishmania parasites, that can cause long-term chronic disabilities. The clinical presentation of CL varies in both type and severity. CL presents as three main clinical forms: localised lesions (localised cutaneous leishmaniasis, LCL); mucocutaneous leishmaniasis (MCL) that affects the mucosa of the nose or the mouth; or as disseminated not ulcerating nodules (diffuse cutaneous leishmaniasis, DCL).\n\nHere we recruited a cohort of CL patients in a newly established leishmaniasis treatment centre (LTC) in Lay Gayint, Northwest Ethiopia, and collected detailed demographic and clinical data.\n\nThe results of our study show that more males than females present to the LTC to seek diagnosis and treatment. 70.2% of CL patients presented with LCL and 20.8% with MCL. A small number of patients presented with DCL, recidivans CL (a rare form of CL where new lesions appear on the edges of CL scars) or with a combination of different clinical presentations. The duration of illness varied from 1 month to 180 months. Over a third of CL patients had additional suspected CL cases in their household. Despite the majority of CL patients having heard about CL, only a minority knew about its transmission or that it could be treated. Most CL patients lived in areas where environmental factors known to be associated with the transmission of CL were present.\n\nThis work highlights that CL is an important public health problem in Lay Gayint and emphasises the urgent need for more CL awareness campaigns, better health education and better disease management practices.","preprint_author_corresponding":"Pascale Kropf","preprint_author_corresponding_institution":"Imperial College London"},{"preprint_doi":"10.1101\/2024.01.07.24300896","published_doi":"10.3389\/fonc.2024.1398411","published_journal":"Frontiers in Oncology","preprint_platform":"medRxiv","preprint_title":"Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures and serum samples from a European Caucasian population","preprint_authors":"Toscano-Guerra, E.; Maggio, V.; Garcia, J.; Semidey, M. E.; Celma, A.; Morote, J.; Torres, I.; Giralt, M.; Ferrer, R.; Paciucci, R.","preprint_category":"genetic and genomic medicine","preprint_date":"2024-01-08","published_date":"2024-08-15","preprint_abstract":"Prostate cancer (PCa) is the most common cancer in men and the third leading cause of cancer death in Europe. The TP53 gene, the most frequently mutated gene in human cancer, is a tumor suppressor gene with crucial functions in preventing tumor development. The single nucleotide polymorphism rs1042522, characterized by the substitution of a proline (PRO) for an arginine (ARG) at the position 72 of the p53 protein (P72R SNP), was studied in 12 primary tumor cultures from prostate biopsies of untreated hormone-naive patients (hnPCs) with aggressive-metastatic cancer (Gleason [&ge;]8), 11 radical prostatectomies, and a cohort of 94 serums from patient with aggressive prostate cancer using DNA sequencing and melting curve analysis. The results identified a high frequency of the P72R SNP in prostate cancer samples compared to the general European (non-cancer) population, suggesting a very significant association (p<0.0001) between this SNP and the risk of prostate cancer with an odds ratio of 7.937 (IC 95% 5.37-11.00). The G allele (R72) was more frequent in patients with high Gleason scores ([&ge;]8) suggesting its association to more undifferentiated-malignant PCa lesions.","preprint_author_corresponding":"Emily Toscano-Guerra","preprint_author_corresponding_institution":"Vall d\\'Hebron Institut de Recerca"},{"preprint_doi":"10.1101\/2024.01.18.24301032","published_doi":"10.1097\/QAI.0000000000003504","published_journal":"JAIDS Journal of Acquired Immune Deficiency Syndromes","preprint_platform":"medRxiv","preprint_title":"Evaluation of four interventions using behavioural economics insights to increase demand for voluntary medical male circumcision in South Africa through the MoyaApp: A quasi-experimental study","preprint_authors":"Mistri, P.; Tomescu, S. M.; Bokolo, S. S.; de Nooy, A.; Pisa, P.; Grove, S.; Schmucker, L.; Chetty-Makkan, C. M.; Long, L.; Buttenheim, A.; Maughan-Brown, B.","preprint_category":"hiv aids","preprint_date":"2024-01-20","published_date":"2024-08-09","preprint_abstract":"BackgroundWhile voluntary medical male circumcision (VMMC) reduces the risk of HIV transmission by 60%, circumcision coverage falls short of the UNAIDS 90% target. We investigated whether behaviourally informed message framing increased demand for VMMC.\n\nSettingAdult users of the MoyaApp, a data free application in South Africa, who viewed a form designed to generate interest in VMMC during August-November 2022.\n\nMethodsA quasi-experimental study was conducted to evaluate four MoyaApp VMMC intervention forms against the Standard of Care (SOC) form. All forms enabled users to provide contact details for follow-up engagement by a call centre. The primary outcome was the proportion of forms submitted. Secondary outcomes included successful contact with the user, VMMC bookings\/referrals and confirmed circumcision. Multivariable ordinary least-squares regression was used for the analysis.\n\nResultsMoyaApp VMMC form viewers totalled 118,337 of which 6% submitted a form. Foot-in-the-Door form viewers were more likely (+1.3 percentage points, p<0.01) to submit a form compared to the SOC group (6.3%). Active Choice (-1.1 percentage points, p<0.01) and Reserved for You (-0.05 percentage points, p<0.05) form viewers were less likely to submit a form compared to SOC. Users submitting on Foot-in-the-Door were less likely to be booked\/referred compared to SOC (-5 percentage points, p<0.05). There were no differences between the intervention and SOC forms for successful contact and circumcisions.\n\nConclusionsMessage framing using behavioural insights was able to nudge men to engage with VMMC services. However, more work is needed to understand how to convert initial interest into bookings and circumcisions.\n\nTrial registrationO_LISouth African Clinical Trials Registry DOH-27-062022-7811\nC_LIO_LIPan-African Clinical Trials Registry PACTR202112699416418\nC_LI","preprint_author_corresponding":"Preethi Mistri","preprint_author_corresponding_institution":"Health Economics and Epidemiology Research Office, Wits Health Consortium, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Afri"},{"preprint_doi":"10.1101\/2023.11.17.23298635","published_doi":"10.1007\/s40264-024-01471-z","published_journal":"Drug Safety","preprint_platform":"medRxiv","preprint_title":"Unveiling the Hidden Toll of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.","preprint_authors":"Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2023-11-17","published_date":"2024-08-15","preprint_abstract":"IntroductionImpulsivity induced by dopaminergic agents, like pramipexole and aripiprazole, can lead to behavioral addictions impacting social functioning and quality of life of patients and families (e.g., resulting in unemployment, marital problems, anxiety). These secondary effects, interconnected in networks of signs and symptoms, are usually overlooked by clinical trials, not reported in package inserts, and neglected in clinical practice.\n\nObjectiveThis study explores the syndromic burden of impulsivity induced by pramipexole and aripiprazole, pinpointing key symptoms for targeted mitigation.\n\nMethodsAn event-event Information Component (IC) on the FDA Adverse Event Reporting System (January 2004 - March 2022) identified the syndrome of events disproportionally co-reported with impulsivity, separately for pramipexole and aripiprazole. A greedy-modularity clustering on composite network analyses (PPMI, Ising, {Phi}) identified subsyndromes. Bayesian network modeling highlighted possible precipitating events.\n\nResultsSuspected drug-induced impulsivity was documented in 7.49% pramipexole and 4.50% aripiprazole recipients. The highest IC concerned obsessive-compulsive disorder (reporting rate = 26.77%; IC median = 3.47, 95%CI = 3.33-3.57) and emotional distress (21.35%; 3.42, 3.26-3.54) for pramipexole, bankruptcy (10.58%; 4.43, 4.26-4.55) and divorce (7.59%; 4.38, 4.19-4.53) for aripiprazole. The network analysis identified delusional jealousy and dopamine dysregulation subsyndromes for pramipexole, obesity-hypoventilation and social issues for aripiprazole. The Bayesian network highlighted anxiety and economic problems as potentially precipitating events.\n\nConclusionThe under-explored consequences of drug-induced impulsivity significantly burden patients and families. Network analyses, exploring syndromic reactions and potential precipitating events, complement traditional techniques and clinical judgment. Characterizing the secondary impact of reactions will support informed patient-centered decision-making.\n\nHighlightsO_LIDrug-induced impulsivity significantly impacts patients lives. Network analyses help characterize reactions as syndromes.\nC_LIO_LIWe explore the impulsivity syndrome and subsyndromes resulting from pramipexole and aripiprazole.\nC_LIO_LIThe manifestation of drug-induced impulsivity was different for the two drugs. Anxiety and economic problems bridge between other symptoms and could be important therapeutical targets.\nC_LI","preprint_author_corresponding":"Michele Fusaroli","preprint_author_corresponding_institution":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Italy"},{"preprint_doi":"10.1101\/2022.12.19.22283408","published_doi":"10.1016\/j.drugalcdep.2024.112415","published_journal":"Drug and Alcohol Dependence","preprint_platform":"medRxiv","preprint_title":"Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour","preprint_authors":"Foo, J. C.; Streit, F. .; Frank, J.; Zachrias, N.; Zillich, L.; Sirignano, L.; Voelker, M. P.; Nuernberg, P.; Wienker, T.; Wagner, M.; Noethen, M. M.; Nothnagel, M.; Walter, H.; Lenz, B.; Spanagel, R.; Kiefer, F.; Winterer, G.; Rietschel, M.; Witt, S. H.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2022-12-19","published_date":"2024-08-15","preprint_abstract":"IntroductionFormal genetics studies show that smoking is influenced by genetic factors; exploring this on the molecular level can offer deeper insight into the etiology of smoking behaviours.\n\nMethodsSummary statistics from the GWAS and Sequencing Consortium of Alcohol and Nicotine (GSCAN) Consortium were used to calculate polygenic risk scores (PRS) in a sample of [~]2,200 smokers\/never-smokers. The association of PRS for Smoking Initiation (i.e. Lifetime Smoking; SI-PRS) with smoking status, and PRS for Cigarettes per Day (CpD-PRS) and Smoking Cessation (SC-PRS) with Fagerstrom Test for Nicotine Dependence (FTND) score were examined, as were distinct\/additive effects of parental smoking on smoking status.\n\nResultsSI-PRS explained 6.65% of variance (Nagelkerke-R2) in smoking status (p=1.71x10-24). In smokers, CpD-PRS (R2=3.15%, p=1.82x10-8) and SC-PRS (R2=2.01%; p=7.18x10-6) were associated with FTND score. Parental smoking alone explained R2=3.06% (p=2.43x10-12) of smoking status, and 1.39% when added to the most informative SI-PRS model (total R{superscript 2}=8.04%).\n\nConclusionThese results show the potential utility of molecular genetic data for research investigating smoking prevention. The fact that PRS explains more variance than family history highlights progress from formal to molecular genetics; the overlap and increased predictive value when using both suggests the importance of combining these approaches.\n\nImplicationsThis study underlines the value of using PRS to predict smoking status\/behaviour. It highlights the importance of molecular genetic methods in research investigating smoking prevention and points to the necessity of combining family history and molecular genetic data.","preprint_author_corresponding":"Stephanie H Witt","preprint_author_corresponding_institution":"Central Institute of Mental Health"},{"preprint_doi":"10.1101\/2022.04.28.22274426","published_doi":"10.31191\/afrijcmr.v7i1.123","published_journal":"African Journal of Current Medical Research","preprint_platform":"medRxiv","preprint_title":"Patient satisfaction in the use of non-pharmacological therapies in the management of postoperative pain: a study in a tertiary hospital, Ghana","preprint_authors":"Tano, P. F.; Apiribu, F.; Tano, E. K.; Agambire, R.; Boateng, I.; Sefah, V.","preprint_category":"nursing","preprint_date":"2022-04-28","published_date":"2024-08-16","preprint_abstract":"BackgroundNon-pharmacological therapies are the non-medicinal methods used in postoperative pain (POP) management by health care practitioners such as massage, positioning, breathing exercise, music therapy, and distraction. It has been discovered that therapies that are non-pharmacological for the relief of pain are effective with minimal side effects. Studies have also revealed that non-pharmacological interventions in the management of pain lessen or alter pain perception by decreasing intensity and intensifying the tolerance of pain. This study, therefore, seeks to determine how frequently non-pharmacological methods (NPMs) are used in the management of POP and the influence of these NPMs on patient satisfaction\n\nMethodsThis study was a descriptive cross-sectional design. A quantitative approach was utilized with a structured questionnaire to obtain responses from patients from October to December 2019. The study was conducted in the female and male surgical wards of Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. 138 patients within the first 72 hours post-operative period who consented and fulfilled the inclusion criteria were enrolled in the study. A convenience sampling method was used to collect the data. Inferential and descriptive statistics were used in analyzing the data.\n\nResultsThe majority of the patients, 52.2% responded to using some form of (NPMs) for pain relief. The most widely used non-pharmacological method of pain relief was walking representing 79.2%, followed by relaxation 5 (6.8%), distraction 4 (5.6%), listening to music 3 (4.2%), deep breathing 2 (2.8%), and meditation 1 (1.4%). The male participants were observed to use more NPMs of pain relief as compared to the females. Most of the patients (51.4%) who used NPMs for their pain relief reported having their pain not relieved. A majority (90.6%) of the participants desired for more pain treatment. The type of surgery the patients underwent had a statistically significant negative correlation with the use of NPMs of pain relief (Spearman Correlation Coefficient = -0.233, p-value <0.05). A higher percentage (71%) of participants were highly satisfied with the overall pain treatment received.\n\nConclusionNon-pharmacological management of POP have been proven to be efficient, inexpensive, and have little or no side effect on patients. There should be continuous education on non-pharmacological management of POP to nurses and other healthcare professionals to help promote the efficiency of intervening in postoperative pain with these methods.","preprint_author_corresponding":"Priscilla  Felicia Tano","preprint_author_corresponding_institution":"Komfo Anokye Teaching Hospital"},{"preprint_doi":"10.1101\/2024.04.16.24305805","published_doi":"10.1002\/ctm2.1796","published_journal":"Clinical and Translational Medicine","preprint_platform":"medRxiv","preprint_title":"Pan-cancer proteogenomic landscape of whole-genome doubling reveals putative therapeutic targets in various cancer types","preprint_authors":"Chang, E.; Hwang, H. S.; Song, K. J.; Kim, K.; Kim, M.-S.; Jang, S. J.; Kim, K. P.; You, S.; An, J.-Y.","preprint_category":"oncology","preprint_date":"2024-04-18","published_date":"2024-08-16","preprint_abstract":"BackgroundWhole-genome doubling (WGD) is prevalent in cancer and drives tumor development and chromosomal instability. Driver mutations in mitotic cell cycle genes and cell cycle upregulation have been reported as the major molecular underpinnings of WGD tumors. However, the underlying genomic signatures and regulatory networks involved in gene transcription and kinase phosphorylation remain unclear. Here, we aimed to comprehensively decipher the molecular landscape underlying WGD tumors.\n\nMethodsWe performed a pan-cancer proteogenomic analysis and compared 10 cancer types by integrating genomic, transcriptomic, proteomic, and phosphoproteomic datasets from the Clinical Proteomic Tumor Analysis Consortium (CPTAC). We also integrated the cancer dependency data of each cancer cell line and the survival properties of each cancer patient to propose promising therapeutic targets for patients with WGD.\n\nResultsOur study delineated distinct copy number signatures characterizing WGD-positive tumors into three major groups: highly unstable genome, focal instability, and tetraploidy. Furthermore, the analysis revealed the heterogeneous mechanisms underlying WGD across cancer types with specific structural variation patterns. Upregulation of the cell cycle and downregulation of the immune response were found to be specific to certain WGD tumor types. Transcription factors (TFs) and kinases exhibit cancer-specific activities, emphasizing the need for tailored therapeutic approaches.\n\nConclusionThis study introduces an integrative approach to identify potential TF targets for drug development, highlighting BPTF as a promising candidate for the treatment of head and neck squamous cell carcinoma. Additionally, drug repurposing strategies have been proposed, suggesting potential drugs for the treatment of WGD-associated cancers. Our findings offer insights into the heterogeneity of WGD and have implications for precision medicine approaches for cancer treatment.","preprint_author_corresponding":"Joon-Yong An","preprint_author_corresponding_institution":"Korea University"},{"preprint_doi":"10.1101\/2023.10.12.23296977","published_doi":"10.1016\/j.heares.2024.109103","published_journal":"Hearing Research","preprint_platform":"medRxiv","preprint_title":"The Audible Contrast Threshold (ACT\u2122) test: a clinical spectro-temporal modulation detection test","preprint_authors":"Zaar, J.; Simonsen, L. B.; Sanchez-Lopez, R.; Laugesen, S.","preprint_category":"otolaryngology","preprint_date":"2023-10-13","published_date":"2024-08-16","preprint_abstract":"Over the last decade, multiple studies have shown that hearing-impaired listeners speech-in-noise reception ability, measured with audibility compensation, is closely associated with performance in spectro-temporal modulation (STM) detection tests. STM tests thus have the potential to provide highly relevant beyond-the-audiogram information in the clinic, but the available STM tests have not been optimized for clinical use in terms of test duration, required equipment, and procedural standardization. The present study introduces a quick-and-simple clinically viable STM test, named the Audible Contrast Threshold (ACT) test. First, an experimenter-controlled STM measurement paradigm was developed, in which the patient is presented binaurally with a continuous audibility-corrected noise via headphones and asked to press a pushbutton whenever they hear an STM target sound in the noise. The patients threshold is established using a Hughson-Westlake tracking procedure with a three-out-of-five criterion and then refined by post-processing the collected data using a logistic function. Different stimulation paradigms were tested in 28 hearing-impaired participants and compared to data previously measured in the same participants with an established STM test paradigm. The best stimulation paradigm showed excellent test-retest reliability and good agreement with the established laboratory version. Second, the best stimulation paradigm with 1-second noise \"waves\" (windowed noise) was chosen, further optimized with respect to step size and logistic-function fitting, and tested in a population of 25 young normal-hearing participants using various types of transducers to obtain normative data. Based on these normative data, the \"normalized Contrast Level\" (in dB nCL) scale was defined, where 0{+\/-}4 dB nCL corresponds to normal performance and the greater the positive value of dB nCL, the greater the audible contrast loss. Overall, the results of the present study indicate that the ACT test may be considered a reliable, quick-and-simple (and thus clinically viable) test of STM sensitivity. The ACT can be measured directly after the audiogram using the same set up, adding only a few minutes to the process.\n\nCITE AS1) In text: Zaar\/Simonsen et al. (2023)\n2) In reference list: Zaar, J.\/Simonsen L. B., Sanchez-Lopez, R., and Laugesen, S. (2023): \"The Audible Contrast Threshold (ACT) test: a clinical spectro-temporal modulation detection test,\" medRxiv.","preprint_author_corresponding":"Johannes Zaar","preprint_author_corresponding_institution":"Eriksholm Research Centre, Technical University of Denmark"},{"preprint_doi":"10.1101\/2024.03.14.24304184","published_doi":"10.1186\/s12911-024-02630-z","published_journal":"BMC Medical Informatics and Decision Making","preprint_platform":"medRxiv","preprint_title":"Predicting Sepsis Mortality Using Machine Learning Methods","preprint_authors":"Gao, J.; Lu, Y.; Domingo, I. R.; Alaei, K.; Pishgar, M.","preprint_category":"health informatics","preprint_date":"2024-03-16","published_date":"2024-08-16","preprint_abstract":"ProblemSepsis, a life-threatening condition, accounts for the deaths of millions of people worldwide. Accurate prediction of sepsis outcomes is crucial for effective treatment and management. Previous studies have utilized machine learning for prognosis, but have limitations in feature sets and model interpretability.\n\nAimThis study aims to develop a machine learning model that enhances prediction accuracy for sepsis outcomes using a reduced set of features, thereby addressing the limitations of previous studies and enhancing model interpretability.\n\nMethodsThis study analyzes intensive care patient outcomes using the MIMIC-IV database, focusing on adult sepsis cases. Employing the latest data extraction tools, such as Google Big- Query, and following stringent selection criteria, we selected 38 features in this study. This selection is also informed by a comprehensive literature review and clinical expertise. Data preprocessing included handling missing values, regrouping categorical variables, and using the Synthetic Minority Over-sampling Technique (SMOTE) to balance the data. We evaluated several machine learning models: Decision Trees, Gradient Boosting, XGBoost, LightGBM, Multilayer Perceptrons (MLP), Support Vector Machines (SVM), and Random Forest. The Sequential Halving and Classification (SHAC) algorithm was used for hyperparameter tuning, and both train-test split and cross-validation methodologies were employed for performance and computational efficiency.\n\nResultsThe Random Forest model was the most effective, achieving an area under the receiver operating characteristic curve (AUROC) of 0.94 with a confidence interval of {+\/-}0.01. This significantly outperformed other models and set a new benchmark in the literature. The model also provided detailed insights into the importance of various clinical features, with the Sequential Organ Failure Assessment (SOFA) score and average urine output being highly predictive. SHAP (Shapley Additive Explanations) analysis further enhanced the models interpretability, offering a clearer understanding of feature impacts.\n\nConclusionThis study demonstrates significant improvements in predicting sepsis outcomes using a Random Forest model, supported by advanced machine learning techniques and thorough data preprocessing. Our approach provided detailed insights into the key clinical features impacting sepsis mortality, making the model both highly accurate and interpretable. By enhancing the models practical utility in clinical settings, we offer a valuable tool for healthcare professionals to make data-driven decisions, ultimately aiming to minimize sepsis-induced fatalities.","preprint_author_corresponding":"Maryam Pishgar","preprint_author_corresponding_institution":"University of Southern California"},{"preprint_doi":"10.1101\/2023.08.15.23294144","published_doi":"10.1038\/s41598-024-70001-9","published_journal":"Scientific Reports","preprint_platform":"medRxiv","preprint_title":"A sweat lactate sensor for detecting anaerobic threshold in patients with heart failure: a prospective clinical trial (LacS-001)","preprint_authors":"KATSUMATA, Y.; Muramoto, Y.; Ishida, N.; Takemura, R.; Nagashima, K.; Ikoma, T.; Kawamatsu, N.; Araki, M.; Goda, A.; Okawara, H.; Sawada, T.; Kawakubo, Y.; Hattori, O.; Yamaoka, K.; Seki, Y.; Ryuzaki, T.; Ikura, H.; Nakashima, D.; Nagura, T.; Nakamura, M.; Sato, K.; Shiraishi, Y.","preprint_category":"sports medicine","preprint_date":"2023-08-17","published_date":"2024-08-16","preprint_abstract":"BackgroundThe ventilatory threshold (VT), which requires an expensive analyzer and expertise in assessment, has not been widely and conveniently used in a clinical setting. This prospective clinical trial (LacS-001) aimed to investigate the safety of a lactate-monitoring sweat sensor, and the correlation between the lactate threshold in sweat (sLT) and the VT, to establish a simple method for determining the anaerobic threshold in patients with heart failure (HF).\n\nMethodsWe recruited 50 patients with HF and New York Heart Association functional classification I-II, with a median age of 63.5 years (interquartile range: 58.0-72.0 years). Incremental exercise tests were conducted, and changes in sweat lactate levels were monitored simultaneously. sLT was defined as the first steep increase in lactate levels from baseline and was evaluated by three independent investigators. The primary outcome measures were a correlation coefficient of 0.6 or greater between sLT and VT, the similarities as assessed by the Bland-Altman analysis, and the standard deviation of the difference between sLT and VT within 15 W.\n\nResultsAmong the 50 patients, a correlation coefficient of 0.651 (95% confidence interval, 0.391-0.815) was achieved in 32 cases. The difference between sLT and VT was -4.9{+\/-}15.0 W, and no comparative error was noted in the Bland-Altman plot. No device-related adverse events were reported among the registered patients.\n\nConclusionsOur sweat lactate sensor provides a safe and accurate means of detecting VT in patients with HF in a clinical setting, thereby offering valuable additional information for treatment.\n\nClinical PerspectiveO_ST_ABSWhat is new?C_ST_ABSO_LISuccessful real-time and continuous monitoring of sweat lactate levels with this experimental device during progressive exercise testing in patients with NYHA class I and II HF.\nC_LIO_LIsLT determined by sweat lactate monitoring correlated strongly with VT, suggesting that VT can be detected with sufficient clinical accuracy.\nC_LIO_LIPatients with intermediate sweat rates are good candidates for determining sLT.\nC_LIO_LIGiven the difficulties presented by the current methods for determining VT, the monitoring of lactate values in sweat by our sensors could be helpful for improving VT detection.\nC_LI\n\nWhat are the clinical implications?O_LIOur sweat lactate sensor provides a safe and accurate means of detecting ventilatory threshold (VT) in patients with heart failure in a clinical setting.\nC_LIO_LIA correlation coefficient of 0.651 (95% confidence interval, 0.391-0.815) was achieved with -4.9{+\/-}15.0 W as the difference between the lactate threshold in sweat and VT and no comparative error.\nC_LIO_LINo device-related adverse events were reported among the registered patients.\nC_LI","preprint_author_corresponding":"YOSHINORI KATSUMATA","preprint_author_corresponding_institution":"Keio University School of Medicine"},{"preprint_doi":"10.1101\/2023.08.24.23294584","published_doi":"10.1093\/ofid\/ofae465","published_journal":"Open Forum Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Epidemiology of pediatric astrovirus gastroenteritis in a Nicaraguan birth cohort","preprint_authors":"Rubinstein, R. J.; Reyes, Y.; Gonzalez, F.; Gutierrez, L.; Toval-Ruiz, C.; Hammond, K.; Bode, L.; Vinje, J.; Vilchez, S.; Becker-Dreps, S.; Bucardo, F.; Vielot, N. A.","preprint_category":"infectious diseases","preprint_date":"2023-08-25","published_date":"2024-08-13","preprint_abstract":"BackgroundAstrovirus is a leading cause of acute gastroenteritis in children worldwide. However, few prospective studies have analyzed astrovirus in community-dwelling pediatric populations in low-and-middle-income countries.\n\nMethodsWe assessed the incidence, risk factors, clinical characteristics, genotypes, viral coinfections and seasonality of astrovirus gastroenteritis in 443 healthy Nicaraguan children born in 2017-2018, followed for 36 months. Children were recruited from maternity hospitals and birth records in an economically-diverse neighborhood of Leon, the second-largest city in Nicaragua. Astrovirus-positive episodes and genotypes were identified from diarrheal specimens with reverse transcription quantitative polymerase chain reaction and Sanger sequencing.\n\nResultsOf 1708 total specimens tested, eighty children (18%) experienced at least 1 astrovirus episode, and 9 experienced repeat episodes, mostly during the rainy season (May-October). The incidence of astrovirus episodes was 7.8\/100 child-years (95% CI: 6.2, 9.8). Genotype-specific incidence of astrovirus also exhibited seasonality. Median age of astrovirus episode onset was 16 months (IQR 9, 23). Initial astrovirus episodes were not associated with protection against future episodes during the age span studied. Astrovirus cases were exclusively breastfed for a shorter period than uninfected children, and the human milk oligosaccharide lacto-N-fucopentaose-I was more concentrated in mothers of these children. Home toilets appeared to protect against future astrovirus episodes (HR=0.19, 95% CI 0.04-0.91). Human astrovirus-5 episodes, comprising 15% of all typed episodes, were associated with longer diarrhea and more symptomatic rotavirus co-infections.\n\nConclusionAstrovirus was a common cause of gastroenteritis in this cohort, and future studies should clarify the role of astrovirus genotype in clinical infection severity.","preprint_author_corresponding":"Rebecca Judith Rubinstein","preprint_author_corresponding_institution":"University of North Carolina at Chapel Hill"},{"preprint_doi":"10.1101\/2024.01.07.24300955","published_doi":"10.1038\/s41598-024-70023-3","published_journal":"Scientific Reports","preprint_platform":"medRxiv","preprint_title":"Phylogeography and reassortment patterns of human influenza A viruses in sub-Saharan Africa","preprint_authors":"Owuor, D. C.; de Laurent, Z. R.; Oketch, J. W.; Murunga, N.; Otieno, J. R.; Chaves, S. S.; Nokes, J.; Agoti, C. N.","preprint_category":"infectious diseases","preprint_date":"2024-01-09","published_date":"2024-08-16","preprint_abstract":"BackgroundThe role of sub-Saharan Africa in the global spread of influenza viruses remains unclear due to insufficient spatiotemporal sequence data.\n\nMethodsHere, we analyzed 222 codon-complete sequences of influenza A viruses (IAVs) sampled between 2011 and 2013 from five countries across sub-Saharan Africa (Kenya, Zambia, Mali, Gambia, and South Africa); these genomes were compared with 1,209 contemporaneous global genomes using phylogeographical approaches.\n\nResultsThe spread of influenza in sub-Saharan Africa was characterized by (i) multiple introductions of IAVs into the region over consecutive influenza seasons, with viral importations originating from multiple global geographical regions, some of which persisted in circulation as intra-subtype reassortants for multiple seasons, (ii) virus transfer between sub-Saharan African countries, and (iii) virus export from sub-Saharan Africa to other geographical regions.\n\nConclusionDespite sparse data from influenza surveillance in sub-Saharan Africa, our findings support the notion that influenza viruses persist as temporally structured migrating metapopulations in which new virus strains can emerge in any geographical region, including in sub-Saharan Africa; these lineages may have been capable of dissemination to other continents through a globally migrating virus population. Further knowledge of the viral lineages that circulate within understudied sub-Saharan Africa regions is required to inform vaccination strategies in those regions.","preprint_author_corresponding":"D. Collins Owuor","preprint_author_corresponding_institution":"Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme"},{"preprint_doi":"10.1101\/2023.06.26.23291248","published_doi":"10.1016\/j.jhlto.2024.100134","published_journal":"JHLT Open","preprint_platform":"medRxiv","preprint_title":"Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation","preprint_authors":"Miano, T. A.; Feng, R.; Griffiths, S.; Kalman, L.; Oyster, M.; Cantu, E.; Yang, W.; Diamond, J.; Christie, J.; Scheetz, M. H.; Shashaty, M.","preprint_category":"pharmacology and therapeutics","preprint_date":"2023-06-27","published_date":"2024-08-06","preprint_abstract":"BackgroundTacrolimus therapy is standard of care for immunosuppression after lung transplantation. However, tacrolimus exposure variability during the early postoperative period may contribute to poor outcomes in this population. Few studies have examined tacrolimus pharmacokinetics (PK) during this high-risk time period.\n\nMethodsWe conducted a retrospective pharmacokinetic study in lung transplant recipients at the University of Pennsylvania who were enrolled in the Lung Transplant Outcomes Group (LTOG) cohort. We derived a model in 270 patients using NONMEM (version 7.5.1) and examined validity in a separate cohort of 114 patients. Covariates were examined with univariate analysis and multivariable analysis was developed using forward and backward stepwise selection. Performance of the final model in the validation cohort was examined with calculation of mean prediction error (PE).\n\nResultsWe developed a one-compartment base model with a fixed rate absorption constant. Significant covariates in multivariable analysis were postoperative day, hematocrit, transplant type, CYP3A5 genotype, total body weight, and time-varying postoperative day, hematocrit, and CYP inhibitor drugs. The strongest predictor of tacrolimus clearance was postoperative day, with median predicted clearance increasing more than threefold over the 14 day study period. In the validation cohort, the final model showed a mean PE of 36.4% (95%CI 30.8%-41.9%) and a median PE of 7.2% (IQR -29.3%-70.53%).\n\nConclusionPostoperative day was the strongest predictor of tacrolimus exposure in the early post-lung transplant period. Future multicenter studies employing intensive sampling to examine a broad set of variables related to critical illness physiology are needed to understand determinants of clearance, volume of distribution and absorption in this population.","preprint_author_corresponding":"Todd A Miano","preprint_author_corresponding_institution":"Perelman School of Medicine at the University of Pennsylvania"},{"preprint_doi":"10.1101\/2024.01.22.24301635","published_doi":"10.1152\/ajpheart.00519.2024","published_journal":"American Journal of Physiology-Heart and Circulatory Physiology","preprint_platform":"medRxiv","preprint_title":"Constipation is associated with an increased risk of major adverse cardiac events in a UK population","preprint_authors":"Zheng, T.; Camargo Tavares, L.; D'Amato, M.; Marques, F. Z.","preprint_category":"cardiovascular medicine","preprint_date":"2024-01-24","published_date":"2024-08-16","preprint_abstract":"BackgroundTraditional cardiovascular risk factors, including hypertension, only explain part of major adverse cardiac events (MACE). Understanding what other risk factors contribute to MACE is essential for prevention. Constipation shares common risk factors with hypertension and is associated with an increased risk of several cardiovascular diseases. We hypothesised that constipation is an under-appreciated risk factor for MACE.\n\nMethodsWe used the population healthcare and genomic data in the UK Biobank (UKBB) (n=408,354) to study the contribution of constipation (ICD-10 K59.0) to the risk of MACE, defined by any episode of acute coronary syndrome (ACS), ischemic stroke and heart failure (HF). Analyses were controlled for traditional cardiovascular risk factors. We also assessed genetic correlations (rg) between constipation and MACE.\n\nResultsConstipation cases (N=23,814) exhibited significantly higher risk of MACE compared to those with normal bowel habits (OR=2.15, P<1.00x10-300). Constipation was also significantly associated with individual MACE subgroups, in order: HF (OR=2.72, P<1.00x10-300), ischemic stroke (OR=2.36, P=2.02x10-230), and ACS (OR=1.62, P=5.82x10-113). In comparison with constipation-free hypertensive patients, hypertensive patients with constipation showed significantly higher odds of MACE (OR=1.68, P=1.05x10-136) and a 34% increased risk of death (P=2.3x10-50) after adjustment for medications that affect gut motility and other traditional cardiovascular risk factors. Finally, we detected positive genetic correlations between constipation and MACE subgroups ACS (rg=0.27, P=2.12x10-6), ischemic stroke (rg =0.23, P=0.011), and HF (rg =0.21, P=0.0062).\n\nConclusionWe identified constipation as a potential risk factor independently associated with higher MACE prevalence. These findings warrant further studies on their causal relationship and identification of pathophysiological mechanisms.","preprint_author_corresponding":"Francine Z. Marques","preprint_author_corresponding_institution":"Monash University"},{"preprint_doi":"10.1101\/2024.04.23.24305825","published_doi":"10.1158\/1078-0432.CCR-24-1563","published_journal":"Clinical Cancer Research","preprint_platform":"medRxiv","preprint_title":"Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome","preprint_authors":"Bartos, L. M.; Quach, S.; Zenatti, V.; Kirchleitner, S. V.; Blobner, J.; Wind-Mark, K.; Kolabas, Z. I.; Ulukaya, S.; Holzgreve, A.; Ruf, V. C.; Kunze, L. H.; Kunte, S. T.; Hoermann, L.; Marlies, H.; Ha-Eun, P.; Gross, M.; Franzmeier, N.; Zatcepin, A.; Zounek, A.; Kaiser, L.; Riemenschneider, M. J.; Perneczky, R.; Rauchmann, B.-S.; Stoecklein, S.; Ziegler, S.; Herms, J.; Ertuerk, A.; Tonn, J. C.; Thonn, N.; von Baumgarten, L.; Prestel, M.; Tahirovic, S.; Albert, N. L.; Brendel, M.","preprint_category":"oncology","preprint_date":"2024-04-24","published_date":"2024-08-16","preprint_abstract":"Local therapy strategies still provide only limited success in the treatment of glioblastoma, the most frequent primary brain tumor in adults, indicating global involvement of the brain in this fatal disease. To study the impact of neuroinflammation distant of the primary tumor site on the clinical course of patients with glioblastoma, we performed translocator protein (TSPO)-PET in patients with newly diagnosed glioblastoma, glioma WHO 2 and healthy controls and compared signals of the non-lesion (i.e. contralateral) hemisphere. Back-translation in syngeneic glioblastoma mice was used to characterize PET alterations on a cellular level. Ultimately, multiplex gene expression analyses served to profile immune cells in remote brain. Our study revealed elevated TSPO-PET signals in contralateral hemispheres of patients with newly diagnosed glioblastoma compared to healthy controls. Contralateral TSPO was associated with persisting epilepsy and short survival independent of the tumor phenotype. Back-translation pinpointed myeloid cells as the source of TSPO-PET signal increases and revealed a complex immune signature comprised of joint myeloid cell activation and immunosuppression in distant brain regions. In brief, neuroinflammation within the contralateral hemisphere is associated with poor outcome in patients with newly diagnosed glioblastoma. TSPO-PET serves to detect patients with global neuroinflammation who may benefit from immunomodulatory strategies.","preprint_author_corresponding":"Matthias Brendel","preprint_author_corresponding_institution":"Dept. of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany"}]}